Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Burlington County Public Health Profile Report: Quick Facts & Health Indicators

map of New Jersey showing county highlighted Burlington County
Health Department
For more information:
http://www.co.burlington.nj.us/290/Health-Department

County Seat: Mount Holly
Largest Municipalities: Evesham, Mount Laurel, Willingboro, Pemberton Twp
Select a
different
county:

Quick Facts

Burlington County New Jersey
Population (2018) 445,384 8,908,520
% of NJ Population (2018) 5.0% 100%
Land Area (sq mi) 798.58 7,354.22
Persons per Sq. Mile (2018) 557.7 1,211.3
Total Births (2018 - preliminary) 4,382 101,171
Total Deaths (2017) 4,202 74,881

You can find more Burlington County Quick Facts at US Census Bureau






Health Insurance Coverage: Percent uninsured, 2020

  • Burlington
    5.5%
    95% Confidence Interval (4.9% - 6.1%)
    State
    8.7%
    U.S.
    10.4%
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Lack of health insurance is strongly associated with lack of access to health care services, particularly preventive and primary care. The uninsured are significantly more likely to be in fair or poor health, to have unmet medical needs or surgical care, not to have had a physician or other health professional visit, and to lack satisfaction in quality of care received.

How Are We Doing?

With the implementation of the Affordable Care Act beginning in 2014, a distinct decrease was seen in the proportion of uninsured persons. The targets for persons under 19 years of age and Whites and Hispanics under 65 years of age were met by mid-decade. As of 2020, the targets for the total population and the black population under 65 years of age had not been met.

What Is Being Done?

NJ FamilyCare is a federal- and state-funded health insurance program created to help qualified New Jersey residents of any age access affordable health insurance. NJ FamilyCare is for people who do not have employer insurance. Beginning January 2014, NJ FamilyCare - New Jersey's publicly funded health insurance program - includes CHIP, Medicaid and Medicaid expansion populations. That means qualified NJ residents of any age may be eligible for free or low cost health insurance that covers doctor visits, prescriptions, vision, dental care, mental health and substance use services and even hospitalization.

Healthy People Objective AHS-1.1:

Increase the proportion of persons with health insurance: Medical insurance
U.S. Target: 100 percent

Related Indicators

Health Care System Factors:


Note

The margins of error used in SAHIE are 90% confidence levels.

Data Sources

US Census Bureau, Small Area Health Insurance Estimates (SAHIE), [https://www.census.gov/data-tools/demo/sahie/#/?s_statefips=34]  

Measure Description for Health Insurance Coverage

Definition: Percentage of New Jersey residents with or without health insurance coverage
Numerator: Number of persons surveyed who did or did not have health insurance coverage at the time of the interview
Denominator: Total number of persons in the survey sample

Indicator Profile Report

Health Insurance Coverage: (exits this report)

Date Content Last Updated

08/03/2023

For more information:

NJ State Health Assessment Data, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, nj.gov/health/shad




Personal Doctor or Health Care Provider: Estimated Percent, 2017-2020*

  • Burlington
    85.5
    95% Confidence Interval (82.6 - 88.0)
    State
    80.0
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

As each new health care need arises, an individual's first point of contact with the health care system is typically his or her personal doctor. In most cases a personal doctor can effectively and efficiently manage a patient's medical care because they understand that person's medical history and social background. Having a regular source of health care is also an indicator of overall access to care.

Risk and Resiliency Factors

Note: [https://www-doh.state.nj.us/doh-shad/query/builder/njbrfs/PriProvider/PriProviderCrude11_.html Custom data views] of self-reported access to a personal doctor or health care provider among New Jersey adults by selected '''sociodemographic and other characteristics''' can be generated using the New Jersey Behavioral Risk Factor Survey interactive query module.

How Are We Doing?

In 2020, 81.1% (crude rate) of New Jerseyans reported having at least one person they think of as their personal doctor or healthcare provider. Lack of a primary care provider was more common among young adults, especially males aged 18 to 34 (only 64% reported having a personal doctor in 2020).

Healthy People Objective AHS-3:

Increase the proportion of people with a usual primary care provider
U.S. Target: 83.9 percent
State Target: 90 percent

Note

*2019 data is not included in the average estimated prevalence. No data is available for 2019.

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Personal Doctor or Health Care Provider

Definition: Percentage of adults who reported having one or more persons they think of as their personal doctor or health care provider.
Numerator: Number of adults who reported having at least one person they think of as their personal doctor or health care provider.
Denominator: Total number of adults interviewed during the same survey period.

Indicator Profile Report

At Least One Primary Provider (exits this report)

Date Content Last Updated

10/11/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




First Trimester Prenatal Care: Percentage of Live Births, 2020

  • Burlington
    79.1%
    95% Confidence Interval (77.8% - 80.3%)
    State
    75.5%
    U.S.
    76.1%
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Women who receive early and consistent prenatal care (PNC) increase their likelihood of giving birth to a healthy child. Health care providers recommend that women begin prenatal care in the first trimester of their pregnancy.

How Are We Doing?

The percentage of mothers receiving first trimester prenatal care (PNC) had been about 75% for over a decade before increasing slightly between 2007 and 2014 to 79%. A change in data collection methods in 2014-2015 resulted in a sharp decline such that the rate now stands back at 75%. The Healthy New Jersey 2020 target was not met. There is a significant difference in onset of PNC by race/ethnicity with more than 80% of White and Asian mothers receiving early PNC compared to 66% of Hispanic and 63% of Black mothers. However, in recent years the rates among Blacks and Asians increased such that their Healthy New Jersey 2020 targets were met, while those for Whites and Hispanics were not.

What Is Being Done?

The [http://nj.gov/health/fhs/ Division of Family Health Services] in the New Jersey Department of Health administers programs to enhance the health, safety and well-being of families and communities in New Jersey. Several programs are aimed at improving birth outcomes. The [https://nj.gov/governor/admin/fl/nurturenj.shtml Nurture NJ] campaign focuses on improving collaboration and programming between all departments, agencies, and stakeholders to make New Jersey the safest and most equitable place in the nation to give birth and raise a baby.

Healthy People Objective MICH-10.1:

Prenatal care beginning in first trimester
U.S. Target: 77.9 percent
State Target: 75.7 percent

Related Indicators

Health Care System Factors:


Note

Beginning in 2014, the calculation of onset of prenatal care (PNC) requires several pieces of information from the birth record. If any of those is missing or invalid, PNC onset cannot be calculated.  The calculation of onset of prenatal care (PNC) requires several pieces of information from the birth record. If any of those is missing or invalid, PNC onset cannot be calculated. This problem is particularly high among births to Camden, Hudson, Passaic, and Salem County resident mothers where the proportion of records with unknown PNC onset is above the statewide rate of 1.9%.

Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Centers for Disease Control and Prevention, National Center for Health Statistics. Natality public-use data. CDC WONDER On-line Database accessed at [http://wonder.cdc.gov/natality.html]  

Measure Description for First Trimester Prenatal Care

Definition: Number of live births to pregnant women who received prenatal care in the first trimester as a percentage of the total number of live births.
Numerator: Number of live births to pregnant women who received prenatal care in the first trimester
Denominator: Number of live births

Indicator Profile Report

First Trimester Prenatal Care (exits this report)

Date Content Last Updated

05/19/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Cesarean Deliveries among Low Risk Women: Percentage of Low-Risk Births, 2020

  • Burlington
    22.6%
    95% Confidence Interval (20.6% - 24.8%)
    State
    26.2%
    U.S.
    25.9%
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Compared to vaginal deliveries, cesareans carry an increased risk of infection, blood clots, longer recovery, and difficulty with future pregnancies.

How Are We Doing?

The cesarean delivery rate among low risk (NTSV) births declined in 2010 for the first time since the mid-1990s and in 2020 stood at 26.2%. The rate is higher among Asian (30.2%) and Black (29.9%) mothers than among Hispanic (25.8%) and White (24.4%) mothers. The Healthy New Jersey 2020 target for all low-risk mothers and for Whites, Hispanics, and Asians were achieved. If the current trend continues, the target for Blacks will also be achieved within a year or two.

What Is Being Done?

In 2017, a team composed of DOH staff and external partners collaborated to develop a plan to reduce low risk c-sections in New Jersey hospitals. In 2018, DOH awarded [https://nj.gov/health/news/2018/approved/20180711a.shtml $4.7 million] to eight agencies to improve health outcomes among infants and mothers in New Jersey, including implementation of a doula pilot program to reduce the likelihood of certain birth and delivery/labor outcomes such as cesarean births. In 2021, the state [https://nj.gov/governor/news/news/562021/approved/20210202b.shtml Medicaid program began covering doula care], while also no longer paying for non-medical early elective deliveries. The same year, the [https://nurturenj.nj.gov/wp-content/uploads/2021/01/20210120-Nurture-NJ-Strategic-Plan.pdf Nurture NJ Strategic Plan] recommended that all NJ birthing hospitals meet or attain NTSV cesarean birth rates lower than the national target by instituting new, comprehensive informed consent processes for all maternity patients so that patients understand the short- and long-term risks of c-sections and the benefits of spontaneous labor for both parents and newborns. The Plan also recommended more aggressive action by state government agencies to ensure improvement, including limitations on participation in provider networks for hospitals who do not meet targets.[https://nurturenj.nj.gov/wp-content/uploads/2021/01/20210120-Nurture-NJ-Strategic-Plan.pdf#page=61 ^1^]

Healthy People Objective MICH-7.1:

Reduce cesarean births among low-risk (full-term, singleton, vertex presentation) women: Women with no prior births
U.S. Target: 24.7 percent
State Target: 27.9 percent

Related Indicators

Health Care System Factors:


Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health  

Measure Description for Cesarean Deliveries among Low Risk Women

Definition: The low-risk cesarean delivery rate is the percentage of cesarean deliveries among '''n'''ulliparous (first birth), '''t'''erm (37 completed weeks or more, based on the obstetric estimate), '''s'''ingleton (one fetus), '''v'''ertex (head first) births, sometimes referred to as NTSV births.
Numerator: Number of cesarean deliveries among nulliparous, full-term, singleton, vertex presentation (NTSV) births
Denominator: Total number of nulliparous, full-term, singleton, vertex presentation (NTSV) births

Indicator Profile Report

Low-Risk Cesarean Deliveries (exits this report)

Date Content Last Updated

05/19/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Vaginal Birth after Previous Cesarean: Percent of Live Births to Mothers with a Previous Cesarean, 2019-2021

  • Burlington
    16.5%
    95% Confidence Interval (15.0% - 18.1%)
    State
    14.5%
    U.S.
    13.9%
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

VBAC is associated with decreased maternal morbidity and a decreased risk of complications in future pregnancies.[https://www.ncbi.nlm.nih.gov/pubmed/30681543 ^1^]

How Are We Doing?

The vaginal birth after cesarean (VBAC) rate rose rapidly and steadily throughout the early 1990s but peaked in 1996 and began a rapid decline that lasted until 2008. The VBAC rate has been slowly but steadily increasing again since then. VBACs are much more common among residents of Ocean County than elsewhere in New Jersey.

Healthy People Objective MICH-7.2:

Reduce cesarean births among low-risk (full-term, singleton, vertex presentation) women: Prior cesarean birth
U.S. Target: 81.7 percent

Related Indicators

Health Care System Factors:


Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health  

Measure Description for Vaginal Birth after Previous Cesarean

Definition: A vaginal delivery by a mother who had a cesarean for one or more previous deliveries.
Numerator: Number of births delivered vaginally after a previous cesarean
Denominator: Total number of live births to mothers who previously had a cesarean

Indicator Profile Report

Vaginal Birth after Previous Cesarean (VBAC) (exits this report)

Date Content Last Updated

08/15/2023

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Childhood Lead Testing Coverage: Percent Tested, 2014

  • Burlington
    62.3%
    95% Confidence Interval NA
    State
    74.4%
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Lead is a heavy metal that has been widely used in industrial processes and consumer products. When absorbed into the human body, lead can have damaging effects on the brain and nervous system, kidneys, and blood cells. Lead exposure is particularly hazardous for pre-school children because their brains and nervous systems are still rapidly developing. Serious potential effects of lead exposure on the nervous system include: learning disabilities, hyperactivity, hearing loss and mental retardation. The primary method for lead to enter the body is through eating or breathing lead-containing substances. Major sources of lead exposure to children are: peeling or deteriorated leaded paint; lead-contaminated dust created by renovation or removal of lead-containing paint; and lead contamination brought home by adults who work in an occupation that involves lead, or who engage in a hobby where lead is used. Lead exposure can also occur through consuming drinking water or food which contains lead.

How Are We Doing?

Exposure to lead is measured by a blood test. New Jersey regulations require health care providers to test for lead exposure among all one- and two-year old children. The percent of children in New Jersey who were tested for lead exposure before 3 years of age increased from 65% for children born in 2000 to almost 75% for children born in 2014. The percentage of children tested for lead exposure before 3 years of age among children born in 2014 was highest in Essex (89.9%), Hunterdon (84.4) and Union (83.6%) Counties. The lowest testing rates were in Sussex (59.9%) and Gloucester (55.3%) Counties.

What Is Being Done?

The New Jersey Department of Health (NJ DOH) maintains a Child Health Program, [http://nj.gov/health/childhoodlead/]. This program coordinates a surveillance system that collects information from laboratories regarding the results of blood lead tests performed on children in New Jersey, identifies children with elevated test results, and notifies local health departments regarding children with elevated blood lead tests who reside in their jurisdiction.

Note

Lead poisoning testing counts and testing rates by county include only those children who could be assigned to a county. Among children born in 2014, <4% of children tested could not be assigned to a specific county.

Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Child Health Program, Family Health Services, New Jersey Department of Health  

Measure Description for Childhood Lead Testing Coverage

Definition: Percent of New Jersey children tested for lead exposure before 36 months of age
Numerator: Number of children tested for lead exposure before 3 years of age, born in a specified year in a geographic area
Denominator: Number of live births to New Jersey resident mothers in a specified year in a geographic area

Indicator Profile Report

Percent of Children Tested for Lead Poisoning Before 3 Years of Age (exits this report)

Date Content Last Updated

04/19/2018

For more information:

Environmental Public Health Tracking Project, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, Phone: 609-826-4984, e-mail: nj.epht@doh.nj.gov, Web: www.nj.gov/health/epht




Self-Reported Breast Cancer Screening Among Women: Estimated Percent (Age-adjusted), 2017-2020*

  • Burlington
    79.3
    95% Confidence Interval (73.8 - 83.9)
    State
    79.4
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

About one in eight women in the United States will develop breast cancer during their lifetime and this risk increases with age. A mammogram is an X-ray picture of the breast and is the most accurate tool for detecting breast cancer. Health care providers use a mammogram to look for early signs of breast cancer.

Risk and Resiliency Factors

Factors that are negatively associated with self-report of breast cancer screening according to current guidelines include having an '''annual income of less than 139% of poverty level''' and being '''non-Hispanic Asian''' or '''non-Hispanic White'''. ([https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093265/ Hall et al., 2018]) Note: [https://www-doh.state.nj.us/doh-shad/query/builder/njbrfs/Mammo/MammoAA11_.html Custom data views] of the estimated prevalence of adherence to breast cancer screening guidelines among New Jersey women by selected '''sociodemographic and other characteristics''' (including '''income''' and '''race/ethnicity''') can be generated using the New Jersey Behavioral Risk Factor Survey interactive query module.

How Are We Doing?

The percentage of New Jersey women who are current with breast cancer screening recommendations has remained stable for over the last five years at approximately 80%.

What Is Being Done?

The New Jersey Cancer Education and Early Detection (NJCEED) Program provides comprehensive outreach, education and screening services for breast, cervical, colorectal and prostate cancers. The services provided by NJCEED include: *Education *Outreach *Screening *Case Management *Tracking *Follow-up *Facilitation into Treatment

Healthy People Objective C-17:

Increase the proportion of women who receive a breast cancer screening based on the most recent guidelines
U.S. Target: 81.1 percent
State Target: 87.5 percent

Note

Estimates are age-adjusted using the 2000 U.S. standard population.  *2019 data is not included in the average estimated prevalence. No data is available for 2019.

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Self-Reported Breast Cancer Screening Among Women

Definition: Estimated percentage of New Jersey women aged 50 to 74 years who reported having a mammogram in the last two years.
Numerator: The number of women 50 to 74 years or older who reported having a mammogram in the last two years.
Denominator: The total number of female survey respondents aged 50 to 74 excluding those who responded "don't know" or "refused" to the numerator question.

Indicator Profile Report

Percentage of Females Aged 50 to 74 Who Reported Having a Mammogram in the Past Two Years (exits this report)

Date Content Last Updated

10/27/2022

For more information:

Office of Cancer Control and Prevention, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, web: nj.gov/health/ccp/index.shtml




Self-Reported Cervical Cancer Screening: Estimated Percent (Age-adjusted), 2017-2020*

  • Burlington
    75.9
    95% Confidence Interval (67.1 - 83.0)
    State
    80.6
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Cervical cancer is one of the most curable cancers if detected early through routine screening. Almost all cases of cervical cancer are caused by infection with high-risk types of the human papillomavirus (HPV). The HPV vaccine protects against the HPV types that most often cause cervical cancer. Women who have had an HPV vaccine still need to have routine Pap smears because the vaccine does not fully protect against all the strains of the virus and other risk factors that can cause cervical cancer. HPV is transmitted through sexual contact. Any woman who is sexually active is at risk for developing cervical cancer. Other risk factors include giving birth to many children, having sexual relations at an early age, having multiple sex partners or partners with many other partners, cigarette smoking, and use of oral contraceptives. The US Preventive Services Task Force (USPSTF) recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years. For women aged 30 to 65 years, the USPSTF recommends screening every 3 years with cervical cytology alone, every 5 years with high-risk human papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV testing in combination with cytology (cotesting).

Risk and Resiliency Factors

Factors that are negatively associated with self-report of cervical cancer screening according to current guidelines include having '''less than a high school education''', being a '''US resident for less than 10 years''', and being '''non-Hispanic Asian'''. ([https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093265/ Hall et al., 2018]) Note: [https://www-doh.state.nj.us/doh-shad/query/builder/njbrfs/PapTest/PapTestAA11_.html Custom data views] of the estimated prevalence of adherence to cervical cancer screening guidelines among New Jersey women by selected '''sociodemographic and other characteristics''' (including '''education level''', '''immigration status''', and '''race/ethnicity''') can be generated using the New Jersey Behavioral Risk Factor Survey interactive query module.

How Are We Doing?

In 2020, approximately 80% of respondents reported that they had received a Pap test within the past three years.

Healthy People Objective C-15:

Increase the proportion of women who receive a cervical cancer screening based on the most recent guidelines
U.S. Target: 93.0 percent
State Target: 93.6 percent

Related Indicators

Risk Factors:

Health Status Outcomes:


Note

All prevalence estimates are age-adjusted to the U.S. 2000 standard population.  *2019 data is not included in the average estimated prevalence. No data is available for 2019.

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Self-Reported Cervical Cancer Screening

Definition: Estimated percentage of women ages 21-65 years who have had a Pap test in the past three years.
Numerator: The number of women ages 21-65 years who reported having a Pap test in the last three years.
Denominator: The total number of female survey respondents ages 21-65 years excluding those who responded "don't know" or "refused" to the numerator question.

Indicator Profile Report

Percentage of Adult Women Ages 21-65 Years who had a Pap Test Within the Past Three Years (exits this report)

Date Content Last Updated

10/27/2022

For more information:

Office of Cancer Control and Prevention, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, web: nj.gov/health/ccp/index.shtml




Self-Reported Colorectal Cancer Screening: Estimated Percent (Age-adjusted), 2017-2020*

  • Burlington
    71.5
    95% Confidence Interval (67.1 - 75.6)
    State
    69.2
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

The fecal occult blood test and sigmoidoscopy are important tools in the detection of various health conditions, especially cancer of the colon and rectum. Colorectal cancer is unfortunately relatively common, does not have symptoms in its early stages, and has a risk that increases with age. Regular colorectal cancer screening is one of the most effective means by which colorectal cancer can be prevented or found early, when treatment is easier. Such screening helps people stay healthy and protects lives. The majority of diagnoses of this type of cancer occur in people who are over the age of 50. As a result, most people are advised to begin receiving these screening tests at age 50. Screening for hidden blood in the stool, using the fecal occult blood test, results in the detection of colorectal cancer at relatively high rates. Additionally, widespread use of this non-invasive, annual test has been shown to decrease both incidence and mortality in randomized controlled trials. By contrast, sigmoidoscopy is a minimally invasive test which uses a tiny video camera to examine the structure of the rectum and the lower part of the colon to find any abnormal areas. A sigmoidoscopy is usually performed only once every 5 years, depending on one's personal risk for colorectal cancer, but is also proven to decrease colorectal cancer incidence and mortality. Although this is a more involved procedure, sigmoidoscopy does have an enhanced ability, when compared to the fecal occult blood test, to find both cancer and colorectal polyps. Polyps are small growths which can over time become cancer, if left in place. Any polyps that are discovered can immediately be extracted through the medical device used for a sigmoidoscopy to prevent possible progression to cancer or to better assess whether or not any cancer is currently present.

Risk and Resiliency Factors

Factors that are negatively associated with self-report of colorectal cancer screening according to current guidelines include having less than a '''high school education''', having an '''annual income''' of less than 139% of poverty level, and being '''non-Hispanic Asian'''. ([https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093265/ Hall et al., 2018]) Note: [https://www-doh.state.nj.us/doh-shad/query/builder/njbrfs/ColScrPSTF/ColScrPSTFAA11_.html Custom data views] of the estimated prevalence of adherence to colorectal cancer screening guidelines among New Jersey adults by selected '''sociodemographic and other characteristics''' (including '''education''', '''income''', and '''race/ethnicity''') can be generated using the New Jersey Behavioral Risk Factor Survey interactive query module.

How Are We Doing?

In 2020, approximately 72 percent of New Jersey adults aged 50-75 reported being current with colorectal cancer screening recommendations.

What Is Being Done?

A fecal occult blood test and sigmoidoscopy are recommended by the Comprehensive Cancer Control Plan 2008-2012. The Comprehensive Cancer Control Plan 2008-2012 has been developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness, and death due to cancer among New Jersey residents.

Healthy People Objective C-16:

Increase the proportion of adults who receive a colorectal cancer screening based on the most recent guidelines
U.S. Target: 70.5 percent
State Target: 70.2 percent

Note

*2019 data is not included in the average estimated prevalence. No data is available for 2019. All prevalence estimates are age-adjusted to the U.S. 2000 standard population.

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Self-Reported Colorectal Cancer Screening

Definition: Estimated percentage of New Jersey adults ages 50-75 years who are current with colorectal cancer screening recommendations. An individual is considered current if they have had a take-home fecal immunochemical test (FIT) or high-sensitivity fecal occult blood test (FOBT) within the past year, and/or a flexible sigmoidoscopy within the past 5 years with a take-home FIT/FOBT within the past 3 years, and/or a colonoscopy within the past ten years.
Numerator: Number of New Jersey adults aged 50-75 years who reported that they are current with colorectal cancer screening recommendations.
Denominator: The total number of survey respondents aged 50-75 excluding those who answered "don't know" or "refused" to the numerator question.

Indicator Profile Report

Percent of Adults Ages 50-75 who are Current with Colorectal Cancer Screening Recommendations (exits this report)

Date Content Last Updated

10/27/2022

For more information:

Office of Cancer Control and Prevention, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, web: nj.gov/health/ccp/index.shtml




Self-Reported Prostate Cancer Screening: Estimated Percent (Age-adjusted), New Jersey, 2017-2020*

  • Burlington
    22.7%
    95% Confidence Interval (17.6% - 27.9%)
    StateNA
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Prostate cancer is the most commonly occurring form of cancer (excluding skin cancer) among men and is the second leading cause of cancer death for men in New Jersey and the U.S. All men over 40 should visit their doctor for a routine health visit which may include a discussion on prostate health.

How Are We Doing?

In 2020, about 15% of New Jersey men aged 40 and over reported that a doctor, nurse, or other health professional have talked to them about the advantages and disadvantages of the PSA test.

Healthy People Objective C-19:

Increase the proportion of men who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider
U.S. Target: 15.9 percent
State Target: 24.4 percent

Related Indicators

Health Status Outcomes:


Note

Age-adjusted to the U.S. 2000 standard population.  *2019 data is not included in the average estimated prevalence. No data is available for 2019.

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Self-Reported Prostate Cancer Screening

Definition: The percentage of men aged 40 and above who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider.
Numerator: The number of men aged 40 and above who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider.
Denominator: The total number of male survey respondents aged 40 or older excluding those who responded "don't know" or "refused" to the numerator question.

Indicator Profile Report

Percentage of Men Aged 40+ Who Reported a Health Professional Has Talked with them about the Advantages and Disadvantages of the PSA Test (exits this report)

Date Content Last Updated

12/07/2022

For more information:

Office of Cancer Control and Prevention, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, web: nj.gov/health/ccp/index.shtml




Self-Reported Cholesterol Screening: Estimated Percent (Age-adjusted), 2020-2021

  • Burlington
    86.9
    95% Confidence Interval (83.2 - 90.5)
    StateNA
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Cholesterol testing is considered a necessary preventive health care measure. High blood cholesterol has been linked to hardening of the arteries, heart disease, as well an increased risk of death from heart attacks.

How Are We Doing?

In 2021, approximately 90% of New Jersey adults have had their blood cholesterol checked by a health professional within the past five years. Asians (92.4%) and Whites (90.7%) have a higher prevalence of cholesterol screenings compared to Blacks (89.4%) and Hispanics (84.9%).

What Is Being Done?

The National Diabetes Education Program has instituted the ABC campaign which promotes the screening for A1c (blood glucose), Blood Pressure, and Cholesterol as monitoring measures to help control diabetes and heart disease. Heart disease is a major complication of diabetes and the Department of Health has suggested that target values for A1c , Blood Pressure, and Cholesterol be established by health providers in partnership with patients based on their individual circumstances.

Healthy People Objective HDS-6:

Increase the proportion of adults who have had their blood cholesterol checked within the preceding 5 years
U.S. Target: 82.1 percent (age-adjusted)
State Target: 86.7 percent (age-adjusted)

Measure Description for Self-Reported Cholesterol Screening

Definition: Proportion of adults aged 18 and older who have had their blood cholesterol checked by a health professional within the past five years.
Numerator: Number of persons aged 18 and over interviewed for this survey who reported that they have had their blood cholesterol level checked in the past five years
Denominator: Total number of persons aged 18 and older interviewed during the same survey period

Indicator Profile Report

Percentage of Adults Aged 18+ Who Reported Having Their Cholesterol Checked Within the Past Five Years (exits this report)

Date Content Last Updated

06/19/2023

For more information:

Community Health and Wellness, Division of Community Health Services, New Jersey Department of Health, Trenton, NJ 08625, Web: https://nj.gov/health/fhs/chronic/




Hemoglobin Screening Among Adults with Diagnosed Diabetes: Estimated Percent (Age-adjusted), 2018-2021

  • Burlington
    72.5%
    95% Confidence Interval (63.2% - 81.8%)
    StateNA
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Proper diabetes management requires regular monitoring of blood sugar levels. Glucometers provide immediate feedback on blood sugar levels. An A1C test, however, tells a person what his or her average blood sugar level has been over the past two or three months and is a more reliable indicator of blood sugar control. An A1C level indicates the amount of sugar that is attached to red blood cells (hemoglobin cells). Red blood cells are replaced every two or three months and sugar stays attached to the cells until they die. When levels of blood sugar are high, more sugar is available to attach to red blood cells. For most people with diabetes, the target A1C level is less than 7 percent. Higher levels suggest that a change in therapy may be needed. Therefore, obtaining regular A1C tests plays an important role in diabetes management. The American Diabetes Association recommends that people with diabetes have an A1C test at least two times a year. However, the test should be conducted more often for individuals who are not meeting target blood sugar goals, or who have had a recent change in therapy. (See [http://care.diabetesjournals.org/cgi/content/full/27/suppl_1/s15#T7])

How Are We Doing?

In 2021, 71.7% of New Jersey adults with diagnosed diabetes had at least two glycosylated hemoglobin measurements a year. Hispanics have a lower screening rate (60.8%) compared to Asians (86.7%), Whites (77.8%), and Blacks (66.5%).

What Is Being Done?

The National Diabetes Education Program has instituted the ABC campaign which promotes the screening for A1c (blood glucose), Blood Pressure, and Cholesterol as monitoring measures to help control diabetes and heart disease. The Department of Health has suggested that target values for A1c , Blood Pressure, and Cholesterol be established by health providers in partnership with patients based on their individual circumstances.

Healthy People Objective D-11:

Increase the proportion of adults with diabetes who have a glycosylated hemoglobin measurement at least twice a year
U.S. Target: 71.1 percent (age-adjusted)
State Target: 73.7 percent (age-adjusted)

Related Indicators

Health Status Outcomes:


Note

*2019 data is not included in the average estimated prevalence. No data is available for 2019. All prevalence estimates are age-adjusted to the U.S. 2000 standard population.

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Hemoglobin Screening Among Adults with Diagnosed Diabetes

Definition: Age-adjusted proportion of adults aged 18 years and older with diagnosed diabetes who self-reported having a glycosylated hemoglobin (A1C) measurement at least twice a year.
Numerator: Number of persons with diagnosed diabetes interviewed for the survey who reported that they have had at least two A1C measurement in the year prior to being surveyed.
Denominator: Total number of persons with diagnosed diabetes interviewed during the same survey period.

Indicator Profile Report

Glycosylated Hemoglobin Screening Rate among Adults Aged 18+ with Diagnosed Diabetes (exits this report)

Date Content Last Updated

08/14/2018

For more information:

Diabetes Prevention and Control Program, Division of Family Health Services, New Jersey Department of Health, PO Box 364, Trenton NJ 08625-0364, Phone: 609-984-6137, Fax: 609-292-9288, Web: http://www.state.nj.us/health/fhs/diabetes/index.shtml




Dilated Eye Exams Among Persons with Diabetes: Estimated Percent (Age-adjusted), 2018-2021

  • Burlington
    72.5%
    95% Confidence Interval (62.4% - 82.5%)
    StateNA
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Individuals with diabetes are at a greater risk for eye related health problems than those without diabetes. A dilated eye exam tests for diabetic retinopathy which is the leading cause of blindness in American adults. Timely treatment and appropriate follow-up care of diabetic retinopathy can reduce the risk of blindness up to 95% according to the National Eye Institute.

How Are We Doing?

In 2021, 66.5% of adults with diagnosed diabetes reported that they had a dilated eye exam within the past year.

What Is Being Done?

The New Jersey Department of Human Services' Commission for the Blind and Visually Impaired Diabetic Eye Disease Detection Program provides dilated eye exams for low income individuals who are uninsured or underinsured.

Healthy People Objective D-10:

Increase the proportion of adults with diabetes who have an annual dilated eye examination
U.S. Target: 58.7 percent (age-adjusted)
State Target: 80.0 percent (age-adjusted)

Note

*2019 data is not included in the average estimated prevalence. No data is available for 2019. All prevalence estimates are age-adjusted to the U.S. 2000 standard population.

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Dilated Eye Exams Among Persons with Diabetes

Definition: Percentage of persons aged 18 years and older with diagnosed diabetes who have had a dilated eye exam within the past year.
Numerator: Number of persons aged 18 years and older with diagnosed diabetes interviewed for this survey who reported that they had a dilated eye exam within the past year
Denominator: Total number of persons aged 18 years and older with diagnosed diabetes interviewed during the same survey period

Indicator Profile Report

Percentage of Adults Aged 18+ with Diagnosed Diabetes Who had a Dilated Eye Exam Within the Past Year (exits this report)

Date Content Last Updated

08/14/2018

For more information:

Diabetes Prevention and Control Program, Division of Family Health Services, New Jersey Department of Health, PO Box 364, Trenton NJ 08625-0364, Phone: 609-984-6137, Fax: 609-292-9288, Web: http://www.state.nj.us/health/fhs/diabetes/index.shtml




Seatbelt Usage (Self-Reported): Estimated Percent, 2017-2020*

  • Burlington
    89.3
    95% Confidence Interval (85.9 - 91.9)
    State
    90.5
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Motor vehicle crashes are the second leading cause of unintentional injury death in New Jersey and in the United States. Seat belt use can help to prevent injuries and death and the use of seat belts is mandatory in New Jersey.

How Are We Doing?

In 2020, about 90% of New Jersey adults reported that they always use a seat belt when driving or riding in a car.

What Is Being Done?

New Jersey's Seat Belt Law (NJS 39:3-76.2f) signed on January 18th, 2010 requires that all vehicle occupants must wear their seat belt regardless of seating position in a vehicle.

Healthy People Objective IVP-15:

Increase use of safety belts
U.S. Target: 92 percent
State Target: 100 percent

Related Indicators

Health Status Outcomes:


Note

*2019 data is not included in the average estimated prevalence. No data is available for 2019.

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Seatbelt Usage (Self-Reported)

Definition: Percentage of New Jersey adults aged 18 and over who who reported wearing a seat belt always in automobiles.
Numerator: Number of persons aged 18 and over who reported wearing a seat belt always in automobiles.
Denominator: Total number of persons aged 18 and over in the sample survey

Indicator Profile Report

Percentage of Adults who Always Use Seat Belts in Automobiles (exits this report)

Date Content Last Updated

10/27/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Cigarette Smoking Among Adults: Estimated Percent (Age-adjusted), 2017-2020*

  • Burlington
    13.5
    95% Confidence Interval (10.6 - 17.0)
    State
    12.8
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Smoking is the leading cause of preventable death, leads to disease and disability, and harms nearly every organ of the body.[https://www.cdc.gov/tobacco/data_statistics/fact_sheets/index.htm ^1^]

Risk and Resiliency Factors

Note: [https://www-doh.state.nj.us/doh-shad/query/builder/njbrfs/SmokeCurrent/SmokeCurrentAA11_.html Custom data views] of the prevalence of cigarette smoking among New Jersey adults by selected '''sociodemographic and other characteristics''' can be generated using the New Jersey Behavioral Risk Factor Survey interactive query module.

How Are We Doing?

Although New Jersey's smoking rates have decreased since its Master Settlement Agreement-funded programs were initiated, more than one million New Jersey adults continue to smoke. People with fewer years of formal education report higher rates of tobacco use compared to the general population. Comprehensive and free quitting services are needed to help New Jersey smokers quit and ensure a decline in tobacco use rates among all population groups.

What Is Being Done?

The [http://www.nj.gov/health/fhs/tobacco/ Office of Tobacco Control] at the New Jersey Department of Health and its partners use comprehensive programs to prevent the initiation of tobacco use among young people, to help tobacco users quit, to eliminate nonsmokers' exposure to secondhand smoke, and to reduce tobacco-related disparities. These programs include free quitting services, school- and community-based prevention programs and education regarding the [http://www.njleg.state.nj.us/2004/Bills/PL05/383_.HTM New Jersey Smoke-Free Air Act].

Healthy People Objective TU-1.1:

Reduce tobacco use by adults: Cigarette smoking
U.S. Target: 12.0 percent (age-adjusted)
State Target: 12.4 percent (age-adjusted)

Note

*2019 data is not included in the average estimated prevalence. No data is available for 2019. All prevalence estimates are age-adjusted to the U.S. 2000 standard population.

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Cigarette Smoking Among Adults

Definition: Percentage of adults aged 18 years and older who smoke cigarettes every day or some days
Numerator: Number of adults aged 18 years and older who have smoked at least 100 cigarettes in their lifetime and who now report smoking cigarettes every day or some days
Denominator: Number of adults aged 18 years and older

Indicator Profile Report

Percentage of Adults who Reported Current Cigarette Smoking (exits this report)

Date Content Last Updated

10/27/2022

For more information:

Office of Tobacco Control, New Jersey Department of Health, Trenton, NJ, 08625, Phone: 609-984-3317, Web: http://www.state.nj.us/health/ctcp/index.shtml




Tobacco Use During Pregnancy: Percentage of Live Births, 2020

  • Burlington
    4.9%
    95% Confidence Interval NA
    State
    2.5%
    U.S.
    5.5%
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Use of tobacco products during pregnancy is associated with poor birth outcomes.

How Are We Doing?

Tobacco use during pregnancy increases the likelihood of delivering preterm (< 37 weeks gestation) and at low birth weight (< 2500 g). Tobacco use during pregnancy is much more prevalent in southernmost New Jersey than in the rest of the state. It is also much more likely among Black and White women than among Asian and Hispanic women. The original and the more stringent revised Healthy New Jersey 2020 targets were achieved by all racial/ethnic groups.

What Is Being Done?

[http://momsquit.com/ Mom's Quit Connection] (MQC) helps pregnant and postpartum women as well as their families by providing free, one-on-one counseling for those who want to quit smoking to protect their children from exposure to harmful tobacco smoke. MQC is a program of Family Health Initiatives funded by the NJ Department of Health.

Healthy People Objective MICH-11.3:

Increase abstinence from alcohol, cigarettes, and illicit drugs among pregnant women: Cigarette smoking
U.S. Target: 98.6 percent

Note

Tobacco use during pregnancy is self-reported and, thus, assumed to be under-reported to some degree. 

Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health  

Measure Description for Tobacco Use During Pregnancy

Definition: Self-reported use of any tobacco product by the mother during pregnancy
Numerator: Number of live births whose mothers used any tobacco product
Denominator: Total number of live births

Indicator Profile Report

Tobacco Use During Pregnancy (exits this report)

Date Content Last Updated

05/19/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Maternal Marital Status: Percentage of Live Births, 2021

  • Burlington
    29.7%
    95% Confidence Interval NA
    State
    31.8%
    U.S.
    40.1%
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Nonmarital births are at higher risk of having adverse birth outcomes such as low birthweight, preterm birth, and infant mortality than are children born to married women.[https://www.cdc.gov/nchs/data/nvsr/nvsr48/nvs48_16.pdf ^1^] Children born to single mothers typically have more limited social and financial resources.[https://www.cdc.gov/nchs/data/misc/wedlock.pdf ^2^]

How Are We Doing?

The proportion of births to unmarried New Jersey mothers had been steadily increasing for several decades but peaked around 2012 and has been generally declining since then. The rates among Blacks and Hispanics are more than triple the rate among Whites, and the White rate is nearly 4 times the rate among Asians. Among those aged 25-44, the proportion of births to unmarried women in 2020 was double the rate in 1990. The share of births to unmarried mothers ranges from 15.3% in Morris to 62.8% in Cumberland County.

Related Indicators

Health Status Outcomes:


Note

Hudson and Warren Counties each have a large proportion (> 15%) of records missing mother's marital status, so records with unknown status were removed from the denominator for all counties, NJ, and the US. Interpret with caution.

Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health  

Measure Description for Maternal Marital Status

Definition: Marital status was determined by response to the following questions on the birth certificate: *For years 1970-1978 - Legitimate? *For years 1979-1988 - Is mother married? *For years after 1988 - Mother married? (At birth, conception, or any time between)
Numerator: Number of live births to unmarried mothers
Denominator: Total number of live births with known marital status

Indicator Profile Report

Births to Unmarried Mothers (exits this report)

Date Content Last Updated

08/15/2023

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Immunization - Influenza, Adults: Estimated Percent, 2017-2020*

  • Burlington
    70.8
    95% Confidence Interval (65.2 - 75.8)
    State
    63.8
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Recommended immunizations for adults aged 65 years and older include a yearly immunization against influenza (flu) and a one-time immunization against pneumococcal disease. Most of the deaths and serious illnesses caused by influenza and pneumococcal disease occur in older adults and others at increased risk for complications of these diseases because of other risk factors or medical conditions. Barriers to adult immunization include not knowing immunizations are needed, misconceptions about vaccines, and lack of recommendations from health care providers.

How Are We Doing?

In 2020, 64.5% of all New Jersey adults aged 65 and older reported having received the influenza vaccination in the past 12 months. Flu vaccination is lower among Blacks (53.5%) compared to Whites (67.8%).

Healthy People Objective IID-12.7:

Increase the percentage of children and adults who are vaccinated annually against seasonal influenza: Noninstitutionalized adults aged 65 years and older
U.S. Target: 90 percent
State Target: 67.4 percent

Note

The survey question for this measure changed in 2011 to "During the past 12 months, have you had either a seasonal flu shot or a flu vaccine that was sprayed into your nose?" In previous years the question was "A flu shot is an influenza vaccine injected in your arm. During the past 12 months, have you had a seasonal flu shot?"  *2019 data is not included in the average estimated prevalence. No data is available for 2019.

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Immunization - Influenza, Adults

Definition: Percentage of adults aged 65+ who report receiving an influenza vaccination in the past 12 months.
Numerator: Number of survey respondents aged 65+ who report receiving an influenza vaccination in the past 12 months.
Denominator: Number of survey respondents aged 65+.

Indicator Profile Report

Influenza Vaccination in the Past 12 Months, Adults Aged 65+ (exits this report)

Date Content Last Updated

10/27/2022

For more information:

Vaccine Preventable Disease Program, Communicable Disease Service, New Jersey Department of Health, Trenton, NJ, 08625, Phone: 609-826-4860, Web: www.nj.gov/health/cd/




Immunizations - Pneumococcal Vaccination: Estimated Percent, 2017-2020*

  • Burlington
    75.5
    95% Confidence Interval (70.0 - 80.4)
    State
    67.8
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Recommended immunizations for adults aged 65 years and older include a yearly immunization against influenza (flu) and a one-time immunization against pneumococcal disease. Most of the deaths and serious illnesses caused by influenza and pneumococcal disease occur in older adults and others at increased risk for complications of these diseases because of other risk factors or medical conditions. Barriers to adult immunization include not knowing immunizations are needed, misconceptions about vaccines, and lack of recommendations from health care providers.

How Are We Doing?

In 2020, 62.5% of all New Jersey adults aged 65 and older reported having received the Pneumococcal vaccination in the past 12 months. Pneumococcal vaccination is lower among Hispanics (41.1%) compared to Whites (69.1%) and Blacks (51.7%).

What Is Being Done?

Since 1998, NJDOH has adopted regulations requiring nursing homes to offer pneumococcal and influenza immunizations to all residents, and for hospitals to offer them to seniors who have been admitted for treatment. Education and outreach methods have also been made throughout the state.

Healthy People Objective IID-13.1:

Increase the percentage of adults who are vaccinated against pneumococcal disease: Noninstitutionalized adults aged 65 years and older
U.S. Target: 90 percent
State Target: 72.2 percent

Note

*2019 data is not included in the average estimated prevalence. No data is available for 2019.

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Immunizations - Pneumococcal Vaccination

Definition: Percentage of adults age 65+ who reported ever receiving a pneumococcal vaccination in their lifetime.
Numerator: Number of survey respondents age 65+ who reported ever receiving a pneumococcal vaccine anytime during their life
Denominator: Number of survey respondents age 65+

Indicator Profile Report

Percentage of Adults 65+ Who Reported Having Ever Received Pneumococcal Vaccination (exits this report)

Date Content Last Updated

10/27/2022

For more information:

Vaccine Preventable Disease Program, Communicable Disease Service, New Jersey Department of Health, Trenton, NJ, 08625, Phone: 609-826-4860, Web: www.nj.gov/health/cd/




Physical Activity-Adult Prevalence: Estimated Percent (Age-adjusted), 2013- 2017 (Odd Years)

  • Burlington
    54.6
    95% Confidence Interval (50.8 - 58.2)
    State
    49.3
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Maintenance of a physically active lifestyle is recognized in public health as one of the essential features of a healthy life. While it has long been known that physical activity can prevent heart disease, newer studies suggest that, on average, physically active persons outlive those who are inactive.

Risk and Resiliency Factors

Note: [https://www-doh.state.nj.us/doh-shad/query/builder/njbrfs/RecPhysicalAct/RecPhysicalActAA11_.html Custom data views] of the prevalence of physical activity among New Jersey adults by selected '''sociodemographic and other characteristics''' can be generated using the New Jersey Behavioral Risk Factor Survey interactive query module.

How Are We Doing?

The percentage of people reporting that they get the recommended level of physical activity in 2017 was about 49%. The 2017 data shows that fewer Hispanics (41%) and Blacks (41%) reported meeting the recommendation compared to Whites (52%) and Asians (57%).

What Is Being Done?

The New Jersey Department of Health coordinates efforts to work with communities to develop, implement, and evaluate interventions that address behaviors related to increasing physical activity, breastfeeding initiation and duration, and the consumption of fruits and vegetables, and to decreasing the consumption of sugar-sweetened beverages and high-energy-dense foods, and to decrease television viewing.

Healthy People Objective PA-2.1:

Increase the proportion of adults who engage in aerobic physical activity of at least moderate intensity for at least 150 minutes/week, or 75 minutes/week of vigorous intensity, or an equivalent combination
U.S. Target: 47.9 percent

Related Indicators

Health Status Outcomes:


Note

All prevalence estimates are age-adjusted to U.S. 2000 population (Except for estimates by age group). Physical activity questions are generally asked in odd years only. 

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Physical Activity-Adult Prevalence

Definition: Among adults, the proportion who engage in aerobic physical activity of at least moderate intensity for at least 150 minutes/week, or 75 minutes/week of vigorous intensity, or an equivalent combination.
Numerator: Number of adults aged 18 years and older who meet aerobic physical activity recommendations of getting at least 150 minutes per week of moderate-intensity activity, or 75 minutes of vigorous-intensity activity, or an equivalent combination of moderate-vigorous intensity activity.
Denominator: Number of surveyed adults aged 18 years and older (excludes unknowns or refusals ).

Indicator Profile Report

Percentage of Adults Aged 18+ Who Meet Aerobic Physical Activity Recommendation (exits this report)

Date Content Last Updated

10/27/2016

For more information:

Community Health and Wellness, Division of Community Health Services, New Jersey Department of Health, Trenton, NJ 08625, Web: https://nj.gov/health/fhs/chronic/




Population Demographics: Ratio, 2021

  • Burlington
    0.43
    95% Confidence Interval (0.42 - 0.45)
    State
    0.49
    U.S.
    0.48
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Demographics are an important determinant of health and well-being.

How Are We Doing?

New Jersey is recognized as one of the most diverse states in the nation: 21.5% of its residents are Hispanic, 12.3% are Black, and 9.9% are Asian. Nearly one-quarter of residents are foreign-born and more than one million (12.1%) residents do not speak English very well. The median age of residents is 40.3 years, 50% of those aged 15 and older are married, 4% of those 18 and older are veterans, and one-tenth of the civilian noninstitutionalized population has a disability. Median per capita income in New Jersey is $47,338. The unemployment rate among those age 16 and older is 8.1%, 10.2% of residents live below the poverty level, and 7.2% have no health insurance. Among those aged 25 and older, 91% have graduated high school and 43% have a bachelor's degree or higher. Among those aged 25 and over and in poverty, 22.4% did not finish high school. Median earnings for employed persons aged 25 and over without a high school diploma or equivalent were $28,336 compared to $37,180 for those with a diploma or GED, $46,071 for those with some college or an associate's degree, $71,258 with a bachelor's degree, and $94,788 with a graduate or professional degree. More than 95% of households have a computer and 92% have a broadband internet subscription.

Note

The Gini Index is a summary measure of income inequality. The Gini coefficient incorporates the detailed shares data into a single statistic, which summarizes the dispersion of income across the entire income distribution. The Gini coefficient ranges from 0, indicating perfect equality (where everyone receives an equal share), to 1, perfect inequality (where only one recipient or group of recipients receives all the income). The Gini is based on the difference between the Lorenz curve (the observed cumulative income distribution) and the notion of a perfectly equal income distribution. More information: [https://www.census.gov/topics/income-poverty/income-inequality/about/metrics/gini-index.html]

Data Sources

American Community Survey, U.S. Census Bureau, [https://www.census.gov/programs-surveys/acs/]  

Measure Description for Population Demographics

Definition: See graph-specific data notes
Numerator: See graph-specific data notes
Denominator: See graph-specific data notes

Indicator Profile Report

Gini Index: (exits this report)

Date Content Last Updated

11/03/2022

For more information:

NJ State Health Assessment Data, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, nj.gov/health/shad




Children Under Five Years of Age Living in Poverty: Estimated Percent, 2016-2020

  • Burlington
    10.9%
    95% Confidence Interval NA
    State
    14.2%
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Poverty affects a wide range of resources that can enhance or diminish quality of life and thus have a significant influence on health outcomes. These resources include safe and affordable housing, access to education, public safety, availability of healthy foods, local emergency/health services, and environments free of life-threatening toxins.[https://www.healthypeople.gov/2020/topics-objectives/topic/social-determinants-of-health ^1^]

How Are We Doing?

Based upon 2020 American Community Survey 5-year estimates from the U.S. Census data, there were wide variations in the county rates of poverty among New Jersey children less than 5 years of age. Counties with the highest percentages of children under 5 years of age living in poverty were Passaic, Salem, Atlantic and Essex Counties. The lowest percentages of poverty among children less than 5 years were in Hunterdon and Morris Counties. In New Jersey, approximately a quarter of Black and Hispanic children under 5 years of age are living in poverty. The rates for White and Asian children under age 5 are 11.4% and 4.5%, respectively.

Data Sources

American Community Survey, U.S. Census Bureau, [https://www.census.gov/programs-surveys/acs/]  

Measure Description for Children Under Five Years of Age Living in Poverty

Definition: Number or percent of children under 5 years of age living in poverty
Numerator: Number of children less than 5 years of age living in poverty in a geographic area
Denominator: Number of children less than 5 years of age living in a geographic area

Indicator Profile Report

Children Under Age 5 Living in Poverty (exits this report)

Date Content Last Updated

03/24/2022

For more information:

Environmental Public Health Tracking Project, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, Phone: 609-826-4984, e-mail: nj.epht@doh.nj.gov, Web: www.nj.gov/health/epht




Risk Factor for Childhood Lead Exposure: Pre-1950 and Pre-1980 Housing: Percent of Pre-1950 Housing Units, as of 2016-2020

  • Burlington
    14.5%
    95% Confidence Interval NA
    State
    25.2%
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

While all children in New Jersey are at risk of exposure to lead, children who reside in homes build prior to 1950 are at highest risk for elevated blood lead due to the potential presence of leaded paint. In addition, children living in homes constructed prior to 1980 are at risk due to the fact that use of lead-based paint for residential homes was not discontinued until 1980. Major sources of lead exposure to children are: peeling or deteriorated leaded paint; lead-contaminated dust created by renovation or removal of lead-containing paint; and lead contamination brought home by adults who work in an occupation that involves lead, or who engage in a hobby where lead is used. Children are more vulnerable to lead poisoning than adults. The first six years of life are the time when the brain grows the fastest, and when the critical connections in the brain and nervous system that control thought, learning, hearing, movement, behavior and emotions are formed. The normal behavior of very young children (crawling, exploring, teething, and putting objects in their mouth) exposes young children to lead that is present in their environment.

How Are We Doing?

In 2020, New Jersey had over 913,000 housing units which were built before 1950. The number of housing units built before 1950 ranged from about 8,000 in Salem County to over 129,000 in Essex County. The percentage of housing units built before 1950 was highest in Essex (40.8%) and Union (39.9%) Counties. Ocean County had the lowest percentage of housing units built before 1950 (7.2%). Also in 2020, New Jersey had approximately 2.4 million housing units which were built before 1980. The number of housing units built before 1980 ranged from approximately 20,000 in Salem County to over 275,000 in Bergen County. The percentage of housing units built before 1980 was highest in Union (82.0%) and Passaic (80.5%) Counties. Somerset County had the lowest percentage of housing units built before 1980 (49.1%).

What Is Being Done?

The New Jersey Department of Health (NJDOH) maintains a Childhood Lead Poisoning Prevention Program, [http://nj.gov/health/childhoodlead/]. This program has a surveillance system that collects information from laboratories regarding the results of blood lead tests performed on children in New Jersey, identifies children with elevated test results, and notifies local health departments regarding children with elevated blood lead tests who reside in their jurisdiction.

Data Sources

American Community Survey, U.S. Census Bureau, [https://www.census.gov/programs-surveys/acs/]  

Measure Description for Risk Factor for Childhood Lead Exposure: Pre-1950 and Pre-1980 Housing

Definition: Number or percent of either pre-1950 or pre-1980 housing units
Numerator: Number of residential housing units built prior to 1950 or pre-1980 in a geographic area (based upon 2020 American Community Survey data)
Denominator: Number of residential housing units in a geographic area (based upon 2020 housing unit data from American Community Survey)

Indicator Profile Report

Housing in New Jersey (exits this report)

Date Content Last Updated

03/22/2022

For more information:

Environmental Public Health Tracking Project, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, Phone: 609-826-4984, e-mail: nj.epht@doh.nj.gov, Web: www.nj.gov/health/epht




Children under 3 Years of Age with a Confirmed Elevated Blood Lead Level: Percent with Confirmed Blood Lead >=5 ug/dL, Born in 2014

  • Burlington
    1.2
    95% Confidence Interval NA
    State
    2.4
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Lead is a heavy metal that has been widely used in industrial processes and consumer products. When absorbed into the human body, lead can have damaging effects on the brain and nervous system, kidneys, and blood cells. Lead exposure is particularly hazardous for pre-school children because their brains and nervous systems are still rapidly developing. Serious potential effects of lead exposure on the nervous system include: learning disabilities, hyperactivity, hearing loss, and mental retardation. The primary method for lead to enter the body is through eating or breathing lead-containing substances. Major sources of lead exposure to children are: peeling or deteriorated leaded paint; lead-contaminated dust created by renovation or removal of lead-containing paint; and lead contamination brought home by adults who work in an occupation that involves lead, or who engage in a hobby where lead is used. Lead exposure can also occur through consuming drinking water or food which contains lead.

How Are We Doing?

Exposure to lead is measured by a blood test. New Jersey regulations require health care providers to test for lead exposure among all one- and two-year old children. An elevated blood lead level in children is currently defined in New Jersey as greater than or equal to 5 micrograms of lead per deciliter of blood (ug/dL). The lowering of the public health intervention level to 5 ug/dL was statutorily required under P.L. 2017, c.7 in February 2017. The NJ DOH's proposed amendments, new rules, and repeals were adopted in August 2017 upon publication in the NJ Register. When we look at children born in 2014 statewide (i.e., the 2014 birth cohort), the percent of tested children who had a confirmed blood lead level greater or equal to 5 ug/dL before 3 years of age was highest in Cumberland, Essex, Mercer, and Passaic Counties. When looking at that same birth cohort of children, the percent of tested children who had a confirmed blood lead level greater or equal to 10 ug/dL before 3 years of age was highest in Cumberland and Essex Counties. The percent of tested children with a confirmed elevated blood lead level greater or equal to 20 ug/dL before 3 years of age was highest in Cumberland, Essex, and Hudson Counties. When we look at children by year of testing, annual statewide blood lead levels in children tested between the years 2000 and 2017 show a decrease in the percentage of children having an elevated blood lead level >=5 ug/dL from a peak of 12% in 2003 to 2.1% in 2017. A similar decreasing trend is seen for children with elevated blood lead levels >=10 ug/dL, from 3.6% in 2000 to 0.5% in 2017. The same decreasing trend can be seen for children with blood lead >=20 ug/dL, from 0.7% in 2000 to 0.1% in 2017.

What Is Being Done?

The New Jersey Department of Health (NJ DOH) maintains a Child Health Program, [http://nj.gov/health/childhoodlead/]. This program coordinates a surveillance system that collects information from laboratories regarding the results of blood lead tests performed on children in New Jersey, identifies children with elevated test results, and notifies local health departments regarding children with elevated blood lead tests who reside in their jurisdiction.

Measure Description for Children under 3 Years of Age with a Confirmed Elevated Blood Lead Level

Definition: Percent of New Jersey children under 3 years of age with confirmed elevated blood lead levels
Numerator: Number of children under 3 years of age with a confirmed elevated blood lead level in a geographic area
Denominator: Number of children under 3 years of age tested for lead exposure in a geographic area

Indicator Profile Report

Percent of Tested Children Under 3 Years of Age (exits this report)

Date Content Last Updated

04/18/2018

For more information:

Environmental Public Health Tracking Project, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, Phone: 609-826-4984, e-mail: nj.epht@doh.nj.gov, Web: www.nj.gov/health/epht




Carbon Monoxide Detectors: Self-Reported Presence in Home: Percentage, 2014 - 2016

  • Burlington
    83.2
    95% Confidence Interval (79.6 - 86.9)
    State
    86.0
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Carbon monoxide (CO) is a colorless, odorless and poisonous gas that is produced by the incomplete burning of solid, liquid and gaseous fuels. CO exposure is often the result of improper ventilation or inhalation of exhaust fumes from cars, trucks and other vehicles, generators, or gas heaters. Although CO poisoning can almost always be prevented, every year more than 500 Americans die as a result of unintentional exposure to this toxic gas, and thousands more require medical care for non-fatal poisoning. CO poisoning can be prevented by the installation and maintenance of CO detectors/alarms, and the proper maintenance of heating systems. Important guidelines: -Install battery-operated or battery back-up CO detectors near every sleeping area in your home. -Check CO detectors regularly to be sure they are functioning properly.

How Are We Doing?

In 2016, 86 percent of N.J. residents reported they had a carbon monoxide detector in their home.

Note

Survey question: "A carbon monoxide or CO detector checks the level of carbon monoxide in your home. It is not a smoke detector. Do you have a CO detector in your home: yes; no; don't know/not sure ?"

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Carbon Monoxide Detectors: Self-Reported Presence in Home

Definition: Percent of NJ residents who self report having a carbon monoxide (CO) detector in their home.
Numerator: Number of people age 18 years and older reporting having a carbon monoxide (CO) detector in their home.
Denominator: Total number of persons aged 18 and older surveyed using relevant question.

Indicator Profile Report

Self-Reported Presence of Carbon Monoxide Detector in Home (exits this report)

Date Content Last Updated

02/06/2020

For more information:

Environmental Public Health Tracking Project, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, Phone: 609-826-4984, e-mail: nj.epht@doh.nj.gov, Web: www.nj.gov/health/epht




Portable Generators: Self-Reported Ownership for Use during Power Outages: Percentage, 2014 - 2016

  • Burlington
    21.1
    95% Confidence Interval (17.5 - 24.7)
    State
    28.6
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Little is known about the percentage of NJ residents who have purchased portable generators for use during power outages. Portable back-up generators produce colorless odorless carbon monoxide (CO) gas which can sicken or kill residents if generator exhaust is not properly vented. CO poisoning claims the lives of hundreds of people every year and makes thousands more ill. Important guidelines: PORTABLE GENERATORS: * Never use a generator inside your home or garage, even if doors and windows are open. * Only use generators outside, more than 20 feet away from your home, doors, and windows. CO DETECTORS: * Install battery-operated or battery back-up CO detectors near every sleeping area in your home. * Check CO detectors regularly to be sure they are functioning properly.

Note

Survey Question: "Do you own at least one portable generator which you plan to use to provide energy to your home during a power outage: yes; no; don't know/not sure?".

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Portable Generators: Self-Reported Ownership for Use during Power Outages

Definition: Percent of NJ residents who self-report owning at least one portable generator for use to provide electricity to their home during a power outage.
Numerator: Number of people age 18 years and older self-reporting owning at least one portable generator for use to provide electricity to their home during a power outage.
Denominator: Total number of persons aged 18 and older interviewed during the same survey period.

Indicator Profile Report

Ownership of a Portable Generator for Use during Power Outages (exits this report)

Date Content Last Updated

02/06/2020

For more information:

Environmental Public Health Tracking Project, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, Phone: 609-826-4984, e-mail: nj.epht@doh.nj.gov, Web: www.nj.gov/health/epht




Naphthalene in Outdoor Air: Mean Concentration (ug/m3), 2017 NATA

  • Burlington
    0.03
    95% Confidence Interval NA
    State
    0.03
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Naphthalene has been used as a household fumigant, such as in mothballs or moth flakes. Large amounts of naphthalene are used as a chemical intermediate to produce other chemicals. Exposure to naphthalene happens mostly from breathing air contaminated from the burning of wood, tobacco, or fossil fuels, industrial discharges, or moth repellents. Exposure to high levels of naphthalene may damage or destroy red blood cells. Children and adults have developed this condition, known as hemolytic anemia, after ingesting mothballs or deodorant blocks containing naphthalene. Symptoms include fatigue, lack of appetite, nausea, restlessness, and pale skin. The International Agency for Research on Cancer (IARC) classifies naphthalene as possibly carcinogenic to humans.

How Are We Doing?

Most New Jersey counties exceed the health benchmark of 0.029 micrograms of naphthalene per cubic meter of air. The highest ambient air concentrations can be found in Hudson and Essex Counties.

What Is Being Done?

Industrial facilities that emit this chemical must obtain permits from the NJDEP Air Program and are also subject to state and federal air pollution control technology requirements.

Note

Data Source: National-scale Air Toxics Assessment (NATA), 2017 and NJDEP Division of Air Quality 

Data Sources

U.S. Environmental Protection Agency (EPA)   Bureau of Air Monitoring, New Jersey Department of Environmental Protection  

Measure Description for Naphthalene in Outdoor Air

Definition: Mean of modeled annual average naphthalene concentration for census tracts in a county using 2017 NATA data
Numerator: Modeled mean naphthalene concentration in micrograms per cubic meter
Denominator: N/A

Indicator Profile Report

Naphthalene Concentrations in Outdoor Air (exits this report)

Date Content Last Updated

03/17/2022

For more information:

Environmental Public Health Tracking Project, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, Phone: 609-826-4984, e-mail: nj.epht@doh.nj.gov, Web: www.nj.gov/health/epht




Perchloroethylene in Outdoor Air: Mean Concentration (ug/m3), 2017 NATA

  • Burlington
    0.04
    95% Confidence Interval NA
    State
    0.04
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Perchloroethylene (also called tetrachloroethylene), is a colorless liquid widely used for dry cleaning of fabrics. Textile mills, chlorofluorocarbon producers, vapor degreasing and metal cleaning operations, and makers of rubber coatings may also use perchloroethylene. It is also commonly used in aerosol formulations, solvent soaps, printing inks, typewriter correction fluid, adhesives, sealants, shoe polishes and lubricants. Perchloroethylene is a central nervous system depressant. Inhaling its vapors can cause dizziness, headache, sleepiness, confusion, nausea, and unconsciousness. Breathing perchloroethylene over long periods of time can cause liver and kidney damage and memory loss. Perchloroethylene is classified by the International Agency for Research on Cancer as a probable human carcinogen.

How Are We Doing?

The highest ambient air concentration can be found in Hudson County.

What Is Being Done?

Industrial facilities that emit this chemical must obtain permits from the NJDEP Air Program and are also subject to state and federal air pollution control technology requirements.

Note

Data Source: National-scale Air Toxics Assessment (NATA), 2017 and NJDEP Division of Air Quality 

Data Sources

U.S. Environmental Protection Agency (EPA)   Bureau of Air Monitoring, New Jersey Department of Environmental Protection  

Measure Description for Perchloroethylene in Outdoor Air

Definition: Mean of modeled annual average perchloroethylene concentration for census tracts in a county using 2017 NATA data
Numerator: Modeled mean perchloroethylene concentration in micrograms per cubic meter
Denominator: N/A

Indicator Profile Report

Perchloroethylene Concentrations in Outdoor Air, (exits this report)

Date Content Last Updated

03/17/2022

For more information:

Environmental Public Health Tracking Project, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, Phone: 609-826-4984, e-mail: nj.epht@doh.nj.gov, Web: www.nj.gov/health/epht




Fecal Coliform or E. coli in Private Wells: Percent of Wells with Fecal Coliform or E. Coli Detected, September 2002 through December 2018

  • Burlington
    0.8
    95% Confidence Interval NA
    StateNA
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Coliform bacteria are organisms that are present in the environment and in the feces of all warm-blooded animals and humans. Coliform bacteria will not likely cause illness. However, their presence in drinking water indicates that disease-causing organisms (pathogens) could be in the water system. Most pathogens that contaminate water supplies come from the feces of humans or animals. Testing drinking water for all possible pathogens is complex, time-consuming, and expensive. It is relatively easy and inexpensive to test for coliform bacteria.

How Are We Doing?

Between September 2002 and December 2018, fecal coliform or E. coli was detected in 2.0 % of 111,010 private wells in sampled New Jersey. Fecal coliform or E. coli was most commonly detected in Somerset (4.3% of wells), Sussex (4.2% of wells), Passaic (3.4% of wells), Hunterdon (3.2% of wells), Warren (3.2% of wells), Mercer (2.9% of wells) and Union (2.8% of wells) Counties. Online maps showing detection of fecal coliform or E. coli are available at the county level, municipal level, and for 2 mile by 2 mile grids from NJDEP, [http://arcg.is/1CPkHyC].

What Is Being Done?

The New Jersey Private Well Testing Act (N.J.S.A. 58:12A-26 et seq.) became effective in September 2002. The PWTA requires the buyer or the seller of a property to test untreated well water prior to the sale and review the results prior the closing of title. It also requires landlords to test the private well water supplied to their tenants every five years and provide their tenants with a written copy of the results. The data generated by this program are provided to the homeowners by the laboratory performing the analyses and then sent to the New Jersey Department of Environmental Protection (NJDEP). The NJDEP notifies local health agencies when a well within their jurisdiction is tested under the PWTA. The data from the PWTA are used by NJDEP to assess the quality of the water from private wells throughout the state.

Note

**Results by county are suppressed when the number of tested wells was less than 10. Denominator is the number of tested private wells. Data Source: NJ Department of Environmental Protection, Division of Water Supply and Geoscience, and Division of Science, Research, and Environmental Health, obtained on March 2, 2020.

Measure Description for Fecal Coliform or E. coli in Private Wells

Definition: Percent of tested private wells with fecal coliform or E. coli detected
Numerator: Number of tested private wells with fecal coliform or E. coli detected
Denominator: Number of tested private wells in a specified period of time

Indicator Profile Report

Fecal Coliform or E. Coli in Private Wells (exits this report)

Date Content Last Updated

03/03/2020

For more information:

Environmental Public Health Tracking Project, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, Phone: 609-826-4984, e-mail: nj.epht@doh.nj.gov, Web: www.nj.gov/health/epht




Nitrate in Private Wells: Percent of Wells Exceeding Nitrate MCL, September 2002 through December 2018

  • Burlington
    1.5
    95% Confidence Interval NA
    StateNA
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Nitrate is a nitrogen compound that occurs naturally in soil, water, plants, and food. It may be formed when microorganisms in the environment break down organic materials, such as plants, animal manure, and sewage. Nitrate can also be found in chemical fertilizers. Nitrate can get into drinking water from runoff of farms, golf courses and lawns, landfills, animal feedlots, and septic systems. High levels of nitrate in drinking water can lead to methemoglobinemia, a form of anemia, particularly in infants ("blue baby syndrome") and pregnant women.

How Are We Doing?

Between September 2002 and December 2018, about 2.9% of 111,011 wells tested had concentrations of nitrate above the maximum contaminant level (MCL) of 10 milligrams per liter. Two counties had much higher rates of MCL exceedance, Cumberland (14.3% of wells) and Salem (10.1% of wells). Online maps showing detection of nitrate are available at the county level, municipal level, and for 2 mile by 2 mile grids from NJDEP, [http://arcg.is/1CPkHyC].

What Is Being Done?

The New Jersey Private Well Testing Act (PWTA) became effective in September 2002. The PWTA requires the buyer or the seller of real property to test the well water prior to sale and review the results prior to closing of title. It also requires landlords to test the private well water supplied to their tenants and provide their tenants with a written copy of the results. Test results are provided to homeowners by the laboratory performing the analyses and are also sent to the New Jersey Department of Environmental Protection (NJDEP). The NJDEP notifies the local health agency when a well within its jurisdiction is tested under the PWTA. The data from the PWTA are used by NJDEP to assess the quality of the water from private wells throughout the state. Nitrate is required to be tested for in private wells in all 21 New Jersey counties.

Note

Data Source: Private Well Testing Act Program, New Jersey Department of Environmental Protection, Well Test Results for September 2002-December 2018  **Results by county are suppressed when the number of tested wells was less than 10. Denominator is the number of tested private wells. Data Source: NJ Department of Environmental Protection, Division of Water Supply and Geoscience, and Division of Science, Research, and Environmental Health, obtained on March 2, 2020.

Measure Description for Nitrate in Private Wells

Definition: Percent of tested private wells with nitrate concentration exceeding the maximum contaminant level (MCL) of 10 milligrams per liter
Numerator: Number of tested private wells with nitrate concentration exceeding the maximum contaminant level of 10 milligrams per liter in a specified time period
Denominator: Number of tested private wells in a specified time period

Indicator Profile Report

Nitrate in Private Wells (exits this report)

Date Content Last Updated

03/03/2020

For more information:

Environmental Public Health Tracking Project, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, Phone: 609-826-4984, e-mail: nj.epht@doh.nj.gov, Web: www.nj.gov/health/epht




Private Well Usage: Self-Reported as Main Source of Drinking Water: Percentage Tested for Contaminants, 2017 & 2020 Combined

  • Burlington
    62.2
    95% Confidence Interval (51.2 - 73.2)
    StateNA
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Water is used for many purposes including drinking, cooking, bathing, cleaning, and recreation. Because water use is so common in daily life, there are many opportunities for contaminated water to impact people. New Jersey has over 600 community water systems which provide drinking water to approximately 87% of the State's population. However, about 13 percent of New Jersey residents obtain their drinking water from private wells.

How Are We Doing?

If you are a New Jersey resident who uses their own source of drinking water, like a well, cistern, or spring, you are responsible for protecting and monitoring your water supply. It is essential that you test your water periodically, and maintain your well. There are no federal or state regulations assuring the quality of the water consumed by NJ residents who obtain their drinking water from private wells. The New Jersey Private Well Testing Act (PWTA) assures that the purchasers and lessees of properties served by private potable wells are aware of the quality of their drinking water source prior to the sale or lease of a home or business. Sampling and testing must be conducted by certified laboratories.

Note

Survey question: "Has your well water ever been tested for contaminants in the last 2 years: yes; no; don't know/not sure ?" This question was only asked to individuals who reported that their main water source was a private well. **Data are not shown for Bergen, Essex, Hudson, Middlesex, or Union Counties due to very low usage of private wells in these counties.

Measure Description for Private Well Usage: Self-Reported as Main Source of Drinking Water

Definition: Percent of NJ residents self-reporting using and testing a private well as the main water source for their home.
Numerator: Number of people age 18 years and older self-reporting using and testing a private well as main water source for their home.
Denominator: Total number of persons aged 18 and older interviewed during the same survey period.

Indicator Profile Report

Self-Reported Testing of Private Well Used for Drinking Water (exits this report)

Date Content Last Updated

07/18/2022

For more information:

Environmental Public Health Tracking Project, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, Phone: 609-826-4984, e-mail: nj.epht@doh.nj.gov, Web: www.nj.gov/health/epht




Birth Rate: Number of Births per 1,000 Residents, 2021

  • Burlington
    10.0
    95% Confidence Interval (9.7 - 10.3)
    State
    10.9
    U.S.
    11.0
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Tracking birth rate patterns among New Jersey and U.S. residents as a whole is critical to understanding population growth and change in this country and in New Jersey.

How Are We Doing?

Birth rates vary widely across the state. Counties with high populations of older persons will have lower birth rates than those with younger, childbearing-age persons. Birth rates also vary by race/ethnicity with Hispanics having 1.5 times the birth rate of Whites. The rates among Asians/Pacific Islanders and Blacks fall in between.

What Is Being Done?

The Division of [http://www.nj.gov/health/fhs/maternalchild/ Family Health Services] in the New Jersey Department of Health administers programs to enhance the health, safety, and well-being of families and communities in New Jersey.

Related Indicators

Health Status Outcomes:


Note

Confidence limits are not available for national data.

Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   National Center for Health Statistics and U.S. Census Bureau. Vintage 2019 bridged-race postcensal population estimates. [http://www.cdc.gov/nchs/nvss/bridged_race.htm] as of July 9, 2020.   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Birth Rate

Definition: Number of live births in a given year per 1,000 persons in the population
Numerator: Number of live births
Denominator: Number of persons in population

Indicator Profile Report

Birth Rate (exits this report)

Date Content Last Updated

07/28/2023

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




General Fertility Rate: Number of Live Births per 1,000 Women Age 15-44, 2021

  • Burlington
    55.1
    95% Confidence Interval (53.5 - 56.6)
    State
    57.9
    U.S.
    56.3
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

The general fertility rate is a more precise measure than the crude birth rate for tracking birth rate patterns. While the crude birth rate and the general fertility rate both look at the total number of live births among the population, the crude birth rate is calculated using the total population including the young, old, male, and female. The general fertility rate is calculated using only females of reproductive age, defined as ages 15 through 44 years, in the denominator. This results in a more sensitive indicator with which to study population growth and change.

How Are We Doing?

The general fertility rate among New Jersey women was 57.9 births per 1,000 women of childbearing age in 2021. The rate varied widely across the state's counties from a low of 49 (Hunterdon) to a high of 98 (Ocean). Rates also varied by race/ethnicity. The rate among Hispanics (66) was significantly higher than the rates among other racial/ethnic groups.

Related Indicators

Health Status Outcomes:


Note

The age range may be slightly different in some publications, so it is important to note what age range is being used especially if comparison with other rates is contemplated.  Confidence limits are not available for national data.

Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for General Fertility Rate

Definition: Number of live births per 1,000 women aged 15-44 years
Numerator: Number of live births
Denominator: Total number of women aged 15-44 years in the population

Indicator Profile Report

General Fertility Rate (exits this report)

Date Content Last Updated

07/28/2023

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Age-Specific Birth Rates: Number of Live Births per 1,000 Females Aged 15-17 Years, 2016-2020

  • Burlington
    2.5
    95% Confidence Interval (2.0 - 2.9)
    State
    4.1
    U.S.
    7.4
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Tracking age-specific birth rate patterns shows not only trends in teen births but also trends among older mothers. Teenage pregnancy and childbearing are ongoing public health concerns and the focus of considerable public policy debate. Babies born to teenage mothers are at elevated risk of poor birth outcomes, including higher rates of low birth weight, preterm birth, and infant death. The limited educational, social, and financial resources often available to teenage mothers add to their higher risk profile.

How Are We Doing?

In New Jersey, the highest birth rate is among mothers 30-34 years old. Birth rates among women 30 years old and over increased while birth rates among mothers under 30 years old decreased between 1990 and 2020. For all age groups under 30, Hispanic mothers have the highest birth rate followed by Blacks and then Whites. For those 30-39 years old, Asians and Whites have the highest rates. Births to teens of all ages and races/ethnicities have been declining for decades and continue to do so. The original and the more stringent revised Healthy New Jersey 2020 targets were achieved by all racial/ethnic groups. The teen birth rate in Cumberland County, however, is significantly higher than the rates of every other New Jersey county.

What Is Being Done?

The [http://www.nj.gov/health/fhs/maternalchild/ Division of Family Health Services] in the New Jersey Department of Health administers programs to enhance the health, safety and well-being of families and communities in New Jersey.

Healthy People Objective FP-8.1:

Reduce the pregnancy rate among adolescent females aged 15 to 17 years
U.S. Target: 36.2 pregnancies per 1,000
State Target: is not comparable because it is for births only, not all pregnancy outcomes

Related Indicators

Relevant Population Characteristics:

Health Status Outcomes:


Note

** Number too small to calculate a reliable rate.

Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Age-Specific Birth Rates

Definition: The number of resident live births to females in a specific age group per 1,000 females in the age group.
Numerator: The number of resident live births to females in a specific age group
Denominator: The number of females in the age group

Indicator Profile Report

Teen Birth Rates (exits this report)

Date Content Last Updated

05/19/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Multiple Births: Percentage of Live Births, 2019-2021

  • Burlington
    3.5%
    95% Confidence Interval NA
    State
    3.2%
    U.S.
    3.2%
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

There is a high risk of adverse outcome for multiple births.[https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2021/06/multifetal-gestations-twin-triplet-and-higher-order-multifetal-pregnancies ^1^] The outcomes are addressed in the respective indicator profiles.

How Are We Doing?

Both the number and rate of multiple births generally increased through the 1990s and 2000s before beginning to decline after 2011. The vast majority (97%) of multiple births are twins. The number of triplets peaked in 1998 (at 467) and the proportion of multiples that were triplets in 2021 is less than one-third of what it was in 1998 (2.8% and 10.1%, respectively). Among New Jersey mothers, there were 3,013 live births that were twins and 88 that were triplets in 2021.

Evidence-based Practices

The American College of Obstetricians and Gynecologists' (ACOG) Committee on Ethics published an Opinion report in 2017 advising obstetrician-gynecologists (Ob/Gyns) to be knowledgeable about the medical risks of multifetal pregnancy, the potential medical benefits of multifetal pregnancy reduction, and the complex ethical issues inherent in decisions regarding multifetal pregnancy reduction. Multifetal pregnancies should be prevented whenever possible. When multifetal pregnancies do occur, incorporating the ethical framework presented in the Committee Opinion will help Ob/Gyns counsel and guide patients as they make decisions regarding continuing or reducing their multifetal pregnancies.[https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/09/multifetal-pregnancy-reduction ^3^]

Note

Each infant in a multiple birth is counted separately, so, for example, three triplets refers to three live born infants, not three sets of triplets and not necessarily three infants from the same triplet set. If, for example, a mother has a triplet pregnancy and one child is not live born, the two live born infants are each still considered to be one of a set of triplets, not twins. 

Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health  

Measure Description for Multiple Births

Definition: Plurality is the number of all live births and pregnancy losses (miscarriages, ectopic pregnancies, fetal deaths, selective reductions) in a pregnancy. Multiple births are twins, triplets, quadruplets, and higher order births.
Numerator: Number of live births which were part of a multiple pregnancy (twin, triplet, etc.)
Denominator: Total number of live births

Indicator Profile Report

Multiple Births (exits this report)

Date Content Last Updated

07/28/2023

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Preterm Births: Percentage of Live Births, 2021

  • Burlington
    9.3%
    95% Confidence Interval (8.4% - 10.1%)
    State
    9.2%
    U.S.
    10.5%
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Prematurity increases the risk for infant morbidity and mortality. Infants born preterm are at greater risk of dying in the first month of life. Preterm infants may require intensive care at birth and are at higher risk of developmental disabilities and chronic illnesses throughout life. They are more likely to require special education services. Health care costs and length of hospital stay are higher for preterm infants. The more preterm an infant is born, the more severe the health problems are likely to be.

How Are We Doing?

New Jersey's overall preterm birth rate decreased from its peak of 10.4% in 2006 to 9.2% in 2021. The preterm birth rate among Black mothers (13.1%) remains significantly higher than among other racial/ethnic groups (7.8%-10.0%). Preterm birth is highly correlated with plurality. While 7.6% of singletons are born preterm, more than half of twins and nearly all triplets are born prior to 37 completed weeks of gestation. Preterm rates are lowest in Ocean County (7.1% of all births, 5.8% of singletons) and highest in Cumberland County (12.0% of all births, 10.3% of singletons). New Jersey's overall very preterm birth rate decreased from its peak of 1.8% in 2006 to 1.3% in 2021 and, among singletons, the rate declined from 1.4% in 2000 to 1.1% in 2021. Very preterm birth is highly correlated with plurality. While 1.1% of singletons were born very preterm, 9.1% of twins, and 40.9% of triplets were born prior to 32 completed weeks of gestation in 2021. Among singletons, very preterm rates are lowest in Hunterdon and Ocean Counties (0.7%) and highest in Essex County (1.7%).

What Is Being Done?

The [http://www.nj.gov/health/fhs/ Division of Family Health Services] in the New Jersey Department of Health administers programs to enhance the health, safety and well-being of families and communities in New Jersey. Several programs are aimed at improving birth outcomes.

Evidence-based Practices

[https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pretermcdc-activities.html CDC Preterm Birth Activities] [https://www.cdc.gov/mmwr/volumes/65/wr/mm6532a4.htm CDC Grand Rounds: Public Health Strategies to Prevent Preterm Birth]

Healthy People Objective MICH-9:

Reduce preterm births
U.S. Target: [[br]]Preterm (<37 weeks): 11.4% [[br]]Very preterm (<32 weeks): 1.8%

Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health  

Measure Description for Preterm Births

Definition: Percent of live born infants born before 37 weeks (preterm) or before 32 weeks (very preterm) of gestation based on obstetric estimate Preterm is synonymous with premature. Infants born before 37 weeks of pregnancy are considered preterm and those born before 32 weeks of pregnancy are considered very preterm. Infants born at or after 37 weeks of pregnancy are called full term. Most pregnancies last around 40 weeks.
Numerator: Number of live born infants born before 37 weeks (preterm) or before 32 weeks (very preterm) of gestation based on obstetric estimate
Denominator: Number of live infants born to resident mothers

Indicator Profile Report

Preterm Births (exits this report)

Date Content Last Updated

08/15/2023

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Low Birth Weight: Percentage of Live Births, 2020

  • Burlington
    6.9%
    95% Confidence Interval (6.2% - 7.8%)
    State
    7.7%
    U.S.
    8.2%
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Low birth weight (LBW) increases the risk for infant morbidity and mortality. LBW infants are at greater risk of dying in the first month of life. LBW infants may require intensive care at birth and are at higher risk of developmental disabilities and chronic illnesses throughout life. They are more likely to require special education services. Health care costs and length of hospital stay are higher for LBW infants.

How Are We Doing?

In New Jersey, the average birth weight is 3,261 grams or 7 lbs 3 oz. The overall low birth weight (LBW) rate reached an all time high of 8.4% in 2011 but has since declined below 8%. The very low birth weight rate (VLBW) among New Jersey births had been around 1.5% since the 1990s before declining to 1.4% in 2015, 1.3% in 2019, and 1.2% in 2020. The Healthy New Jersey 2020 targets for LBW and VLBW among all births were achieved. Black mothers are more likely to deliver LBW (13%) and VLBW (3%) infants than are other racial/ethnic groups. LBW rates for New Jersey's counties range from 5.8% in Sussex to 9.7% in Salem County. Birth weight is highly correlated with plurality and gestational age. While 2.4% of full term singletons are of LBW, 23.2% of full term twins are born at a weight below 2,500 grams. Similarly, 1.0% of singletons are of VLBW compared to 7% of twins and half of triplets.

What Is Being Done?

The [http://www.nj.gov/health/fhs/ Division of Family Health Services] in the New Jersey Department of Health administers programs to enhance the health, safety and well-being of families and communities in New Jersey. Several programs are aimed at improving birth outcomes.

Healthy People Objective MICH-8.1:

Low birth weight (LBW)
U.S. Target: 7.8 percent
State Target: 7.7 percent

Note

Confidence intervals are not available for U.S. data.

Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health  

Measure Description for Low Birth Weight

Definition: Percent of live-born infants delivered with a birth weight of less than 2,500 grams (low birth weight) or less than 1,500 grams (very low birth weight) 2,500 grams is about 5 lbs, 8 oz and 1,500 grams is about 3 lbs, 5 oz.
Numerator: Number of live-born infants with a birth weight of less than 2,500 grams (LBW) or less than 1,500 grams (VLBW) born to resident mothers
Denominator: Number of live infants born to resident mothers

Indicator Profile Report

Birth Weight: (exits this report)

Date Content Last Updated

05/19/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Fetal Mortality Rate: Fetal Deaths per 1,000 Live Births Plus Fetal Deaths, 2018-2021

  • Burlington
    5.9
    95% Confidence Interval (4.8 - 7.0)
    State
    6.6
    U.S.
    5.8
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

The fetal mortality rate is a critical measure of a population's health and is an important indicator of fetal and maternal health status and medical care.

How Are We Doing?

There are approximately 600-700 fetal deaths of 20 or more weeks gestation among New Jersey residents each year. The New Jersey fetal mortality rate (FMR) in 2021 was 6.2 fetal deaths per 1,000 live births plus fetal deaths. The rate among non-Hispanic black mothers is two to three times the rates among other racial/ethnic groups.

What Is Being Done?

The Division of [http://www.nj.gov/health/fhs/ Family Health Services] in the New Jersey Department of Health administers programs to enhance the health, safety and well-being of families and communities in New Jersey. Several programs are aimed at improving children's health, including reducing fetal mortality. The Department of Health has provided state funding to improve perinatal public health services and birth outcomes in communities. Fetal deaths are reviewed by the [https://www.nj.gov/health/fhs/maternalchild/mchepi/mortality-reviews/ Fetal Infant Mortality Review] Team and recommendations to reduce future deaths are made to public and private sources of care including hospitals, clinics, and health care professionals throughout the state. Efforts are continuing to increase public and provider awareness of needs for greater access to maternal preconception care, more awareness of risky preconception and post-conception behavior and for better general maternal health care.

Healthy People Objective MICH-1.1:

Fetal deaths at 20 or more weeks of gestation
U.S. Target: 5.6 fetal deaths per 1,000 live births and fetal deaths

Note

**Too few fetal deaths to calculate a reliable rate. Confidence limits are not available for US data.

Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Fetal Death Certificate Database, Office of Vital Statistics and Registration, New Jersey Department of Health  

Measure Description for Fetal Mortality Rate

Definition: The number of resident fetal deaths of 20 or more weeks gestation per 1,000 resident live births plus fetal deaths of 20 or more weeks of gestation in the same year. A fetal death is death prior to the complete expulsion or extraction from its mother of a product of conception; the fetus shows no signs of life such as breathing or beating of the heart, pulsation of the umbilical cord, or definite movement of voluntary muscles.
Numerator: Number of resident fetal deaths of 20 or more weeks gestation in a given year
Denominator: Number of live births plus fetal deaths of 20 or more weeks gestation to resident mothers in the same year

Indicator Profile Report

Fetal Mortality Rate (exits this report)

Date Content Last Updated

08/22/2023

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Infant Mortality Rate: Deaths per 1,000 Live Births, 2016-2020

  • Burlington
    4.8
    95% Confidence Interval (3.9 - 5.7)
    State
    4.2
    U.S.
    5.7
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

The infant death rate is a critical measure of a population's health and a worldwide indicator of health status and social well-being.

How Are We Doing?

The infant mortality rate in New Jersey has been generally decreasing since the early 1900s. However, the rate varies widely across the state and by several maternal and infant characteristics. The rate among Blacks is more than triple the rate among Whites and Asians and more than double the rate among Hispanics. Regardless of age, unmarried mothers have higher rates than those of married mothers. Twin and triplet, low birth weight, and preterm infants are much more likely to die than singleton, normal birth weight, and full term infants, respectively. Two-thirds of infant deaths occur in the neonatal period (deaths at less than 28 days of age). The leading causes of infant death are congenital anomalies and short gestation/low birth weight. The [https://www.nj.gov/health/chs/hnj2020/topics/maternal-child-health.shtml Healthy New Jersey 2020] targets for the total population, Hispanics, and Asians had been met by mid-decade, so new targets were assigned.

What Is Being Done?

The [http://www.nj.gov/health/fhs/ Division of Family Health Services] in the New Jersey Department of Health administers several programs aimed at improving children's health, including reducing infant mortality. In an effort to improve health outcomes among Black infants and mothers in New Jersey, six maternal and child health agencies across the state were awarded $4.3 million in grant funding in July, 2018, as part of the Department of Health's "[https://nj.gov/health/news/2018/approved/20180711a.shtml Healthy Women, Healthy Families]" initiative. In addition to these funds, the Department devoted $450,000 to implement a doula pilot program in municipalities with high Black IMRs. [https://nj.gov/governor/admin/fl/nurturenj.shtml Nurture NJ] is a multifaceted initiative to eliminate racial disparities in birth outcomes.

Healthy People Objective MICH-1.3:

All infant deaths (within 1 year)
U.S. Target: 6.0 infant deaths per 1,000 live births
State Target: 4.8 infant deaths per 1,000 live births

Note

** Number of deaths too small to calculate a reliable rate.

Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Linked Infant Death-Birth Database, Center for Health Statistics, New Jersey Department of Health  

Measure Description for Infant Mortality Rate

Definition: Rate of death occurring under 1 year of age in a given year per 1,000 live births in the same year
Numerator: Number of resident deaths occurring under 1 year of age in a given year
Denominator: Number of live births to resident mothers in the same year

Indicator Profile Report

Infant Mortality Rate (exits this report)

Date Content Last Updated

12/30/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Neonatal Mortality Rate: Deaths per 1,000 Live Births, 2016-2020

  • Burlington
    3.4
    95% Confidence Interval (2.6 - 4.1)
    State
    2.8
    U.S.
    3.8
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Neonatal mortality is an important indicator of newborn and maternal health status and medical care (pre- and post-delivery).

How Are We Doing?

Two-thirds of infant deaths occur in the neonatal period. The neonatal mortality rate in New Jersey has been decreasing, yet disparities exist across the state and by maternal and infant characteristics. The rate among children of Black mothers is 2 to 3 times that of other racial/ethnic groups and most of the counties with high neonatal mortality rates are in South Jersey. The leading causes of neonatal mortality are the same as those among all infants: short gestation (prematurity)/low birth weight and congenital anomalies. These two causes account for about 40% of neonatal deaths.

What Is Being Done?

The [http://www.nj.gov/health/fhs/ Division of Family Health Services] in the New Jersey Department of Health administers several programs aimed at improving children's health, including reducing infant mortality. In an effort to improve health outcomes among Black infants and mothers in New Jersey, six maternal and child health agencies across the state were awarded $4.3 million in grant funding in July, 2018, as part of the Department of Health's "[https://nj.gov/health/news/2018/approved/20180711a.shtml Healthy Women, Healthy Families]" initiative. In addition to these funds, the Department devoted $450,000 to implement a doula pilot program in municipalities with high Black infant mortality rates. [https://nj.gov/governor/admin/fl/nurturenj.shtml Nurture NJ] is a multifaceted initiative to eliminate racial disparities in birth outcomes.

Healthy People Objective MICH-1.4:

Neonatal deaths (within the first 28 days of life)
U.S. Target: 4.1 neonatal deaths per 1,000 live births

Note

** The number of deaths is too small to calculate a reliable rate.

Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Linked Infant Death-Birth Database, Center for Health Statistics, New Jersey Department of Health  

Measure Description for Neonatal Mortality Rate

Definition: Rate of death occurring before 28 days of age in a given year per 1,000 live births in the same year Infant mortality is death within the first year of life. It is divided into two components: death before the 28th day of life is neonatal mortality; death between 28 days and one year is postneonatal mortality.
Numerator: Number of resident deaths occurring under 28 days of age in a given year
Denominator: Number of live births to resident mothers in the same year

Indicator Profile Report

Neonatal Mortality Rate (exits this report)

Date Content Last Updated

08/16/2023

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Perinatal Mortality Rate: Deaths per 1,000 Live Births Plus Fetal Deaths, 2018-2020

  • Burlington
    5.2
    95% Confidence Interval NA
    State
    5.0
    U.S.
    5.6
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

The perinatal death rate is a critical measure of a population's health. Fetal and neonatal mortality, the components of perinatal mortality, are important indicators of fetal, infant, and maternal health status and medical care (pre- and post-delivery).

How Are We Doing?

The perinatal mortality rate in New Jersey is slowly declining, yet disparities exist across the state and by maternal and infant characteristics. For example, the rate among children of Black mothers is well above that of other race/ethnicity groups.

What Is Being Done?

The Division of [https://nj.gov/health/fhs/ Family Health Services] in the New Jersey Department of Health administers programs to enhance the health, safety and well-being of families and communities in New Jersey. Several programs are aimed at improving children's health, including reducing perinatal mortality. Information on programs that promote availability and use of [http://njparentlink.nj.gov/njparentlink/health/before/ prenatal care services] and programs that promote [http://njparentlink.nj.gov/njparentlink/health/safety/ newborn health] are available online. The Department of Health has provided state funding to improve perinatal public health services and birth outcomes in communities. Perinatal deaths are reviewed by the [https://www.nj.gov/health/fhs/maternalchild/outcomes/mortality-reviews/ Fetal Infant Mortality Review Team] and recommendations to reduce future deaths are made to public and private sources of care including hospitals, clinics, and health care professionals throughout the state. Efforts are continuing to increase public and provider awareness of needs for greater access to maternal preconception care, more awareness of risky preconception and post-conception behavior and for better general maternal health care.

Healthy People Objective MICH-1.2:

Fetal and infant deaths during perinatal period (28 weeks of gestation to 7 days after birth)
U.S. Target: 5.9 perinatal deaths per 1,000 live births and fetal deaths

Note

This indicator uses NCHS Definition I of perinatal mortality. Please note the age for neonatal deaths and the gestational age for fetal deaths when making comparisons to other data sources as Definition II is more inclusive and therefore produces higher rates than Definition I.  ** The number of deaths is too small to calculate a reliable rate.

Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Fetal Death Certificate Database, Office of Vital Statistics and Registration, New Jersey Department of Health   Linked Infant Death-Birth Database, Center for Health Statistics, New Jersey Department of Health  

Measure Description for Perinatal Mortality Rate

Definition: Rate of fetal deaths at 28 or more weeks of gestation plus infant deaths less than 7 days of age in a given year, per 1,000 live births plus fetal deaths of 28 or more weeks gestation in the same year. [NCHS Definition I] Fetal death, which is also referred to as stillbirth or miscarriage, is defined as death prior to the complete expulsion or extraction of the fetus from its mother, where the fetus shows no signs of life. Additionally, only spontaneous fetal deaths, not induced or intentional terminations of pregnancy, are included in this definition.
Numerator: Number of resident fetal deaths at 28 or more weeks of gestation plus resident infant deaths less than 7 days old in a given year
Denominator: Number of live births plus fetal deaths of 28 or more weeks gestation to resident mothers in the same year

Indicator Profile Report

Perinatal Mortality Rate (exits this report)

Date Content Last Updated

08/22/2023

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Postneonatal Mortality Rate: Deaths per 1,000 Live Births, 2016-2020

  • Burlington
    1.5
    95% Confidence Interval (1.0 - 2.0)
    State
    1.3
    U.S.
    1.9
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Postneonatal mortality is an important indicator of infant and maternal health status and medical care (pre and post delivery), as well as a measure of how certain behavioral factors affect infant health.

How Are We Doing?

One-third of infant deaths occur in the postneonatal period. The postneonatal mortality rate among children of Black mothers is three to six times that of other racial/ethnic groups. The leading causes of postneonatal mortality are sudden infant death syndrome (SIDS) and congenital anomalies (birth defects). These two causes account for about 40% of postneonatal deaths.

What Is Being Done?

The [http://www.nj.gov/health/fhs/ Division of Family Health Services] in the New Jersey Department of Health administers several programs aimed at improving children's health, including reducing infant mortality. In an effort to improve health outcomes among Black infants and mothers in New Jersey, six maternal and child health agencies across the state were awarded $4.3 million in grant funding in July, 2018, as part of the Department of Health's "[https://nj.gov/health/news/2018/approved/20180711a.shtml Healthy Women, Healthy Families]" initiative. In addition to these funds, the Department devoted $450,000 to implement a doula pilot program in municipalities with high Black infant mortality rates.

Healthy People Objective MICH-1.5:

Postneonatal deaths (between 28 days and 1 year)
U.S. Target: 2.0 postneonatal deaths per 1,000 live births

Note

** The number of deaths is too small to calculate a reliable rate.

Data Sources

Birth Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Linked Infant Death-Birth Database, Center for Health Statistics, New Jersey Department of Health  

Measure Description for Postneonatal Mortality Rate

Definition: Rate of death occurring from 28 days to 364 days of age in a given year per 1,000 live births in the same year Infant mortality is death within the first year of life. This is divided into two components: death before the 28th day of life is neonatal mortality; death between 28 days and one year is postneonatal mortality.
Numerator: Number of resident deaths occurring from 28 days to 364 days of age in a given year
Denominator: Number of live births to resident mothers in the same year

Indicator Profile Report

Postneonatal Mortality Rate (exits this report)

Date Content Last Updated

08/16/2023

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




General Health Status: Estimated Percent, 2017-2020*

  • Burlington
    85.9
    95% Confidence Interval (83.3 - 88.2)
    State
    84.7
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Self-rated health (SRH) is an independent predictor of important health outcomes including mortality, morbidity, and functional status. It is considered to be a reliable indicator of a person's perceived health and is a good global assessment of a person's well being.

How Are We Doing?

In 2020, 88.4% of New Jersey adults aged 18 and older reported good, very good or excellent general health status.

Note

Question Text: "Would you say that in general your health is excellent, very good, good, fair, or poor?"  *2019 data is not included in the average estimated prevalence. No data is available for 2019.

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for General Health Status

Definition: Percentage of adults in designated subgroup who reported good, very good, or excellent general health
Numerator: Weighted number of survey respondents in designated subgroup who reported good, very good, or excellent general health
Denominator: Weighted total number of survey respondents in designated subgroup except those with missing, "Don't know/Not sure," and "Refused" responses

Indicator Profile Report

Percent of Adults Aged 18 Years or Older Reporting Good, Very Good, or Excellent Health Status (exits this report)

Date Content Last Updated

10/27/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Obesity Among Adults: Estimated Percent (Age-adjusted), 2017-2020*

  • Burlington
    30.5
    95% Confidence Interval (26.3 - 34.9)
    State
    27.9
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Adults who are obese are at increased risk of morbidity from hypertension, high LDL cholesterol, type 2 diabetes, coronary heart disease, stroke, and osteoarthritis.

Risk and Resiliency Factors

'''Genetic''' or '''familial''' factors may increase the risk for being overweight or obese for some people, but anyone whose '''calorie intake''' exceeds the number of calories they burn is at risk. '''Physical activity''' and a '''healthy diet''' are both important for obtaining and maintaining a healthy weight. Note: [https://www-doh.state.nj.us/doh-shad/query/builder/njbrfs/BMIObese/BMIObeseAA11_.html Custom data views] of the prevalence of obesity among New Jersey adults by selected '''sociodemographic and other characteristics''' (including '''physical activity)''' can be generated using the New Jersey Behavioral Risk Factor Survey interactive query module.

How Are We Doing?

The age-adjusted prevalence of obese New Jersey adults increased from 23.8% in 2011 to 28.6% in 2020.

What Is Being Done?

The New Jersey Nutrition, Physical Activity, and Obesity (NPAO) Program within the NJDOH Office of Nutrition and Fitness coordinates efforts to work with communities to develop, implement, and evaluate interventions that address behaviors related to increasing physical activity, breastfeeding initiation and duration, and the consumption of fruits and vegetables, and to decreasing the consumption of sugar-sweetened beverages and high-energy-dense foods, and to decrease television viewing.

Healthy People Objective NWS-9:

Reduce the proportion of adults who are obese
U.S. Target: 30.6 percent (age-adjusted)
State Target: 23.8 percent (age-adjusted)

Note

All prevalence estimates are age-adjusted to the U.S. 2000 standard population (except for estimates by age group). Respondents tend to overestimate their height and underestimate their weight leading to underestimation of BMI and the prevalence of obesity.  *2019 data is not included in the average estimated prevalence. No data is available for 2019.

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Obesity Among Adults

Definition: Percentage of respondents who have a body mass index (BMI) greater than or equal to 30.0 kg/m2 calculated from self-reported weight and height. BMI is calculated by dividing weight in kilograms by the square of height in meters.
Numerator: Number of respondents who have a body mass index (BMI) greater than or equal to 30.0 kg/m2 calculated from self-reported weight and height.
Denominator: Number of adult respondents for whom BMI can be calculated from their self-reported weight and height (excludes unknowns or refusals for weight and height).

Indicator Profile Report

Percentage of Adults Aged 20+ Who are Obese (exits this report)

Date Content Last Updated

10/27/2022

For more information:

Nutrition, Physical Activity, and Obesity Program, Office of Nutrition and Fitness, Division of Family Health Services, New Jersey Department of Health, 50 E State St, Trenton, NJ 08625, Phone: 609-292-2209, Web: http://www.nj.gov/health/nutrition/




Asthma Prevalence in Adults: Estimated Percent (Age-adjusted), 2017-2020*

  • Burlington
    9.6%
    95% Confidence Interval (7.6% - 12.1%)
    State
    8.5%
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Asthma is a serious personal and public health issue that has far reaching medical, economic, and psychosocial implications. People with asthma are more likely to miss school or work, report feelings of depression, and experience an overall reduced quality of life. Asthma is also costly, with expenses from routine checkups, emergency department visits, hospitalizations, and medications putting a significant burden on families, the health care sector, and the economy. Though it cannot be cured, asthma can be controlled through quality health care, appropriate medications, and good self-management skills. When asthma is controlled, people with the disease have few, if any, symptoms, and can live normal and productive lives.

How Are We Doing?

In 2020, the adult asthma prevalence in New Jersey was 8.7%. Blacks (12.2%) have higher prevalence of asthma compared to Whites (8.9%) and Asians (3.2%) in the state. Adult asthma prevalence is higher for women than men in every age category.

What Is Being Done?

New Jersey is conducting outreach to provide asthma self-management education to reduce asthma related visits to the emergency departments for both adults and children with asthma. The NJ In-Home Asthma Program will be implemented to 1) improve asthma control; 2) improve use of routine Primary Care Provider (PCP) visits for asthma management; 3) reduce ED or Urgent Care use for uncontrolled asthma; 4) provide education and resources for reducing asthma triggers in the home; and 5) provide PCPs with updates regarding participant status and summary of asthma visit program outcomes. [https://www.nj.gov/health/fhs/chronic/asthma/in-nj/] [https://www.cdc.gov/asthma/]

Evidence-based Practices

The home-based intervention is for both pediatric and adult patients with poorly controlled asthma. It is based on a staffing model that employs Community Health Workers (CHWs), with supervision by a Clinical Supervisor. It is a modified version of the NJ In-Home Asthma Pilot Project, funded by The Nicholson Foundation. The intervention is based on [https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1939375/ Krieger's pediatric asthma care model], and is one of the interventions used by the [http://www.asthmaregionalcouncil.org/our-work/neaic/about-neaic/ New England Asthma Innovations Collaborative (NEAIC)], funded by the [https://www.usa.gov/federal-agencies/centers-for-medicare-and-medicaid-services/ Centers for Medicare and Medicaid Services]. The NJ In-Home Asthma Program includes both children and adults and will add to the literature base.

Note

All prevalence estimates are age-adjusted to the U.S. 2000 standard population (except for rates by age group).  *2019 data is not included in the average estimated prevalence. No data is available for 2019

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Asthma Prevalence in Adults

Definition: Adults aged 18 and over, who reported having been told by a doctor that they have asthma and who currently have asthma.
Numerator: Total number of respondents answering "yes" to both of the BRFSS asthma core questions: 1. Have you ever been told by a doctor, nurse, or other health professional that you had asthma? 2. Do you still have asthma?
Denominator: Includes all survey respondents ages 18 years and older except those with missing, don't know, or refused answers to the core asthma questions

Indicator Profile Report

Asthma Prevalence Among Adults Aged 18 and Over (exits this report)

Date Content Last Updated

05/13/2019

For more information:

Community Health and Wellness, Division of Community Health Services, New Jersey Department of Health, Trenton, NJ 08625, Web: https://nj.gov/health/fhs/chronic/




Asthma Hospitalizations and Emergency Department Visits: Rate per 10,000 Residents, 2020

  • Burlington
    5.0
    95% Confidence Interval NA
    State
    3.8
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Asthma is a chronic disease that affects the airways that carry oxygen in and out of the lungs. Asthma cannot be cured, but it can be controlled with an effective medical management plan and avoidance of environmental or occupational triggers.

How Are We Doing?

In New Jersey, over 600,000 adults (9.0%) and 167,000 children (8.7%) are estimated to have asthma currently. The number of women with asthma is almost double the number of men with asthma; however, asthma occurs more frequently in boys than girls. Anyone can develop asthma; however, children, Black, Hispanic, and urban residents are most likely to be affected. Individuals with allergies and people with a family history of asthma are also most likely to suffer from this disease. Hospitalization rates for asthma do not represent the total burden of the illness. Most asthma attacks are successfully managed without hospitalization. Many people with asthma prevent serious asthma attacks through avoidance of triggers and effective medical management. In addition, many people with asthma episodes are treated in emergency departments and are not included in hospitalization statistics. Hospitalization rates measure an infrequent, severe outcome of this disease. Asthma inpatient hospitalization and emergency department (ED) visit rates vary widely among New Jersey counties. Rates for emergency visits are highest in Cumberland, Essex, and Camden Counties, and lowest in Somerset, Morris and Hunterdon Counties. Disparities in inpatient hospitalization and emergency department visit rates likely reflect differences in: access to effective medical management; co-existing chronic diseases; and environmental or occupational asthma triggers. The Healthy New Jersey 2020 targets for hospitalizations and ED visits were revised due to the change in medical record coding to ICD-10-CM. Hospital claim volume for the 2020 calendar year was markedly lower than for 2019, mostly due to the COVID-19 pandemic.

What Is Being Done?

The NJ Department of Health's [http://nj.gov/health/fhs/chronic/asthma/ Asthma Awareness and Education Program] (AAEP) provides information on asthma for consumers and health professionals. The NJ Department of Health's Occupational Health Service has a [http://www.state.nj.us/health/eoh/survweb/wra/index.shtml Work-Related Asthma Program] that provides information to workers and employers about prevention of asthma in the workplace. State law (Statute Amendment 18A:40-12.3) requires school districts to allow students to carry and administer their own asthma medication. The law further requires both public and non-public schools to provide and maintain at least one nebulizer for students with asthma.

Healthy People Objective RD-2:

Reduce hospitalizations for asthma
U.S. Target: a. children under 5 years of age: 18.2, b. persons aged 5 to 64 years: 8.7 (age-adjusted), c. persons aged 65 years and older: 20.1 (age-adjusted)

Note

Hospital claim volume for the 2020 calendar year was markedly lower than for 2019, mostly due to the COVID-19 pandemic. See Data Interpretation Issues for more information.

Data Sources

Population Estimates, [http://lwd.state.nj.us/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development   Uniform Billing Patient Summary, Division of Health Care Quality and Assessment, New Jersey Department of Health, [http://www.nj.gov/health/healthcarequality/health-care-professionals/njddcs/]  

Measure Description for Asthma Hospitalizations and Emergency Department Visits

Definition: Hospitalizations or emergency department (ED) visits with a primary diagnosis of asthma. *ICD-9-CM code: 493 (2000 through 2015) *ICD-10-CM code: J45 (2016 and onward)
Numerator: Number of hospitalizations or ED visits due to asthma occurring among residents of a geographic area in a time period.
Denominator: For rates, estimated population of a geographic area in a time period using mid-year population estimates.

Indicator Profile Report

Asthma (exits this report)

Date Content Last Updated

02/10/2022

For more information:

Environmental Public Health Tracking Project, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, Phone: 609-826-4984, e-mail: nj.epht@doh.nj.gov, Web: www.nj.gov/health/epht




Chronic Obstructive Pulmonary Disease (COPD) Prevalence: Estimated Percent (Age-adjusted), 2018-2020*

  • Burlington
    6.7
    95% Confidence Interval (4.6 - 9.8)
    State
    4.6
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

COPD is a serious lung disease that makes it hard to breathe and gets worse over time. COPD can cause coughing with or without large amounts of mucus, wheezing, shortness of breath, chest tightness, and other symptoms. When COPD is severe, it can cause serious, long-term disability.

How Are We Doing?

In 2020, the adult COPD age-adjusted prevalence in New Jersey was 4.5%. Blacks (4.9%) and Whites (4.6%) have a higher prevalence of COPD compared to Hispanics (3.9%), and Asians (2.5%) in the state.

Note

*2019 data is not included in the average estimated prevalence. No data is available for 2019. All prevalence estimates are age-adjusted to the U.S. 2000 standard population.

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Chronic Obstructive Pulmonary Disease (COPD) Prevalence

Definition: Estimated percentage of New Jersey adults (ages 18 and over) who have been diagnosed with COPD. In the United States, the term "COPD" includes two main conditions: emphysema and chronic bronchitis. Because most people diagnosed with COPD have both emphysema and chronic bronchitis, the general term "COPD" is often used.
Numerator: Number of adults from the Behavioral Risk Factor Surveillance System who have been told by a doctor, nurse or other health professional that they have COPD, emphysema or chronic bronchitis.
Denominator: Number of survey respondents excluding those with missing, "Don't know/Not sure," and "Refused" responses.

Indicator Profile Report

Prevalence of Diagnosed COPD among Adults (exits this report)

Date Content Last Updated

02/01/2023

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Chronic Obstructive Pulmonary Disease (COPD) Hospitalizations & ED Visits: Emergency Department Visits per 10,000 Population, 2020

  • Burlington
    12.25
    95% Confidence Interval NA
    State
    13.65
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production and wheezing. COPD is caused by long-term exposure to irritating gases or particulate matter, most often from cigarette smoke. People with COPD are at increased risk of developing heart disease, lung cancer and a variety of other conditions. Emphysema and chronic bronchitis are the two most common conditions that contribute to COPD. Chronic bronchitis is inflammation of the lining of the bronchial tubes, which carry air to and from the air sacs (alveoli) of the lungs. It's characterized by daily cough and mucus (sputum) production. Emphysema is a condition in which the alveoli at the end of the smallest air passages (bronchioles) of the lungs are destroyed as a result of damaging exposure to cigarette smoke and other irritating gases and particulate matter. Chronic lower respiratory disease, primarily COPD, was the fourth leading cause of death in the United States in 2019. Over eleven million Americans are believed to have been diagnosed with COPD.

How Are We Doing?

Since 2017, the inpatient hospitalization rate has shown a steady decrease. Inpatient hospitalization rates for COPD do not represent the total burden of the illness. Most cases of COPD are managed without hospitalization. Individuals with COPD prevent hospitalization through avoidance of triggers and medical management. In addition, many people with COPD are treated in emergency departments and are not included in inpatient hospitalization statistics. Hospitalization rates measure a severe outcome of this disease. COPD inpatient hospitalization and emergency department (ED) visit rates vary widely among New Jersey counties. Rates for inpatient hospitalizations are highest in Cape May and Cumberland Counties. Rates for emergency department visits are highest in Atlantic and Cumberland Counties. Disparities in inpatient hospitalization and emergency department visit rates likely reflect differences in: smoking; access to effective medical management; co-existing chronic diseases; and environmental or occupational triggers.

Note

Incidence rates per 10,000 population are age-adjusted to the 2000 US standard population (18 age groups: <5, 5-9, ... , 80-84, 85+).

Data Sources

American Community Survey, U.S. Census Bureau, [https://www.census.gov/programs-surveys/acs/]   Office of Health Care Quality and Assessment, New Jersey Department of Health, [http://www.nj.gov/health/healthcarequality/]  

Measure Description for Chronic Obstructive Pulmonary Disease (COPD) Hospitalizations & ED Visits

Definition: Number or rate of hospitalizations or emergency room visits due to chronic obstructive pulmonary disease (COPD) in a geographic area in a time period (primary diagnosis of COPD, defined by ICD-9 490-492, 493.2 (only when 490-492 or 496 is present), 496 or ICD-10 codes J40-44).
Numerator: Number of hospitalizations or emergency room visits due to COPD occurring among residents of a geographic area in a time period
Denominator: For rates, estimated population of a geographic area in a time period using mid-year population estimates.

Indicator Profile Report

Chronic Obstructive Pulmonary Disease (COPD) (exits this report)

Date Content Last Updated

01/06/2022

For more information:

Environmental Public Health Tracking Project, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, Phone: 609-826-4984, e-mail: nj.epht@doh.nj.gov, Web: www.nj.gov/health/epht




Heart Attack (Acute Myocardial Infarction) Hospitalizations: Rate per 10,000 Residents, 2020

  • Burlington
    24.74
    95% Confidence Interval NA
    State
    23.48
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

A heart attack (acute myocardial infarction) occurs because of coronary heart disease, which is the narrowing of the coronary arteries that supply blood to the heart muscle. When the blood supply to part of the heart is interrupted or blocked, the heart muscle is deprived of oxygen. This can result in chest pain, shortness of breath, nausea, palpitations, sweating and anxiety. Risk factors for coronary heart disease include: high levels of low-density lipoprotein ("bad cholesterol") and triglycerides in the blood; high blood pressure; diabetes; a diet high in saturated fat; physical inactivity; obesity; and excessive alcohol use. Recent research has shown that fine particulate matter air pollution can increase the risk of heart attacks.

How Are We Doing?

According the the CDC, cardiovascular disease, listed as an underlying cause of death, accounts for nearly 801,000 deaths in the US. That's about 1 of every 3 deaths in the US. Nationally, about 2,200 Americans die of cardiovascular disease each day, an average of 1 death every 40 seconds. The American Heart Association reports the estimated annual incidence of heart attack in the US is 580,000 new attacks and 210,000 recurrent attacks. Average age at the first heart attack is 65.3 years for males and 71.8 years for females. From 2004 to 2020, the annual death rate attributable to coronary heart disease has steadily declined. Progress in reducing heart disease death rates may be attributed to changes in behaviors to reduce risk factors, improved medical management, and advances in medical treatment. Inpatient hospitalization rates for heart attack do not reflect the total burden of illness due to heart disease, since some people die of a coronary event in an emergency department or without being hospitalized. However, since heart attack inpatient hospitalization has been associated with fine particulate matter air pollution, this has been selected as an indicator for Environmental Public Health Tracking. In New Jersey, the age-adjusted hospitalization rate for acute myocardial infarction among adults 35 years and older has been slowly decreasing since 2002.

Note

Rates are age-adjusted to the U.S. 2000 population.

Data Sources

Office of Health Care Quality and Assessment, New Jersey Department of Health, [http://www.nj.gov/health/healthcarequality/]  

Measure Description for Heart Attack (Acute Myocardial Infarction) Hospitalizations

Definition: Number or rate of hospitalizations due to acute myocardial infarction (heart attack) in a geographic area in a period of time (primary diagnosis of acute myocardial infarction, defined by ICD-9 codes 410.00-410.92 for January 2000 through September 2015, and ICD-10 codes I21 and I22 for the last quarter of 2015 and beyond)
Numerator: Number of inpatient hospitalizations due to acute myocardial infarction occurring among residents aged 35 and older within a geographic area in a period of time
Denominator: For rates, estimated population of a specified age within a specified geographic area using mid-year population estimates

Indicator Profile Report

Hospitalizations Due to Heart Attack (exits this report)

Date Content Last Updated

02/16/2022

For more information:

Environmental Public Health Tracking Project, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, Phone: 609-826-4984, e-mail: nj.epht@doh.nj.gov, Web: www.nj.gov/health/epht




Hospitalization and Emergency Department Visits for Heat Related Illnesses: Annual Age-Adjusted Hospitalization Rates per 100,000, May through September, 2017-2021

  • Burlington
    1.63
    95% Confidence Interval NA
    State
    1.60
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

The relationship between extreme heat and increased daily morbidity is well established. This indicator captures inpatient hospital admissions or emergency department visits for heat-related illness or hyperthermia.

How Are We Doing?

Average annual temperatures in New Jersey have increased about 1.2 degrees Fahrenheit (F) between the period of 1971-2000 and the period of 2001-2010. In New Jersey, the total number of days over 90 degrees F has increased by roughly 36 percent since 1949. On average, based on data from 16 weather station locations spread across New Jersey, the number of days over 90 degrees F have increased from about 17 to 23 per year. There are however considerable temperature differences between north and south, coastal and inland, and urban and rural sections of New Jersey. Extreme heat events are predicted to increase in both intensity and duration in future years. Currently, New Jersey generally experiences two heat waves per year with temperatures exceeding 90 F, and the heat waves last about four days. By the 2020s, it is projected that New Jersey will annually experience three to four heat waves lasting four to five days each. Annual number of days over 90 degrees F are projected to rise from an average of 14 days in 2000 to 23-29 days by the 2020s.

What Is Being Done?

The NJDOH is using data collected from emergency departments and hospitals to identify and track excessive heat related illnesses among New Jersey's residents. NJDOH will use the information to implement targeted excessive heat event notification and actions that focus surveillance and relief efforts on high risk populations or communities. Appropriate actions include: establishing enhanced real-time syndromic surveillance systems to alert public health officials about increases in heat-related illnesses; enhancing real-time public notification regarding extreme heat events through the web, broadcast media, and social media; and enhancing access to cooling centers.

Related Indicators

Risk Factors:

Health Status Outcomes:


Note

** Rates and counts are suppressed if fewer than 10 cases were reported in a specific category.

Data Sources

Office of Health Care Quality and Assessment, New Jersey Department of Health, [http://www.nj.gov/health/healthcarequality/]  

Measure Description for Hospitalization and Emergency Department Visits for Heat Related Illnesses

Definition: Count or rate of hospitalization and emergency department visits for heat-related illnesses for a defined population in a specified time interval. Cases were selected using the following ICD-9 codes through September 2015: 992.0 - 992.9, E900.0, or E900.9 as a primary diagnosis, injury cause, or other diagnosis for occurrences during the months of May through September. Cases were excluded if a man-made source of heat (ICD-9 E900.1) was listed. Beginning October 2015, heat-related illness was defined by ICD-10 codes T67, X30, and X32 (exclusion W92).
Numerator: Count of inpatient hospitalizations or emergency department visits for heat related illnesses among a defined population during the months of May through September.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

Heat-related Illnesses (exits this report)

Date Content Last Updated

07/27/2023

For more information:

Environmental Public Health Tracking Project, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, Phone: 609-826-4984, e-mail: nj.epht@doh.nj.gov, Web: www.nj.gov/health/epht




Incidence of All Invasive Cancers: Rate per 100,000 Standardized Population, 2020*

  • Burlington
    471.7
    95% Confidence Interval (454.0 - 490.0)
    State
    442.1
    U.S.
    438.0
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Many cancers are preventable and screening is effective in identifying some types of cancers in early, often highly treatable stages.

How Are We Doing?

New Jersey's overall cancer incidence rate continues to decline. The rate is highest among Whites followed by Blacks and Hispanics with significant differences between the rate for each racial/ethnic group. Rates by site are higher among males than females for lung and bronchus, colon and rectum, melanoma of the skin, and non-Hodgkin lymphoma. Rates by county range from a low of 350.6 in Hudson to a high of 529.8 in Cape May.

What Is Being Done?

A [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm Comprehensive Cancer Control Plan] was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness, and deaths due to cancer among New Jersey residents.

Note

Rates are per 100,000 and age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) standard; Confidence intervals (Tiwari mod) are 95% for rates. Data Source: NJ State Cancer Registry SEER*Stat Database: February 17, 2023 analytic file. Created on 3/23/23. *NJ 2020 data is considered preliminary and should not be used in trend analyses; an approximate 10% decrease in the number of cancer cases diagnosed in 2020 compared to 2019, is partly due to the COVID-19 pandemic. US data are for 2019.

Data Sources

New Jersey State Cancer Registry, Cancer Epidemiology Services, New Jersey Department of Health, [https://www.nj.gov/health/ces/reporting-entities/njscr/]  

Measure Description for Incidence of All Invasive Cancers

Definition: The age-adjusted rate of invasive cancer per 100,000 population. ICD-O codes: C00-C97
Numerator: Number of persons with invasive cancer
Denominator: Total number of persons in the population

Indicator Profile Report

Invasive Cancer Incidence Rates (exits this report)

Date Content Last Updated

05/19/2023

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Bladder Cancer: Age-Adjusted Rate per 100,000 Males, 2014-2018

  • Burlington
    45.3
    95% Confidence Interval (41.5 - 49.3)
    State
    39.6
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

During 2018, over 1,800 men and 640 women in New Jersey were diagnosed with cancer of the urinary bladder. Bladder cancer is more common among men than women, and is more common among whites than blacks. Bladder cancer occurs more frequently as people age. Smoking is an established risk factor for bladder cancer, with smokers being diagnosed with bladder cancer twice as often as non-smokers.

How Are We Doing?

Between 1990 and 2018, the age-adjusted incidence rate of bladder cancer in New Jersey men averaged about 44 cases per 100,000 over the interval. Among New Jersey women, age-adjusted bladder cancer incidence averaged about 12 cases per 100,000 over the interval. The lifetime risk of developing bladder cancer is 1 in 26 for men and 1 in 85 for women.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents, [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Bladder Cancer

Definition: Incidence rate of invasive and in situ urinary bladder cancer for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of invasive and in situ urinary bladder cancer among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

NJ Age-Adjusted Invasive Urinary Bladder Cancer Incidence (exits this report)

Date Content Last Updated

10/04/2021

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Brain and Other Nervous System Cancers: Age-Adjusted Rate per 100,000 Males, 2014-2018

  • Burlington
    8.6
    95% Confidence Interval (6.9 - 10.4)
    State
    8.0
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

In New Jersey, 363 males and 331 females were diagnosed with brain and other nervous system (ONS) cancers during 2018. While a variety of risk factors have been found for brain and ONS cancers, the cause of most of these tumors is not fully understood.

How Are We Doing?

Between 1990 and 2018, the average age-adjusted incidence rate of brain and ONS cancer in New Jersey was 8.6 cases per 100,000 in males and 6.1 per 100,00 in females. The lifetime risk of developing brain and other nervous system cancer is 1 in 145 for men and 1 in 182 for women.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents, [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Related Indicators

Relevant Population Characteristics:


Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Brain and Other Nervous System Cancers

Definition: Incidence rate of invasive brain and other nervous system cancers for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of brain and other nervous system cancers among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

NJ Age-Adjusted Invasive Brain and ONS Cancer Incidence (exits this report)

Date Content Last Updated

10/04/2021

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Childhood Brain and Central Nervous System Cancers: Age-Adjusted Rate per 100,000, 1990-2018

  • Burlington
    3.8
    95% Confidence Interval (3.1 - 4.7)
    State
    3.7
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

In general, childhood cancers are rare and represent about 1% of all cancers. Cancers of the brain and central nervous system (CNS) are the second most common type of childhood cancers (ages 0 - 14), and represent over 20% of all cancers in this age group. At this time, we do not know what causes most childhood brain and CNS cancers.

How Are We Doing?

On average, 75 children ages 0-19 are diagnosed annually with brain and CNS cancers in New Jersey. Between 1990 and 2018, the New Jersey brain and central nervous system cancers incidence rates in children ages 0 - 14 and 0 - 19 were generally stable. Mortality rates for most types of childhood cancers have steadily decreased in recent years due to improved treatments.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Related Indicators

Health Status Outcomes:


Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases over the defined interval.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Childhood Brain and Central Nervous System Cancers

Definition: Incidence rate of brain and central nervous system cancers in children for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of brain and other nervous system cancers in children among a defined population in a specified time interval. Cases were selected using ICCC recode ICD-0-3/WHO recode.
Denominator: Defined population in a specified time interval. Population age groups 0-14 and 0-19 are both found to be useful by the International Classification of Childhood Cancers (ICCC).

Indicator Profile Report

Incidence of Childhood Brain and Central Nervous System Cancers (exits this report)

Date Content Last Updated

10/25/2021

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Childhood Leukemia: Age-Adjusted rate per 100,000, 1990-2018

  • Burlington
    5.4
    95% Confidence Interval (4.5 - 6.4)
    State
    5.3
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

In general, childhood cancers are rare and represent about 1% of all cancers. Leukemias are the most common childhood cancers, accounting for about 30 percent of all cancers in children age 0 - 14 years. Acute lymphocytic leukemia (ALL) accounts for about 75 percent of childhood leukemias. At this time, we do not know what causes most leukemias.

How Are We Doing?

Between 1990 and 2018, New Jersey childhood leukemia incidence rates (ages 0 - 14, and 0 - 19), were generally stable. On average, 107 children ages 0-19 are diagnosed annually with leukemia in New Jersey. Mortality rates for most types of childhood cancers have steadily decreased in recent years due to improved treatments.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Related Indicators

Health Status Outcomes:


Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases over the defined interval.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Childhood Leukemia

Definition: Incidence rate of leukemia in children for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of leukemia in children among a defined population in a specified time interval. Cases were selected using ICCC recode ICD-0-3/WHO recode.
Denominator: Defined population in a specified time interval. Population age groups 0-14 and 0-19 are both found to be useful by the International Classification of Childhood Cancers (ICCC).

Indicator Profile Report

Incidence of Childhood Leukemia in New Jersey (exits this report)

Date Content Last Updated

09/22/2020

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Breast Cancer in Females: Age-Adjusted Rate per 100,000, 2014-2018

  • Burlington
    148.4
    95% Confidence Interval (142.0 - 155.0)
    State
    137.2
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

In New Jersey, 7,855 women were diagnosed with breast cancer in 2018. Breast cancer is the most common cancer among women in the United States, other than skin cancer. It is the second leading cause of cancer death in American women, after lung cancer.

Risk and Resiliency Factors

According to the [https://www.cancer.gov/types/breast/hp/breast-prevention-pdq National Cancer Institute], the major risk factors for breast cancer are '''female sex''' and '''increasing age'''. Women with '''dense breasts''' have an increased risk proportionate to the degree of density. Among women with a '''family history of breast cancer''', risk is doubled if a single first-degree relative is affected and risk is increased fivefold if two first-degree relatives are diagnosed. Also, the lifetime risk is 55% to 65% for '''BRCA1''' mutation carriers and 45% to 47% for '''BRCA2''' mutation carriers compared to a lifetime risk of 12% in the general population. Reproductive risk factors: Women who have a '''full-term pregnancy''' before age 20 years have a 50% decrease in breast cancer risk compared with nulliparous women or women who give birth after age 35 years, and women who practice '''breast-feeding''' have a 4% decrease in risk of breast cancer for every 12 months of breast-feeding in addition to 7% for each birth. Also, undergoing oophorectomy or other forms of '''premature menopause''' may reduce breast cancer risk as much as 75% depending on age, weight, and parity, with the greatest reduction for young, thin, nulliparous women. Conversely, women who experience '''menarche at age 11 years or younger''' have about a 20% greater chance of developing breast cancer than do those who experience menarche at age 14 years or older. Behavioral risk factors: [https://www-doh.state.nj.us/doh-shad/query/builder/njbrfs/AlcoholChrnHvy/AlcoholChrnHvyCrude11_.html Alcohol consumption] is associated with increased breast cancer risk in a dose-dependent fashion and '''obesity''' is associated with an increased breast cancer risk in postmenopausal women who have not used combination hormone therapy (although it is uncertain whether either reduced alcohol consumption among women who are heavy drinkers or weight reduction among obese women decreases the risk of breast cancer). Conversely, '''exercising strenuously''' for more than 4 hours per week is associated with an average RR reduction of 30% to 40%. (The effect may be greatest for premenopausal women of normal or low body weight.) [Last reviewed: 1/26/20]

How Are We Doing?

Between 1990 and 2018, the average age-adjusted breast cancer rate in females was 135.7 per 100,000. During the same time period, the age-adjusted breast cancer rate for women age 50 and older decreased from 397.5 cases to 361.1 cases per 100,000. The lifetime risk of developing breast cancer is 1 in 8 for women and 1 in 769 for men.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Breast Cancer in Females

Definition: Incidence rate of invasive breast cancer in females for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of breast cancer in females among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

NJ Age-Adjusted Invasive Breast Cancer Incidence in Females (exits this report)

Date Content Last Updated

10/18/2021

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Esophageal Cancer: Age-Adjusted Rate per 100,000 Males, 2014-2018

  • Burlington
    7.4
    95% Confidence Interval (5.9 - 9.0)
    State
    7.4
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

During 2018, 379 male and 112 female New Jersey residents were diagnosed with cancer of the esophagus. Esophageal cancer does have some modifiable risk factors. You can reduce your risk of developing this disease by avoiding tobacco and alcohol, watching your diet and body weight, and getting treated for gastroesophageal reflux disease or Barrett's esophagus.

How Are We Doing?

Between 1990 and 2018, the age-adjusted esophageal cancer rate in males averaged 8.4 cases per 100,000. In females, the average rate was 2.2 cases per 100,000. The lifetime risk of developing esophageal cancer is 1 in 125 for men and 1 in 417 for women.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents, [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Esophageal Cancer

Definition: Incidence rate of invasive esophagus cancer for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of esphageal cancer among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

NJ Age-Adjusted Invasive Esophageal Cancer Incidence (exits this report)

Date Content Last Updated

09/22/2020

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Kidney and Renal Pelvis Cancer: Age-Adjusted Rate per 100,000 Males, 2014-2018

  • Burlington
    28.4
    95% Confidence Interval (25.5 - 31.6)
    State
    23.0
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

During 2018, 1,179 male and 658 female New Jersey residents were diagnosed with kidney and renal pelvis cancer. Cancer of the kidney and renal pelvis is more common among people over 50, and occurs more often among men than women. The risk of kidney cancer among smokers is about 40% higher than among nonsmokers.

How Are We Doing?

Between 1990 and 2018, the age-adjusted kidney and renal pelvis cancer rate in males increased from about 15 cases to 24 cases per 100,000. In females the increase was from about 8 cases to 11 cases per 100,000. The reasons for the increase are not clear, though increased use of diagnostic imaging techniques may allow the finding of more kidney cancers. The lifetime risk of developing kidney and renal pelvis cancer is 1 in 46 for men and 1 in 81 for women.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Kidney and Renal Pelvis Cancer

Definition: Incidence rate of invasive kidney and renal pelvis cancer for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of kidney and renal pelvis cancer among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

NJ Age-Adjusted Invasive Kidney and Renal Pelvis Cancer Incidence (exits this report)

Date Content Last Updated

10/04/2021

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Laryngeal Cancer: Age-Adjusted Rate per 100,000 Males, 2014-2018

  • Burlington
    4.5
    95% Confidence Interval (3.5 - 5.9)
    State
    5.1
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

During 2018, 245 male and 72 female New Jersey residents were diagnosed with cancer of the larynx (voice box). Factors that can increase your risk of laryngeal cancer include: tobacco use, including smoking and chewing tobacco; heavy alcohol consumption; and possibly a virus called the human papillomavirus (HPV).

How Are We Doing?

Between 1990 and 2018, the age-adjusted rate of laryngeal cancer in males decreased from 9.5 to 4.8 cases per 100,000. In females, the rate decreased from 2.2 to 1.1 per 100,000 during the same interval. The lifetime risk of developing laryngeal cancer is 1 in 189 for men and 1 in 769 for women.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Laryngeal Cancer

Definition: Incidence rate of invasive laryngeal cancer for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of laryngeal cancer among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

NJ Age-Adjusted Invasive Laryngeal Cancer Incidence (exits this report)

Date Content Last Updated

10/07/2021

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Leukemia: Age-Adjusted Rate per 100,000 Males, 2014-2018

  • Burlington
    22.8
    95% Confidence Interval (20.2 - 25.8)
    State
    20.4
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

During 2018, 943 New Jersey males and 678 females of all ages were diagnosed with leukemias. At this time, we do not know what causes most leukemias.

How Are We Doing?

The four most common types of leukemias occur with differing frequencies in adults versus children. Acute lymphocytic leukemia (ALL) is the most common type of childhood leukemia and also affects adults, especially those age 65 and older. Acute myeloid leukemia (AML) occurs in both adults and children. Chronic lymphocytic leukemia most commonly affects adults over age 55, and rarely occurs in children. Chronic myeloid leukemia (CML) occurs mainly in adults. Leukemia incidence rates and counts by age group are provided for the four most common types of leukemia. Detailed incidence rates and counts by gender and county are provided for the two most common types of leukemia (AML and CLL). Although it is often thought of as a children's disease, most cases of leukemia occur in older adults. Leukemia is ten times more common in adults than in children, and more than half of all leukemia cases occur in people over the age of 65. The lifetime risk of developing leukemia is 1 in 54 for men and 1 in 78 for women.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Related Indicators

Health Status Outcomes:


Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Leukemia

Definition: Incidence rate of leukemia by sub-type for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of leukemia by sub-type among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

NJ Leukemia Incidence (exits this report)

Date Content Last Updated

10/04/2021

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Liver Cancer: Age-Adjusted Rate per 100,000 Males, 2014-2018

  • Burlington
    13.3
    95% Confidence Interval (11.4 - 15.5)
    State
    12.5
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

During 2018, 561 male and 211 female New Jersey residents were diagnosed with liver cancer. Cancer of the liver is more common in older people, and is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral hepatitis infection.

How Are We Doing?

Between 1990 and 2018, the age-adjusted liver cancer rate in males increased from 4.6 to 10.6 cases per 100,000. Among New Jersey females, the age-adjusted rate increased from 1.6 to 3.4 cases per 100,000 during the same interval. The lifetime risk of developing liver and bile duct cancer is 1 in 69 for men and 1 in 161 for women.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Liver Cancer

Definition: Incidence rate of invasive liver cancer for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of liver cancer among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

NJ Age-Adjusted Invasive Liver Cancer Incidence (exits this report)

Date Content Last Updated

10/07/2021

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Lung & Bronchus Cancer: Age-Adjusted Rate per 100,000 Males, 2014-2018

  • Burlington
    67.7
    95% Confidence Interval (63.2 - 72.5)
    State
    59.5
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

In New Jersey 2,845 men and 3,161 women were diagnosed with cancer of the lung or bronchus during 2018. Lung cancer causes the most cancer deaths among New Jersey residents - over 1,670 among men and 1,650 among women in 2019. Cigarette smoking is believed to be responsible for almost 90% of all lung cancer cases. Other risk factors include second-hand smoke, residential radon exposure, high doses of ionizing radiation such as might be received from therapeutic radiation treatment, and certain occupational exposures. Air pollution, specifically particulates from burning fossil fuel, is also a risk factor for lung cancer.

Risk and Resiliency Factors

Personal risk factors include cigarette smoking, personal or family history of lung cancer, and a history of radiation therapy to the chest,

How Are We Doing?

Between 1990 and 2018, the age-adjusted incidence rate of lung and bronchus cancer in New Jersey men declined from about 107 cases per 100,000 to about 57 cases per 100,000. Among NJ woman in the lung and bronchus age-adjusted cancer incidence rate increased and then decreased slightly averaging 53.9 cases per 100,000 for the same time period, 1990-2018. Past smoking patterns among men and women are the main cause for these trends. The percentage of women who smoke began decreasing rapidly in the mid-1980's, while the percentage of men who smoke began decreasing rapidly much earlier (before 1965). The lifetime risk of developing lung and bronchus cancer is 1 in 15 for men and 1 in 17 for women.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Lung & Bronchus Cancer

Definition: Incidence rate of invasive lung and bronchus cancer for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of lung and bronchus cancer among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

NJ Age-Adjusted Invasive Lung and Bronchus Cancer Incidence (exits this report)

Date Content Last Updated

10/07/2021

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Melanoma of the Skin: Age-Adjusted Rate per 100,000 Males, 2014-2018

  • Burlington
    33.7
    95% Confidence Interval (30.5 - 37.1)
    State
    28.5
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Cancer of the skin is by far the most common of all cancers. Melanoma accounts for less than 5% of skin cancer cases but causes a large majority of skin cancer deaths. Most melanoma of the skin is caused by exposure to ultraviolet (UV) radiation from the sun. Whites have age-adjusted incidence rates that are more than 15 times higher than Blacks. People with light complexions have the highest risk of melanoma of the skin.

Risk and Resiliency Factors

The NCI^1^ has determined that '''sun and UV radiation''' exposure (including indoor tanning) are associated with a substantial increase in the risk of squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), and that there is fair evidence that '''intermittent acute sun exposure leading to sunburn''' is associated with an increased risk of melanoma. 1. National Cancer Institute. [https://www.cancer.gov/types/skin/hp/skin-prevention-pdq Skin Cancer Prevention - Health Professional Version]. [last reviewed: 1/29/20]

How Are We Doing?

During 2018, 1,309 men and 965 women in New Jersey were diagnosed with melanoma of the skin. Between 1990 and 2018, age-adjusted incidence rates for melanoma of the skin increased from 14.4 to 26.5 cases per 100,000 for males and from 10.2 cases to 16.8 cases per 100,000 in females. During the same interval, age-adjusted incidence rates increased in Whites from 13.1 to 24.6 per 100,000. The lifetime risk of developing melanoma of the skin is 1 in 36 for men and 1 in 56 for women.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Related Indicators

Risk Factors:

Health Status Outcomes:


Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Melanoma of the Skin

Definition: Incidence rate of invasive melanoma of the skin for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of melanoma of the skin among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

NJ Age-Adjusted Invasive Melanoma of the Skin Incidence (exits this report)

Date Content Last Updated

10/18/2021

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Mesothelioma: Age-Adjusted Rate per 100,000 Males, 2014-2018

  • Burlington
    1.4
    95% Confidence Interval (0.8 - 2.3)
    State
    1.8
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

During 2018, 73 male and 40 female New Jersey residents were diagnosed with mesothelioma. The main risk factor for developing mesothelioma is exposure to asbestos.

How Are We Doing?

Between 1990 and 2018, the average age-adjusted mesothelioma rate in males was 2.7 per 100,000. In females, the average age-adjusted mesothelioma rate was 0.6 per 100,000.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. **Rates/counts are suppressed if fewer than 5 cases were reported in the specified category. Number of cases (numerator) is the total count of cases in five years.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Mesothelioma

Definition: Incidence rate of invasive mesothelioma for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of mesothelioma among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

NJ Age-Adjusted Invasive Mesothelioma Incidence (exits this report)

Date Content Last Updated

10/04/2021

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Non-Hodgkin Lymphoma: Age-Adjusted Rate per 100,000 Males, 2014-2018

  • Burlington
    27.0
    95% Confidence Interval (24.1 - 30.1)
    State
    26.5
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

In New Jersey, 1,317 males and 1096 females were diagnosed with non-Hodgkin lymphoma during 2018.

How Are We Doing?

Between 1990 and 2018, the age-adjusted incidence rate of non-Hodgkin lymphoma in New Jersey males increased from 22.3 cases per 100,000 to about 26.9 cases per 100,000. Among New Jersey females, the incidence rates increased from 14.7 cases per 100,000 in 1990 to 18.2 cases per 100,000 in 2018. The lifetime risk of developing non-Hodgkin lymphoma is 1 in 41 for men and 1 in 52 for women.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Non-Hodgkin Lymphoma

Definition: Incidence rate of non-Hodgkin lymphoma for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of non-Hodgkin lymphoma among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

NJ Age-Adjusted Non-Hodgkin Lymphoma Incidence (exits this report)

Date Content Last Updated

10/04/2021

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Oral Cavity and Pharynx Cancer: Age-Adjusted Rate per 100,000 Males, 2014-2018

  • Burlington
    16.1
    95% Confidence Interval (14.0 - 18.4)
    State
    17.0
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

During 2018, 898 male and 405 female New Jersey residents were diagnosed with cancer of the oral cavity and pharynx. The most common sites for oral cavity and pharynx cancers are the tongue, floor of the mouth, gums, lip, tonsil, or lower pharynx. The most common risk factors for getting cancer of the oral cavity are tobacco use (both cigarette smoking and smokeless/chewing tobacco) and drinking alcoholic beverages in excess.

Risk and Resiliency Factors

While most cancers of the oral cavity, oropharynx, hypopharynx, and larynx are attributable to the use of '''tobacco products''', [https://www-doh.state.nj.us/doh-shad/query/builder/njbrfs/AlcoholChrnHvy/AlcoholChrnHvyCrude11_.html heavy alcohol use] is also a risk factor for the development of head and neck cancers and its effects are independent of those of tobacco use. According to the [https://www.cancer.gov/types/head-and-neck/hp/oral-prevention-pdq#_122_toc National Cancer Institute (NCI)], the risk for current cigarette smokers is about tenfold that of never-smokers while the risk for people who drink five or more alcoholic beverages per day is approximately fivefold compared with nondrinkers, and the risk is dose related in both cases. Moreover, when '''both risk factors''' are present, the risk of cancer is about two to three times greater for oral cavity and oropharyngeal cancers than the simple multiplicative effect, with risks for persons who both smoke and drink heavily approximately 35-fold that of persons who both never smoke and never drink. Other significant risk factors identified by the NCI include '''oral infection with HPV 16''', which confers about a 15-fold increase in risk of oropharyngeal cancer relative to individuals without oral HPV 16 infection. [Last reviewed: 1/27/20]

How Are We Doing?

Between 1990 and 2018, the age-adjusted oral cavity and pharynx cancer rate in males averaged 15.9 cases per 100,000 population. In females, the age-adjusted oral cavity and pharynx cancer rate averaged 6.3 cases per 100,000 population. The lifetime risk of developing oral cavity and pharynx cancer is 1 in 60 for men and 1 in 141 for women.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Oral Cavity and Pharynx Cancer

Definition: Incidence rate of invasive oral cavity and pharynx cancer for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of oral cavity and pharynx cancer among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

NJ Age-Adjusted Invasive Oral Cavity and Pharynx Cancer Incidence (exits this report)

Date Content Last Updated

09/22/2020

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Pancreatic Cancer: Age-Adjusted Rate per 100,000 Males, 2014-2018

  • Burlington
    17.2
    95% Confidence Interval (14.9 - 19.7)
    State
    16.3
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

During 2018, 853 male and 803 female New Jersey residents were diagnosed with cancer of the pancreas.

How Are We Doing?

Between 1990 and 2018, the age-adjusted pancreatic cancer rate averaged 15 cases in males and 11.8 cases per 100,000 among females. The lifetime risk of developing pancreatic cancer is 1 in 60 for men and 1 in 63 for women.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Pancreatic Cancer

Definition: Incidence rate of invasive cancer of the pancreas for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of cancer of the pancreas among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

NJ Age-Adjusted Invasive Pancreas Cancer Incidence (exits this report)

Date Content Last Updated

10/07/2021

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Prostate Cancer: Age-Adjusted Rate per 100,000 Males, 2014-2018

  • Burlington
    154.2
    95% Confidence Interval (147.6 - 161.1)
    State
    134.5
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

During 2018, 7,550 men in New Jersey were diagnosed with cancer of the prostate. Prostate cancer is the most frequently diagnosed cancer among men in NJ and the US, excluding basal and squamous cell carcinomas of the skin. Prostate cancer occurs more frequently as men age, with most cases occurring after age 50.

How Are We Doing?

Prostate cancer incidence rates have decreased overall after 1992. This trend is thought to be due to changes in prostate cancer screening practices. The lifetime risk of developing prostate cancer is 1 in 9 for men.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Related Indicators

Health Status Outcomes:


Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Prostate Cancer

Definition: Incidence rate of invasive prostate cancer for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of prostate cancer among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

NJ Age-Adjusted Invasive Prostate Cancer Incidence (exits this report)

Date Content Last Updated

10/04/2021

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Incidence of Thyroid Cancer: Age-Adjusted Rate per 100,000 Females, 2014-2018

  • Burlington
    28.1
    95% Confidence Interval (25.1 - 31.4)
    State
    27.7
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

During 2018, 423 male and 1,267 female New Jersey residents were diagnosed with thyroid cancer. Thyroid cancer is different than many adult cancers in that it occurs about 3 times more often in women than in men, and it is more frequently diagnosed in younger adults.

How Are We Doing?

Between 1990 and 2018, the age-adjusted thyroid cancer rate in females rose from 6.9 cases per 100,000 to 26.5 cases per 100,000. In males, the increase was smaller, from about 3 per 100,000 to about 9 per 100,000 in 2018. The reason for the sharp increase in thyroid cancer incidence rates, especially in recent years, is unknown. Theorized explanations include increased diagnosis of thyroid cancer by medical practitioners and increased prevalence of possible risk factors such as diagnostic radiation and obesity. The lifetime risk of developing thyroid cancer is 1 in 143 for men and 1 in 52 for women.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Note

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]   NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]  

Measure Description for Incidence of Thyroid Cancer

Definition: Incidence rate of invasive thyroid cancer for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of thyroid cancer among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.

Indicator Profile Report

NJ Age-Adjusted Invasive Thyroid Cancer Incidence (exits this report)

Date Content Last Updated

10/07/2021

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Cardiovascular Disease - High Blood Pressure: Estimated Percent (Age-adjusted), 2013-2017 (Odd Years)

  • Burlington
    29.2
    95% Confidence Interval (26.8 - 31.7)
    State
    29.0
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

High blood pressure is a risk factor for cardiovascular disease (i.e., heart attack, heart failure, or stroke) and kidney failure. For adults who have high blood pressure, controlling it through lifestyle modifications (i.e., diet and exercise) as well as medications can help reduce the likelihood of developing cardiovascular disease or kidney failure.

How Are We Doing?

In 2017, the percentage of New Jersey adults who have ever been told they have high blood pressure by a health professional was 30.2%. Blacks (41.0%) have highest prevalence of diagnosed high blood pressure compared to Whites (28.4%), Asians (27.7%) and Hispanics (31.0%) in the state.

What Is Being Done?

The New Jersey Heart Disease and Stroke Prevention Program (NJHDSPP) seeks to reduce the burden of heart disease and stroke for New Jersey residents through evidence-based systems level interventions that support prevention, detection and control of high blood pressure, a leading cause of heart disease and stroke. Since 2013, HDSPP has partnered with 22 health systems including Federally Qualified Health Centers (FQHCs), Regional Planning Collaboratives (RPCs), and Accountable Care Organizations (ACOs) to: *Increase electronic health records (EHR) adoption *Increase the use of health information technology and team based care *Changing roles and adding new positions to enhance care coordination teams *Improve control measures for high blood pressure *Implement Clinical Decision Support Systems (CDS) *Incorporating clinical guidelines that are a part of a decision support system *Improving usability and applicability of alerts, order sets, registries, and other clinical data available through electronic health records (EHRs) and health information exchanges (HIEs) *Promote awareness High Blood Pressure among patients with the condition

Evidence-based Practices

The NJHDSPP reduces the burden of high blood pressure on New Jersey residents by implementing health systems interventions that increase awareness, promote reporting of clinical quality measures (NQF 18), and increase quality improvement processes such as Team Based Care (TBC). These practices are recommended by the Community Guide for Preventive Services and the Centers for Disease Control and Prevention as effective, evidence based practices to reduce the burden of high blood pressure.

Note

The high blood pressure question is administered only in odd-numbered years. All prevalence estimates are age-adjusted to the U.S. 2000 standard population (except for rates by age group). 

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Cardiovascular Disease - High Blood Pressure

Definition: Estimated percentage of New Jersey adults (age 18 and over) who have ever been told by a doctor, nurse or other health professional that they have high blood pressure.
Numerator: Number of adults from the Behavioral Risk Factor Surveillance System who have ever been told they have high blood pressure by a health professional.
Denominator: Number of survey respondents excluding those with missing, "Don't know/Not sure," and "Refused" responses.

Indicator Profile Report

Prevalence of Diagnosed High Blood Pressure among Adults (exits this report)

Date Content Last Updated

06/19/2019

For more information:

Community Health and Wellness, Division of Community Health Services, New Jersey Department of Health, Trenton, NJ 08625, Web: https://nj.gov/health/fhs/chronic/




Cardiovascular Disease - High Cholesterol: Estimated Percent (Age-adjusted), 2013-2017 (Odd Years)

  • Burlington
    28.5
    95% Confidence Interval (25.9 - 31.2)
    State
    32.7
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

High cholesterol is a risk factor for cardiovascular disease (i.e., heart attack, heart failure, or stroke). Regular physical activity and eating a healthy diet can help prevent high cholesterol and improve cholesterol levels that are not optimal. Smoking can decrease levels of "good" HDL cholesterol, which also increases risk for cardiovascular disease.

How Are We Doing?

In 2017, the age-adjusted percentage of New Jersey adults who have been told they have high cholesterol by a health professional was about 31.7%. Asians (33.4%) have highest prevalence of diagnosed high cholesterol compared to Whites (31.9%), Blacks (29.8%) and Hispanics (32.2%).

What Is Being Done?

The New Jersey Heart Disease and Stroke Prevention Program (NJHDSPP) seeks to reduce the burden of high total blood cholesterol in New Jersey residents through evidence-based systems level interventions that support prevention, detection and control of high blood pressure, a leading cause of heart disease and stroke. Since 2013, HDSPP has partnered with 22 health systems including Federally Qualified Health Centers (FQHCs), Regional Planning Collaboratives (RPCs), and Accountable Care Organizations (ACOs) to: *Increase electronic health records (EHR) adoption *Increase the use of health information technology and team based care *Changing roles and adding new positions to enhance care coordination teams *Improve control measures for high blood pressure *Implement Clinical Decision Support Systems (CDS) *Incorporating clinical guidelines that are a part of a decision support system *Improving usability and applicability of alerts, order sets, registries, and other clinical data available through electronic health records (EHRs) and health information exchanges (HIEs) *Promote awareness High Blood Pressure among patients with the condition

Evidence-based Practices

The NJHDSPP reduces the burden of high total cholesterol on New Jersey residents by implementing health systems interventions that increase awareness, promote reporting of clinical quality measures, and increase quality improvement processes such as Team Based Care (TBC). These practices are recommended by the Community Guide for Preventive Services and the Centers for Disease Control and Prevention as effective, evidence based practices to reduce the burden of high total cholesterol.

Healthy People Objective HDS-7:

Reduce the proportion of adults with high total blood cholesterol levels
U.S. Target: 13.5 percent

Note

The high cholesterol question is administered only in odd years. All prevalence estimates are age-adjusted to the U.S. 2000 standard population (except for rates by age group). 

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Cardiovascular Disease - High Cholesterol

Definition: Estimated percentage of New Jersey adults (ages 18 and over) who have ever been told by a doctor, nurse or other health professional that they have high cholesterol.
Numerator: Number of adults from the Behavioral Risk Factor Surveillance System who have ever been told they have high cholesterol by a health professional.
Denominator: Number of survey respondents excluding those with missing, "Don't know/Not sure," and "Refused" responses.

Indicator Profile Report

Prevalence of Diagnosed High Cholesterol among Adults (exits this report)

Date Content Last Updated

06/19/2019

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Diabetes (Diagnosed) Prevalence: Estimated Percent (Age-adjusted), New Jersey, 2017-2020*

  • Burlington
    11.8
    95% Confidence Interval (9.8 - 14.2)
    StateNA
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Diabetes and its frequent precursor, prediabetes, are conditions on a continuum marked by high levels of blood glucose (blood sugar) due to defects in insulin production, insulin action, or both. Insulin is a hormone needed to absorb and use glucose as fuel for the body's cells. Diabetes can lower life expectancy and increase the risk of heart disease. It is the leading cause of kidney failure, lower limb amputation, and adult-onset blindness. Diabetes and its complications can often be prevented or delayed. People who are diagnosed with diabetes or prediabetes need to learn about their condition and build the skills and confidence necessary to successfully take care of themselves, with the help of their health care team and community resources. About one-quarter of people with diabetes don't know they have it, and most people with prediabetes don't know they have it. Unfortunately, people who are undiagnosed can't take steps to manage their condition. Data in this Profile are only about diagnosed diabetes prevalence.

How Are We Doing?

In 2020, the age-adjusted prevalence of diagnosed diabetes in New Jersey was 8.5%. Hispanics (13.1), Asians (13.0%), and Blacks (11.5%) have a higher prevalence of diagnosed diabetes compared to Whites (6.3%).

What Is Being Done?

The Diabetes Prevention and Control Program (DPCP) approach to addressing diabetes in New Jersey is driven by population-based and evidence-based strategies to increase community-clinical linkages and clinical innovations to support the prevention and management of diabetes. The overall goal of the DPCP is to reduce the burden of diabetes on New Jersey residents by implementing community clinical linkages and health systems interventions that increase awareness of the disease, control disease related complications, and increase quality improvement processes in health systems, in the delivery of services to residents with diabetes. DPCP partners with organizations across the state to create Diabetes Resources Coordination Centers (DRCCs). These DRCCs liaise between community-based diabetes self-management education (DSME), diabetes prevention programs (DPP), and healthcare systems, to increase access to community-based programs, by helping providers establish referral policies and practices for diabetic patients. DPCP partners with NJ 2-1-1, the statewide non-emergency, information call center and website, to promote ADA-recognized, AADE-accredited and/or Stanford licensed diabetes self-management education, and lifestyle change workshops, and direct callers to increase utilization and access of these programs among New Jersey residents. NJ211 and the NJ Academy of Family Physicians also partners to leverage NJAFPs membership, through their statewide reach, to promote diabetes prevention and self-management resources to primary care providers. The Diabetes Prevention and Control Program collaborates with Department of Human Services (DHS) - Commission for the Blind and Visually Impaired (CBVI) - Diabetic Eye Disease Detection (DEDD) Program to increase access to free eye examinations for uninsured or underinsured residents with diabetes. To increase state capacity to prevent type 2 diabetes in adults, NJDOH teamed up with the New Jersey Hospital Association (NJHA) to build capacity in the state by offering free Lifestyle Change Coach trainings to health systems and organizations interested in adopting the National Diabetes Prevention Program (NDPP). The Diabetes Prevention and Control Program (DPCP) currently partners with 22 Federally Qualified Health Centers (FQHCs) to adopt evidence-based strategies for the enhancement of electronic health records and/or team-based care appropriate for treating patients with diabetes in healthcare systems. Finally, DPCP collaborates with Regional Planning Collaboratives to leverage new clinical decision support systems for management of patients with diabetes to determine if there is a significant and sustainable impact on diabetes control and prevention in their patient populations. Through their enhanced health information exchanges, the RPCs confidentially report National Quality Forum measures 18 and 59, medication adherence measures, and other quality measures among providers (and to NJDOH) to support quality improvement activities.

Evidence-based Practices

Successful strategies implemented for FQHC partners include interventions such as incorporating clinical guidelines that are a part of a decision support system; changing roles and adding new positions to enhance care coordination teams; and improving usability and applicability of alerts, order sets, registries, and other clinical data available through electronic health records (EHRs) and health information exchanges (HIEs)

Healthy People Objective D-15:

Increase the proportion of persons with diabetes whose condition has been diagnosed
U.S. Target: 80.1 percent

Note

All prevalence estimates are age-adjusted to the U.S. 2000 standard population (except for rates by age group).  *2019 data is not included in the average estimated prevalence. No data is available for 2019

Data Sources

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health, [http://www.state.nj.us/health/chs/njbrfs/]  

Measure Description for Diabetes (Diagnosed) Prevalence

Definition: Diabetes prevalence is the estimated percentage of New Jersey adults 18 years and older with diagnosed diabetes.
Numerator: Number of adult (18 and older) New Jersey respondents who responded, "yes" (within the survey year) to the BRFSS question: "Has a doctor, nurse, or other health professional ever told you that you have diabetes?".
Denominator: Number of New Jersey adults (18 and older) who responded to the BRFSS within the survey year.

Indicator Profile Report

Diagnosed Diabetes Prevalence in Adults Ages 18 and Over, (exits this report)

Date Content Last Updated

02/01/2023

For more information:

Diabetes Prevention and Control Program, Division of Family Health Services, New Jersey Department of Health, PO Box 364, Trenton NJ 08625-0364, Phone: 609-984-6137, Fax: 609-292-9288, Web: http://www.state.nj.us/health/fhs/diabetes/index.shtml




Life Expectancy at Birth: Age in Years, 2020

  • Burlington
    78.3
    95% Confidence Interval (78.2 - 78.4)
    State
    77.7
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Life expectancy is a summary mortality measure often used to describe the overall health status of a population.

How Are We Doing?

Life expectancy was slowly increasing among all racial and ethnic groups as well as among both males and females until 2015. Small declines in overall life expectancy were experienced the following three years before again increasing slightly in 2019. The COVID-19 pandemic in 2020 caused average life expectancy (ALE) among all New Jersey residents to decline 3 years. The impact on ALE was not the same among different groups. Between 2019 and 2020, ALE declined by 7.7 years among Hispanics, 6.1 years among Asians, 4.7 years among Blacks, and 1.7 years among Whites. ALE among males declined 3.3 years while the decline among females was 2.4 years. As of 2020, the average life expectancy among New Jersey residents was 77.7 years. Life expectancy among females (80.7 years) was six years greater than among males (74.8). Among New Jersey residents, life expectancy is highest among Asians (86.1 years), followed by Hispanics and Whites (both 78.4), and Blacks (72.2). By county, estimates range from 72.3 years in Salem to 82.4 years in Hunterdon.

Note

Life expectancy from birth is very sensitive to infant and child mortality. Life expectancy from age 65 is less sensitive to infant and child mortality than life expectancy from birth and is thought to better represent overall adult health status. In NJSHAD, life expectancy is calculated using a method developed by CL Chiang. For more information on calculation of life expectancy in NJSHAD, please visit the [https://www-doh.state.nj.us/doh-shad/query/LifeExp.html life expectancy documentation page]. 

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Life Expectancy at Birth

Definition: Average life span or number of years of life that could be expected if current death rates were to remain constant
Numerator: Not applicable. For information on life expectancy calculation, please see [https://www-doh.state.nj.us/doh-shad/query/LifeExp.html Life Expectancy].
Denominator: See numerator note.

Indicator Profile Report

Life Expectancy at Birth (exits this report)

Date Content Last Updated

04/28/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Average Age at Death: Average age at death (years), 2021

  • Burlington
    74.3
    95% Confidence Interval (73.8 - 74.8)
    State
    74.2
    U.S.NA
    NA=Data not available.
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Average age at death can be used as an easier-to-calculate proxy for life expectancy.

How Are We Doing?

Average age at death is highest among Whites, followed, in order, by Asians, Blacks, and Hispanics. (Note that this may be due, in part, to the underlying age composition of each racial/ethnic group.) The average age at death among females is 7 years higher than among males. Among all causes of death, Alzheimer's disease has the highest average age (87.7 years). Unintentional injury has the lowest average age (52.0) among the ten leading causes of death. Deaths due to non-chronic conditions generally have much lower average ages at death than deaths due to chronic conditions.

Note

Average age at death does not take into account the average age of the corresponding population. This can bias results in demographic groups whose age composition varies greatly from that of the overall population. 

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health  

Measure Description for Average Age at Death

Definition: The arithmetic mean age, in years, at which a group of persons died
Numerator: The sum of ages at death among decedents in a given time period
Denominator: Total number of decedents in that time period

Indicator Profile Report

Average Age at Death (exits this report)

Date Content Last Updated

07/28/2023

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Age-Adjusted Death Rate: Deaths per 100,000 Standardized Population, 2020

  • Burlington
    802.5
    95% Confidence Interval (776.4 - 828.7)
    State
    834.3
    U.S.
    835.4
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Age-adjusted death rates are constructs that show what the level of mortality would be if no changes occurred in the age composition of the population from year to year. Age-adjusted death rates are better than crude death rates as indicators of relative risk when comparing mortality across geographic areas or between gender or racial/ethnic subgroups of the population that have different age compositions.

How Are We Doing?

The age-adjusted death rate had been decreasing fairly steadily until the opioid crisis took hold in 2017. The decline resumed in 2018 and 2019 but the COVID-19 pandemic caused New Jersey's age-adjusted death rate to climb 26.7% between 2019 and 2020, reaching a level not seen in twenty years. Between 2019 and 2020, the age-adjusted death rate rose 70.1% among Hispanics, 50.8% among Asians, 39.5% among Blacks, and 17.4% among Whites. Despite the wide variation in these increases, the rate remained highest among Blacks, followed in order by Whites, Hispanics, and Asians. In 2020, the age-adjusted death rate among Blacks was 1.4 times the rate among Whites (up from 1.2 in 2019), 1.5 times the rate among Hispanics (down from 1.8 in 2019), and 2.5 times the rate among Asians (down from 2.7 in 2019). The age-adjusted death rate among males was 1.5 times the rate among females in 2020. The rate rose 29.2% among males and 23.5% among females between 2019 and 2020. Rates varied across New Jersey counties from a low of 592.8 in Hunterdon County to a high of 1,105.6 in Cumberland County.

Related Indicators

Health Status Outcomes:


Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Age-Adjusted Death Rate

Definition: The number of resident deaths per 100,000 population age-adjusted to the US 2000 standard population
Numerator: The number of resident deaths
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate (exits this report)

Date Content Last Updated

04/20/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Deaths due to Alzheimer's Disease: Deaths per 100,000 Standardized Population, 2018-2020

  • Burlington
    19.2
    95% Confidence Interval (16.8 - 21.6)
    State
    22.2
    U.S.
    31.0
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Alzheimer's disease was the seventh leading cause of death among U.S. and New Jersey residents in 2020.

How Are We Doing?

The age-adjusted death rate due to Alzheimer's disease has been rising for over two decades. In New Jersey, nearly 2,700 deaths annually are due to Alzheimer's disease. In the total population and among each racial/ethnic group, females have higher death rates than males. In 2020, Alzheimer's disease was the fifth leading cause of death among women and eleventh among men in New Jersey. The age-adjusted death rate due to Alzheimer's disease among Whites in New Jersey is significantly higher than among other racial/ethnic groups. Alzheimer's disease was the fourth leading cause of death among persons aged 85 years and over in 2020. County rates per 100,000 population (age-adjusted) ranged from a low of 9.2 in Hunterdon to a high of 37.1 in Cumberland in 2018-2020.

Related Indicators

Relevant Population Characteristics:


Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Alzheimer's Disease

Definition: Deaths with Alzheimer's disease as the underlying cause of death. ICD-10 code: G30
Numerator: Number of deaths due to Alzheimer's disease
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Alzheimer's Disease (exits this report)

Date Content Last Updated

04/28/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Deaths due to Cancer: Deaths per 100,000 Standardized Population, 2020

  • Burlington
    139.1
    95% Confidence Interval (128.2 - 150.0)
    State
    133.3
    U.S.
    144.1
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

For decades, cancer was the second leading cause of death in the U.S. and New Jersey. In 2020, it was New Jersey's third leading cause of death after heart disease and COVID-19.

How Are We Doing?

The age-adjusted death rate due to cancer has been slowly declining for many years. In New Jersey, more than 15,000 deaths each year are due to cancer. In the total population and among each racial/ethnic group, males have higher death rates than females. The age-adjusted death rate due to cancer is highest among Blacks and Whites in New Jersey. County rates per 100,000 population (age-adjusted) range from a low of 112 in Hudson to a high of 180 in Cumberland. The revised Healthy New Jersey 2020 targets were achieved by all racial/ethnic groups except Asians.

What Is Being Done?

The [https://www.nj.gov/health/ces/public/resources/occp.shtml Office of Cancer Control and Prevention] (OCCP) coordinates comprehensive cancer control efforts in New Jersey and participates in the national efforts of the CDC to establish state-based comprehensive cancer control plans, conduct prevention of cancer risk factors, enhance early detection of preventable cancers, and facilitate survivorship through the activities of its Regional Chronic Disease Coalitions. The [https://nj.gov/health/ces/public/resources/njceed.shtml New Jersey Cancer Education and Early Detection] (NJCEED) Program provides comprehensive outreach, education and screening services for breast, cervical, colorectal and prostate cancers to eligible residents.

Evidence-based Practices

The risk of getting many common kinds of cancer can be lowered by making healthy choices like keeping a healthy weight, avoiding tobacco, and limiting alcohol consumption. Getting screening tests regularly may find breast, cervical, and colorectal cancers early, when treatment is likely to work best. Vaccines can help prevent several kinds of cancer. For example, the human papillomavirus (HPV) vaccine helps prevent most cervical cancers and several other kinds of cancer and the hepatitis B vaccine can help lower liver cancer risk.[https://www.cdc.gov/cancer/dcpc/prevention/ ^1^]

Healthy People Objective C-1:

Reduce the overall cancer death rate
U.S. Target: 161.4 deaths per 100,000 population (age-adjusted)
State Target: 135.5 deaths per 100,000 population (age-adjusted)

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Cancer

Definition: Deaths with malignant neoplasm (cancer) as the underlying cause of death. ICD-10 codes: C00-C97
Numerator: Number of deaths due to all types of cancer
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to All Cancers (exits this report)

Date Content Last Updated

05/02/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Deaths due to Colorectal Cancer: Deaths per 100,000 Population, 2018-2020

  • Burlington
    13.7
    95% Confidence Interval (11.7 - 15.6)
    State
    12.6
    U.S.
    13.1
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Colorectal cancer is the second leading cause of cancer death in New Jersey and the US.

Risk and Resiliency Factors

According to the [https://www.cancer.gov/types/colorectal/hp/colorectal-prevention-pdq National Cancer Institute], both cigarette smoking and obesity are associated with an increased risk of mortality from as well as incidence of colorectal cancer. Conversely, there is solid evidence that daily use of aspirin reduces the risk of mortality from as well as incidence of colorectal cancer. [Last reviewed: 1/26/20]

How Are We Doing?

The age-adjusted death rate due to colorectal cancer decreased 46% between 2000 and 2020 and, by 2013, the original Healthy New Jersey targets for Whites, Blacks, and the total population had been met. By 2020, the revised targets for Whites, Blacks, Asians, and the total population had been achieved. The rate is highest among Blacks, followed in order by Whites, Hispanics, and Asians. The rate is higher among men than among women but the gap is narrowing. County rates ranged from a low of 10 in Morris to a high of 17 in Salem.

Evidence-based Practices

Screening can find precancerous polyps (abnormal growths in the colon or rectum) so they can be removed before turning into cancer. Screening also helps find colorectal cancer at an early stage, when treatment often leads to a cure. [https://www.cdc.gov/cancer/colorectal/basic_info/screening/ ^1^]

Healthy People Objective C-5:

Reduce the colorectal cancer death rate
U.S. Target: 14.5 deaths per 100,000 population (age-adjusted)
State Target: 12.9 deaths per 100,000 population (age-adjusted)

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Colorectal Cancer

Definition: Deaths with malignant neoplasm (cancer) of the colon, rectum, and anus as the underlying cause of death ICD-10 codes: C18-C21
Numerator: Number of deaths due to cancer of the colon, rectum, and anus
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Colorectal Cancer (exits this report)

Date Content Last Updated

05/05/2022

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Deaths due to Breast Cancer: Deaths per 100,000 Female Population, 2018-2020

  • Burlington
    22.2
    95% Confidence Interval (18.6 - 25.7)
    State
    20.1
    U.S.
    19.4
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Breast cancer is the second leading cause of deaths due to cancer among women in New Jersey, claiming more than 1,200 lives annually.

How Are We Doing?

The age-adjusted death rate due to breast cancer among New Jersey females declined 37% between 2000 and 2020 and currently stands at 19.6 per 100,000. The rate is highest among Blacks, followed in order by Whites, Hispanics, and Asians. Healthy NJ 2020 targets were met by most racial/ethnic groups by the middle of the decade, so revised targets were set for the remainder of the decade. The revised targets for Blacks and Asians were achieved.

Evidence-based Practices

Getting mammograms regularly can lower the risk of dying from breast cancer. The United States Preventive Services Task Force recommends that average-risk women who are 50 to 74 years old should have a screening mammogram every two years.[https://www.cdc.gov/cancer/breast/basic_info/screening.htm ^1^]

Healthy People Objective C-3:

Reduce the female breast cancer death rate
U.S. Target: 20.7 deaths per 100,000 females (age-adjusted)
State Target: 19.0 deaths per 100,000 females (age-adjusted)

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Breast Cancer

Definition: Deaths with malignant neoplasm (cancer) of the female breast as the underlying cause of death. ICD-10 code: C50
Numerator: Number of deaths among females due to breast cancer
Denominator: Total number of females in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Female Breast Cancer (exits this report)

Date Content Last Updated

08/03/2023

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Deaths due to Lung Cancer: Deaths per 100,000 Population, 2020

  • Burlington
    28.4
    95% Confidence Interval (23.4 - 33.3)
    State
    26.5
    U.S.
    31.9
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Lung cancer is the leading cause of deaths due to cancer in New Jersey and in the nation as a whole. This is true for both males and females and for each racial/ethnic group. In the United States, 80-90% of lung cancer deaths are due to smoking[https://www.cdc.gov/cancer/lung/basic_info/risk_factors.htm ^1^] which is an avoidable risk factor.

Risk and Resiliency Factors

According to the NCI[https://www.cancer.gov/types/lung/hp/lung-prevention-pdq ^3^], exposure to radiation or occupational exposure to asbestos, arsenic, beryllium, cadmium, chromium, or nickel increases the risk of lung cancer mortality in addition to incidence in a dose-dependent manner. Exposure to outdoor air pollution, specifically small particles, also increases the risk of lung cancer mortality in addition to incidence.

How Are We Doing?

The age-adjusted death rate due to lung cancer halved between 2000 and 2020 and the original and revised Healthy New Jersey 2020 targets have been met by all racial/ethnic groups. The rates among Whites and Blacks are more than double those of Hispanics and Asians and the rate among males is well above that of females but the gap is narrowing. Rates by county range from a low of 19 in Hudson to a high of 42 in Cumberland.

Evidence-based Practices

The most important thing you can do to lower your lung cancer risk is to quit smoking and avoid secondhand smoke. The second leading cause of lung cancer is radon, a naturally occurring gas that comes from rocks and dirt and can get trapped in houses and buildings. Get your home tested for radon.[https://www.cdc.gov/cancer/lung/basic_info/prevention.htm ^2^]

Healthy People Objective C-2:

Reduce the lung cancer death rate
U.S. Target: 45.5 deaths per 100,000 population (age-adjusted)
State Target: 31.5 deaths per 100,000 population (age-adjusted)

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Lung Cancer

Definition: Deaths with malignant neoplasm (cancer) of the trachea, bronchus, and lung as the underlying cause of death ICD-10 codes: C33-C34
Numerator: Number of deaths due to cancer of the trachea, bronchus, and lung
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Lung Cancer (exits this report)

Date Content Last Updated

08/03/2023

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Deaths due to Prostate Cancer: Deaths per 100,000 Male Population, 2018-2020

  • Burlington
    18.6
    95% Confidence Interval (15.3 - 21.9)
    State
    16.2
    U.S.
    18.5
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Prostate cancer is the second most common cancer among men in the U.S.[http://www.cdc.gov/cancer/prostate/ ^1^] and, in New Jersey, is the second leading cause of death due to cancer among men.

How Are We Doing?

The death rate due to prostate cancer among all New Jersey males is trending downward and all original Healthy New Jersey 2020 targets have been met. The rate among Blacks has halved since 2000 but remains more than double the rates among other racial/ethnic groups.

What Is Being Done?

The New Jersey [https://nj.gov/health/ces/public/resources/occp.shtml Office of Cancer Control and Prevention (OCCP)] coordinates comprehensive cancer control efforts in New Jersey. Comprehensive cancer control is a collaborative process by which a community and its partners pool resources to reduce illness and death due to cancer through prevention, early detection, treatment, rehabilitation, and palliation.

Healthy People Objective C-7:

Reduce the prostate cancer death rate
U.S. Target: 21.8 deaths per 100,000 males (age-adjusted)
State Target: 15.4 deaths per 100,000 males (age-adjusted)

Related Indicators

Health Care System Factors:

Risk Factors:

Health Status Outcomes:


Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Prostate Cancer

Definition: Deaths with malignant neoplasm (cancer) of the prostate as the underlying cause of death ICD-10 code: C61
Numerator: Number of deaths among males due to cancer of the prostate
Denominator: Total number of males in the population

Indicator Profile Report

Age-adjusted Death Rate due to Prostate Cancer (exits this report)

Date Content Last Updated

04/29/2022

For more information:

Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov, web: www.nj.gov/health/ces




Deaths due to Chronic Lower Respiratory Diseases: Deaths per 100,000 Standardized Population, 2020

  • Burlington
    25.4
    95% Confidence Interval (20.7 - 30.1)
    State
    25.0
    U.S.
    36.4
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Chronic lower respiratory disease (CLRD) was the sixth leading cause of death in New Jersey and the US in 2020.

How Are We Doing?

In New Jersey, about 3,000 deaths each year are due to chronic lower respiratory disease (CLRD). In the total population and among each racial/ethnic group, males have a higher age-adjusted death rate than females. Among females, the rate is highest among Whites, but among males, the rate is highest among Blacks. County rates per 100,000 population (age-adjusted) range from a low of 15 in Hunterdon to a high of 48 in Salem.

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Chronic Lower Respiratory Diseases

Definition: Deaths with chronic lower respiratory disease (CLRD) as the underlying cause of death. CLRD includes emphysema, chronic bronchitis, asthma, and other chronic lower respiratory diseases. ICD-10 codes: J40-J47
Numerator: Number of deaths due to chronic lower respiratory diseases
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Chronic Lower Respiratory Diseases (exits this report)

Date Content Last Updated

04/29/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Deaths due to COVID-19: Deaths per 100,000 Standardized Population, 2020

  • Burlington
    85.2
    95% Confidence Interval (76.6 - 93.8)
    State
    141.6
    U.S.
    85.0
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

COVID-19 (coronavirus disease 2019) is a disease caused by a virus named SARS-CoV-2 discovered in December 2019. It is very contagious and has quickly spread around the world.[https://www.cdc.gov/coronavirus/2019-ncov/your-health/about-covid-19/basics-covid-19.html ^1^] COVID-19 was the second leading cause of death in New Jersey in 2020.

Related Indicators

Health Status Outcomes:


Data Sources

Centers for Disease Control and Prevention, National Center for Health Statistics. Underlying Cause of Death File. CDC WONDER On-line Database accessed at [https://wonder.cdc.gov/Deaths-by-Underlying-Cause.html]   Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to COVID-19

Definition: Deaths with COVID-19 as the underlying cause of death. ICD-10 code: U07.1
Numerator: Number of deaths due to COVID-19
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to COVID-19 (exits this report)

Date Content Last Updated

10/17/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Deaths due to Diabetes: Deaths per 100,000 Standardized Population, 2018-2020

  • Burlington
    17.0
    95% Confidence Interval (14.8 - 19.2)
    State
    18.2
    U.S.
    22.6
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Diabetes was the eighth leading cause of death among U.S. and New Jersey residents in 2020.

How Are We Doing?

The age-adjusted death rate due to diabetes had been steadily declining for many years before increasing in 2020. In recent years, about 1,900 NJ resident deaths each year were due to diabetes. In 2020, there were over 2,400 such deaths. It is conceivable that the COVID-19 pandemic caused an increase in other causes of death due to delays in medical care and fears of going to the hospital and being exposed to COVID. In the total population and among each racial/ethnic group, males have a higher death rate than females. The rate among Blacks in 2020 was 2.7 times the rate among Whites. County rates ranged from a low of 10.4 deaths per 100,000 residents (age-adjusted) in Hunterdon to a high of 28.8 in Cumberland in 2020. Prior to 2020, the Healthy New Jersey 2020 original targets had been achieved by Whites, Blacks, and Hispanics and the revised targets had been met by Blacks and Hispanics as well.

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Diabetes

Definition: Deaths with diabetes as the underlying cause of death. ICD-10 codes: E10-E14
Numerator: Number of deaths due to diabetes
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Diabetes (exits this report)

Date Content Last Updated

05/03/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Deaths due to Heart Disease: Deaths per 100,000 Standardized Population, 2020

  • Burlington
    165.8
    95% Confidence Interval (153.9 - 177.8)
    State
    166.1
    U.S.
    168.2
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Heart disease affects every segment of the population. It is the leading cause of death among all Americans, all New Jerseyans, and for both men and women.

How Are We Doing?

The age-adjusted death rate due to heart disease had been steadily declining for many years before increasing in 2020. In recent years, nearly 19,000 NJ resident deaths each year were due to heart disease. In 2020, there were over 19,700 such deaths. In the total population and among each racial/ethnic group, males have a higher death rate than females. Among the four major racial/ethnic groups in New Jersey, the rate is highest among Blacks. In 2020, county rates ranged from a low of 124 deaths per 100,000 residents (age-adjusted) in Somerset to a high of 253 in Cumberland.

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Heart Disease

Definition: Deaths with heart disease as the underlying cause of death. ICD-10 codes: I00-I09,I11,I13,I20-I51
Numerator: Number of deaths due to heart disease
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Heart Disease (exits this report)

Date Content Last Updated

04/20/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Deaths due to Coronary Heart Disease: Deaths per 100,000 Standardized Population, 2020

  • Burlington
    79.2
    95% Confidence Interval (71.0 - 87.5)
    State
    99.5
    U.S.
    107.8
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Heart disease is the leading cause of death of men and women in the United States and in New Jersey. Coronary heart disease is the most common type of heart disease and can cause heart attack, angina, heart failure, and arrhythmias.

How Are We Doing?

Age-adjusted death rates due to coronary heart disease have been declining for several decades and as of 2019, the Healthy New Jersey 2020 (HNJ2020) targets had been achieved by all groups. An across-the-board increase in coronary heart disease deaths in 2020 put the rates back above the HNJ2020 targets. However, this was likely due to the COVID-19 pandemic causing delays in medical care and fears of going to the hospital and being exposed to COVID. The age-adjusted coronary heart disease death rate in New Jersey is highest among Blacks, followed in order by Whites, Hispanics, and Asians. The rate among men is 1.8 times the rate among women. County rates range from a low of 73 in Somerset to a high of 174 in Cumberland.

What Is Being Done?

The New Jersey [http://www.nj.gov/health/fhs/chronic/heart-disease-stroke/ Heart Disease and Stroke Prevention Program] (NJHDSPP) produces models for improving the prevention and management of heart disease and stroke in New Jersey. NJHDSPP uses these models to assist New Jersey-based healthcare organizations in meeting nationally-recognized best practices and standards for the prevention and treatment of heart disease and stroke. NJHDSPP administers federal funding to private and public sector recipients to affect policy and systems level change and seeks partnerships to perform facility and process assessments.

Evidence-based Practices

Living a healthy lifestyle keeps blood pressure, cholesterol, and blood sugar levels normal and lowers the risk for heart disease and heart attack. More information: [https://www.cdc.gov/heartdisease/prevention.htm]

Healthy People Objective HDS-2:

Reduce coronary heart disease deaths
U.S. Target: 103.4 deaths per 100,000 population (age-adjusted)
State Target: Not comparable. Healthy People 2020 objective does not include hypertensive heart disease (ICD-10 code I11).

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Coronary Heart Disease

Definition: Deaths with coronary heart disease as the underlying cause of death. ICD-10 codes: I11 (hypertensive heart disease), I20-I25 (ischemic heart disease)
Numerator: Number of deaths due to coronary heart disease
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Coronary Heart Disease (exits this report)

Date Content Last Updated

08/10/2021

For more information:

Heart Disease and Stroke Prevention Program, Chronic Disease Prevention and Control Services, Division of Family Health Services, New Jersey Department of Health, Trenton, NJ 08625, Phone: 609-292-8540, Web: http://nj.gov/health/fhs/chronic/stroke.shtml




Deaths due to HIV Disease: Deaths per 100,000 Population, 2016-2020

  • Burlington
    1.0
    95% Confidence Interval (0.6 - 1.4)
    State
    1.8
    U.S.
    1.5
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

HIV is a virus that weakens a person's immune system by destroying cells that fight disease and infection. No cure exists for HIV but with proper medical care, HIV can be controlled.[https://www.cdc.gov/hiv/basics/index.html ^1^]

How Are We Doing?

The age-adjusted death rate due to HIV disease has been steadily declining since 1996. All original Healthy New Jersey 2020 (HNJ2020) targets were achieved by 2010 and the revised targets were met by 2018. While the rate among Blacks decreased 88% between 2000 and 2020, it remains about 16 times the White rate and 4 times the Hispanic rate. The rate among males remains more than double that of females.

What Is Being Done?

New Jersey has initiated an HIV Pre Exposure Prophylaxis (PrEP) initiative that places PrEP Counselors in 31 locations across the state. Free, confidential rapid HIV testing is offered at over 100 rapid HIV testing sites throughout NJ. The HIV Prevention Patient Navigator Program located in 15 HIV clinics is a linkage to care initiative that can help persons who test positive or are not in HIV care obtain an appointment for care and treatment on the same or next business day. There are also 44 community-based projects providing HIV prevention services to high risk populations located in areas that have been heavily impacted by the HIV epidemic. Several state-wide initiatives also provide intensive, specialized HIV prevention and risk reduction services including drop-in centers, syringe access programs, and church based prevention initiatives.

Healthy People Objective HIV-12:

Reduce deaths from HIV infection
U.S. Target: 3.3 deaths per 100,000 population (age-adjusted)
State Target: 4.2 deaths per 100,000 population (age-adjusted)

Note

** Number of deaths too small to calculate a reliable rate.

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to HIV Disease

Definition: Deaths with human immunodeficiency virus (HIV) disease as the underlying cause of death. ICD-10 codes: B20-B24
Numerator: Number of deaths due to HIV disease
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to HIV Disease (exits this report)

Date Content Last Updated

05/05/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Deaths due to Kidney Disease: Deaths per 100,000 Standardized Population, 2018-2020

  • Burlington
    19.0
    95% Confidence Interval (16.7 - 21.3)
    State
    14.3
    U.S.
    12.8
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Kidney disease was the tenth leading cause of death among New Jersey residents and in the nation as a whole in 2020.

How Are We Doing?

More than 1,600 New Jersey residents die due to kidney disease each year. The age-adjusted death rate due to kidney disease declined through 2013, but since then there has been a slight intermittent increase through 2020. The rate among Blacks remains more than double the rate among other racial/ethnic groups. Additionally, the rate among Blacks and Asians increased noticeably between 2019 and 2020 while only increasing slightly among Hispanics and decreasing among Whites. It is conceivable that the COVID-19 pandemic caused an increase in deaths due to delays in medical care and fears of going to the hospital and being exposed to COVID. In the total population and among each racial/ethnic group, males have a higher death rate than females. County rates range from a low of 5 deaths per 100,000 residents (age-adjusted) in Hunterdon to a high of 23 in Cumberland.

Evidence-based Practices

[https://www.cdc.gov/kidneydisease/prevention-risk.html Prevention and Risk Management]

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Kidney Disease

Definition: Deaths with nephritis, nephrotic syndrome, and nephrosis (kidney disease) as the underlying cause of death. ICD-10 codes: N00-N07, N17-N19, N25-N27
Numerator: Number of deaths due to kidney disease
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Kidney Disease (exits this report)

Date Content Last Updated

05/03/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Deaths due to Influenza and Pneumonia: Deaths per 100,000 Standardized Population, 2018-2020

  • Burlington
    9.5
    95% Confidence Interval (7.9 - 11.2)
    State
    12.5
    U.S.
    13.4
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Influenza and pneumonia combined were the eleventh leading cause of death among New Jersey residents and ninth among all US residents in 2020. (Influenza and pneumonia are combined for ranking as a leading cause of death, however the majority of those deaths are due to pneumonia.)

How Are We Doing?

The age-adjusted death rate due to influenza and pneumonia had been generally declining for many years, however the rate increased in 2020. In the total population and among each racial/ethnic group, males have a significantly higher death rate than females. For 2018-2020, county rates per 100,000 population (age-adjusted) ranged from a low of 9.5 in Burlington to a high of 25.0 in Salem.

What Is Being Done?

The New Jersey Department of Health has several programs that track influenza and pneumonia infections or that [https://njiis.nj.gov/core/web/index.html#/mission track] and/or promote vaccination. Health care professionals are to immediately call in confirmed or suspected cases of influenza to the local health department. The [https://njiis.nj.gov/core/web/index.html#/vfcDocs Vaccines for Children Program] provides pediatric vaccines at no cost to doctors who serve children who might not otherwise be vaccinated because of inability to pay.

Evidence-based Practices

Annual influenza vaccination is the most effective method for preventing influenza virus infection and its complications.[https://www.cdc.gov/flu/prevent/index.html ^1^] Vaccination against pneumococcal disease has been effective in reducing infections among seniors and persons with certain medical conditions.[https://www.cdc.gov/pneumonia/prevention.html ^2^]

Note

Influenza and pneumonia are combined for ranking as a leading cause of death, however the majority (86.0 to 99.9%, depending on the year) of those deaths are due to pneumonia. Not all pneumonia deaths are related to influenza. Pneumonia can also be due to other viruses as well as bacteria. See [https://icd.who.int/browse10/2019/en#/J09-J18] for a complete list. 

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Influenza and Pneumonia

Definition: Deaths with influenza or pneumonia as the underlying cause of death. ICD-10 codes: J09-J18
Numerator: Number of deaths due to influenza and pneumonia
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Influenza and Pneumonia (exits this report)

Date Content Last Updated

05/05/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Deaths due to Septicemia: Deaths per 100,000 Standardized Population, 2018-2020

  • Burlington
    14.9
    95% Confidence Interval (12.8 - 17.0)
    State
    17.3
    U.S.
    9.8
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Septicemia is an infection that happens when bacteria or other germs enter the bloodstream and spread throughout the body. That can trigger sepsis, which is the body's reaction to the infection. Septicemia was the ninth leading cause of death among New Jersey residents and fifteenth in the U.S. in 2020.

How Are We Doing?

In New Jersey, about 2,000 deaths each year are due to septicemia. In the total population and among each racial/ethnic group, males have higher death rates than females. The age-adjusted death rate due to septicemia is significantly higher among Blacks in New Jersey than among other racial/ethnic groups. County rates per 100,000 population (age-adjusted) range from a low of 9 in Hunterdon to a high of 23 in Essex.

What Is Being Done?

In 2017, New Jersey became the third state to mandate sepsis protocols in its hospitals. [https://nj.gov/health/legal/documents/adoption/8_43G-14.9%20Sepsis%20Protocols.pdf ^2^] Under state law, New Jersey hospitals are required to submit uniform data to the New Jersey Department of Health on health care facility-associated infections. The Department reviews and analyzes these data and reports the results in New Jersey's annual [http://www.nj.gov/health/healthcarequality/health-care-professionals/submit-reporting/hais/index.shtml hospital performance report]. (Note that not all cases of septicemia are acquired in a healthcare setting.)

Note

Septicemia refers to the presence of a pathogen in the blood, whereas sepsis is the condition that is caused by the pathogen. In the context of mortality, if the cause of death is septicemia, sepsis is implied. 

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Septicemia

Definition: Deaths with septicemia as the underlying cause of death. ICD-10 codes: A40-A41
Numerator: Number of deaths due to septicemia
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Septicemia (exits this report)

Date Content Last Updated

04/29/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Deaths due to Stroke: Deaths per 100,000 Standardized Population, 2020

  • Burlington
    44.6
    95% Confidence Interval (38.4 - 50.8)
    State
    31.8
    U.S.
    38.8
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Stroke was the fifth leading cause of death in New Jersey and the US in 2020. It is a major cause of serious disability for adults and it is preventable and treatable.

How Are We Doing?

In New Jersey, more than 3,500 deaths each year are due to stroke. The age-adjusted death rate due to stroke was steadily declining before slight increases in 2019 and 2020. Blacks have the highest age-adjusted death rate due to stroke and experienced a large (25%) increase between 2019 and 2020 while the rate among Asians rose 6%, among Whites 2%, and decreased among Hispanics. It is conceivable that the COVID-19 pandemic caused an increase in deaths due to delays in medical care and fears of going to the hospital and being exposed to COVID. In the total population and among each racial/ethnic group, males have a higher death rate than females. County rates range from a low of 22.2 deaths per 100,000 residents (age-adjusted) in Hunterdon to a high of 48.5 in Salem. The Healthy New Jersey 2020 (HNJ2020) target was achieved by Blacks in 2018-2019 but the rate rose above the target in 2020. No other racial/ethnic group achieved its HNJ2020 target during the decade.

Evidence-based Practices

[https://www.cdc.gov/stroke/prevention.htm Prevent Stroke: What You Can Do]

Healthy People Objective HDS-3:

Reduce stroke deaths
U.S. Target: 34.8 deaths per 100,000 population (age-adjusted)
State Target: 28.6 deaths per 100,000 population (age-adjusted)

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Stroke

Definition: Deaths with cerebrovascular disease (stroke) as the underlying cause of death. ICD-10 codes: I60-I69
Numerator: Number of deaths due to stroke
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Stroke (exits this report)

Date Content Last Updated

05/03/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Deaths due to Unintentional Injury: Deaths per 100,000 Standardized Population, 2020

  • Burlington
    54.6
    95% Confidence Interval (47.7 - 61.4)
    State
    50.5
    U.S.
    57.6
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Unintentional injury was the leading cause of deaths among persons aged 15-44 years and the fourth leading cause among all ages combined in 2020. Unintentional injuries are, for the most part, preventable.

How Are We Doing?

In New Jersey, nearly 4,800 deaths were due to unintentional injuries in 2020. These include poisonings, falls, motor vehicle-related fatalities, suffocation, drowning, fire and smoke-related injuries, and others. New Jersey's age-adjusted death rate due to unintentional injury rose sharply between 2014 and 2018 due to a rise in unintentional poisonings but has been relatively stable since then. In 2019, falls became the second leading cause of unintentional injury deaths for the first time, while motor vehicle crashes dropped to third. This was due to both a slow decline in motor vehicle-related injuries and a slow increase in fall-related injuries. In the total population and among each racial/ethnic group, males have much higher death rates than females. In 2020, the age-adjusted death rate due to unintentional injury was highest among Black males followed by White males. County rates per 100,000 population (age-adjusted) ranged from a low of 24.4 in Hunterdon to a high of 105.5 in Cape May.

Healthy People Objective IVP-11:

Reduce unintentional injury deaths
U.S. Target: 36.4 deaths per 100,000 population

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Unintentional Injury

Definition: Deaths with unintentional injury as the underlying cause of death. ICD-10 codes: V01-X59, Y85-Y86 Unintentional injuries are commonly referred to as accidents and include poisonings (drugs, alcohol, fumes, pesticides, etc.), motor vehicle crashes, falls, fire, drowning, suffocation, and any other external cause of death.
Numerator: Number of deaths due to unintentional injury
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Unintentional Injury (exits this report)

Date Content Last Updated

07/12/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Deaths due to Motor Vehicle-Related Injuries: Deaths per 100,000 Population, 2018-2020

  • Burlington
    7.5
    95% Confidence Interval (6.0 - 9.0)
    State
    6.5
    U.S.
    11.9
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Motor vehicle crashes are the 2nd leading cause of unintentional injury death in the United States and in New Jersey.

How Are We Doing?

The number of motor vehicle crashes occurring in New Jersey experienced a large decline in 2020, from over 270,000 each year between 2016 and 2019 to fewer than 191,000 in 2020. Meanwhile, the injury rate remained stable at about 22% of crashes.[https://www.state.nj.us/transportation/refdata/accident/crash_statistics.shtm ^1^] However, fatalities rose in 2020. Death rates due to motor vehicle-related injuries are on a slow downward trend in New Jersey and the United States dating back to the early 1990's, however there were increases in both the US and New Jersey rates between 2019 and 2020. In New Jersey, most of the increase was among Blacks. While there is usually no statistically significant difference in age-adjusted death rates among Blacks, Whites, and Hispanics in New Jersey, in 2020 the rate among Blacks was significantly higher than among other racial/ethnic groups. It is conceivable that the COVID-19 pandemic caused an increase in other causes of death due to delays in medical care and fears of going to the hospital and being exposed to COVID. The age-adjusted motor vehicle-related death rate among males is nearly triple that of females and about 70% of motor vehicle-related fatalities are among males. County rates vary from 3.7 per 100,000 population (age-adjusted) in Hudson to 16.9 in Cumberland (2018-2020 data).

What Is Being Done?

The National Highway Traffic Safety Administration's "[http://www.nhtsa.gov/CIOT Click It or Ticket]" campaign is the most successful seat belt enforcement campaign ever, helping achieve an all-time high national seat belt usage rate of 90 percent.[https://www.nhtsa.gov/risky-driving/seat-belts ^2^] New Jersey's laws to protect drivers, passengers, bicyclists, and pedestrians are among the most stringent in the nation and can be viewed at [https://www.ghsa.org/state-laws].

Healthy People Objective IVP-13.1:

Reduce motor vehicle crash-related deaths: Deaths per 100,000 population
U.S. Target: 12.4 deaths per 100,000 population (age-adjusted)
State Target: 7.1 deaths per 100,000 population (age-adjusted)

Note

County is the decedent's county of residence, not the county where the injury occurred.

Data Sources

Centers for Disease Control and Prevention, National Center for Health Statistics. Underlying Cause of Death File. CDC WONDER On-line Database accessed at [https://wonder.cdc.gov/Deaths-by-Underlying-Cause.html]   Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Motor Vehicle-Related Injuries

Definition: Deaths with motor vehicle-related injury as the underlying cause of death. Motor vehicle-related deaths include motor vehicle and motorcycle drivers and passengers, pedestrians, and bicyclists struck by motor vehicles both on roadways in traffic and in other areas such as parking lots and driveways. ICD-10 codes: V02-V04, V09.0, V09.2, V12-V14, V19.0-V19.2, V19.4-V19.6, V20-V79, V80.3-V80.5, V81.0-V81.1, V82.0-V82.1, V83-V86, V87.0-V87.8, V88.0-V88.8, V89.0, V89.2
Numerator: Number of deaths due to motor vehicle-related injuries
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Motor Vehicle-Related Injuries (exits this report)

Date Content Last Updated

06/29/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Deaths due to Unintentional Poisoning: Deaths per 100,000 Population, 2020

  • Burlington
    33.4
    95% Confidence Interval (28.1 - 38.8)
    State
    32.1
    U.S.
    26.9
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Every day in the U.S., an average of 240 people die as a result of unintentional poisoning and 4,900 others are treated in emergency departments (2020 data).[http://www.cdc.gov/injury/wisqars/index.html ^1^] Unintentional poisoning deaths in the United States increased nearly sevenfold between 2000 and 2020.[https://wonder.cdc.gov/ucd-icd10.html ^2^]

How Are We Doing?

In approximately 96% of unintentional poisoning deaths nationally and 97% in New Jersey, drugs are the poison. This includes unintentional overdose, wrong drug given or taken in error, drug taken inadvertently, and mistakes in the use of drugs in medical and surgical procedures. Not included are cases where the correct drug was properly administered but had an unforeseen adverse effect such as an allergic reaction. There are a handful of alcohol poisoning and carbon monoxide poisoning deaths each year and even fewer due to exposure to other noxious substances.

What Is Being Done?

The [https://nj.gov/humanservices/dmhas/home/ Division of Mental Health and Addiction Services] promotes the prevention and treatment of substance disorders and supports the recovery of individuals affected by substance use disorder (SUD). The 2013 [http://www.njleg.state.nj.us/2012/Bills/PL13/46_.HTM Overdose Prevention Act] (P.L. 2013, c.46) provides immunity from liability and professional discipline to health care professionals who prescribe, dispense, or administer naloxone (or any similarly acting and approved drug) in an emergency to an individual who the person believes is experiencing an opioid overdose. The Act also contains Good Samaritan provisions, which provide immunity from arrest and prosecution for drug possession to those non-health professional individuals who call 911 for suspected overdoses, and makes naloxone available to family members who could be taught to administer the drug in case of an emergency. The Health Commissioner expanded the scope of practice for Emergency Medical Technicians in 2014 to allow for the administration of [http://www.nj.gov/health/ems/ems-toolbox/ naloxone] in cases of life threatening opioid overdoses. The same year, the Governor established a program to train and equip police officers to administer naloxone. A 2015 law expanding the scope of the NJ Prescription Monitoring Program (NJPMP) requires all physicians and pharmacists practicing in NJ to register for access and mandates physicians to check the NJPMP when patients return for refills on opioid medications. A 2017 law ([http://www.njleg.state.nj.us/2016/Bills/PL17/28_.HTM P.L. 2017, c.28]) set a five-day limit on initial prescriptions for opioids (reduced from seven days) and mandates that insurance companies accept those facing drug addiction into treatment for up to six months and without the need for prior coverage authorization. In 2016, NJDOH was awarded a CDC grant for [https://www.cdc.gov/drugoverdose/foa/ddpi.html Prescription Drug Overdose: Data-Driven Prevention Initiative] (DDPI), with funding used to advance data collection and analysis, and to evaluate state-level actions that address opioid misuse, abuse, and overdose. The [https://www.state.nj.us/health/populationhealth/opioid/ NJ Overdose Data Dashboard] was developed under this project. In 2017, the NJDOH was awarded CDC funds for [https://www.cdc.gov/drugoverdose/foa/state-opioid-mm.html Enhanced State Opioid Overdose Surveillance] (ESOOS), which leveraged the existing National Violent Death Reporting System data platform to collect additional toxicology, situation, and death scene data on fatal overdoses. In 2019, these programs were folded into CDC's [https://www.cdc.gov/drugoverdose/od2a/index.html Overdose Data to Action] (OD2A), a cooperative agreement supporting 66 state, county, and local jurisdictions to use data to track and understand the complex nature of drug overdoses, and stresses data integration in developing and implementing effective overdose prevention programs. Since 2018, the Governor's Office has focused on inter-departmental strategies that include increasing access to treatment and harm-reduction resources, enhancing recovery support systems, implementing law enforcement strategies targeting the supply of illicit drugs, and strengthening systems and data infrastructure. In addition to NJDOH, other departments involved in these efforts include Department of Human Services, Department of Children and Families, Department of Labor, Office of the Attorney General, Division of Consumer Affairs, and Department of Corrections. Information on programs and policies implemented by state agencies or signed into law under this approach is included in [https://www-doh.state.nj.us/doh-shad/indicator/other_resources/PoisoningDth.html Other Resources] or as part of the [https://www-doh.state.nj.us/doh-shad/topic/SubstanceUse.html Substance Abuse Topic].

Healthy People Objective IVP-9.3:

Prevent an increase in the rate of poisoning deaths: Unintentional or undetermined intent among all persons
U.S. Target: 11.1 deaths per 100,000 population
State Target: is not comparable because it does not include poisoning deaths of undetermined intent

Note

** The number of deaths in Hunterdon County is too small to calculate a reliable rate.

Data Sources

Centers for Disease Control and Prevention, National Center for Health Statistics. Underlying Cause of Death File. CDC WONDER On-line Database accessed at [https://wonder.cdc.gov/Deaths-by-Underlying-Cause.html]   Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Unintentional Poisoning

Definition: Deaths with unintentional poisoning by and exposure to noxious substances as the underlying cause of death. '''''This includes, but is not limited to, opioids and other drugs.'''''[[br]] ICD-10 codes: X40-X49 (includes poisoning by legal and illegal drugs, alcohol, gases and vapors such as carbon monoxide and automobile exhaust, pesticides, and other chemicals and noxious substances)
Numerator: Number of deaths due to unintentional poisoning
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Unintentional Poisoning (exits this report)

Date Content Last Updated

07/25/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Deaths due to Firearm-related Injury: Deaths per 100,000 Population, 2016-2020

  • Burlington
    5.5
    95% Confidence Interval (4.5 - 6.4)
    State
    5.0
    U.S.
    12.2
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Violence is a major public health concern throughout the United States.

How Are We Doing?

The Healthy New Jersey 2020 targets for age-adjusted death rates among the total population and Blacks were achieved by 2019 but rates rose above the targets in 2020. The targets for males aged 15-19 were achieved and remain below the targets through 2020. The firearm-related age-adjusted death rate among Blacks is more than 5 times the rates among Whites and Hispanics. County rates per 100,000 population (age-adjusted) range from a low of 1.8 in Bergen to a high of 12.9 in Salem (2016-2020).

What Is Being Done?

New Jersey already has some of the strictest firearm laws in the nation. In January, 2017, the Governor signed into law a revision of certain existing laws concerning domestic violence and firearms ([https://www.njleg.state.nj.us/2016/Bills/PL16/91_.PDF P.L.2016, c.91]), which enhances protections for domestic violence victims by restricting access to firearms by a person convicted of a domestic violence crime or subject to a domestic violence restraining order. For female homicide victims, more than half of homicides are committed by a current or former intimate partner, and a majority of those deaths involve a firearm.[http://www.state.nj.us/health/chs/njvdrs/ ^1^] The Governor's Study Commission on Violence released a [https://www.nj.gov/oag/library/SCV-Final-Report--10-13-15.pdf report of recommendations] to the Governor on ways to combat all types of violence from a public health perspective in October, 2015. The New Jersey Department of Health maintains the [http://www.state.nj.us/health/chs/njvdrs/ New Jersey Violent Death Reporting System] (NJVDRS), a CDC-funded surveillance system that tracks suicides, homicides, unintentional firearm deaths, injury deaths of undetermined intent, and deaths by legal intervention and is used to educate public health and public safety professionals in the state and inform their interventions and decision-making, with the ultimate goal of reducing the incidence of violent deaths. NJVDRS is part of the [https://www.cdc.gov/violenceprevention/datasources/nvdrs/index.html National Violent Death Reporting System].

Healthy People Objective IVP-30:

Reduce firearm-related deaths
U.S. Target: 9.3 deaths per 100,000 population (age-adjusted)
State Target: 4.7 deaths per 100,000 population (age-adjusted)

Related Indicators

Health Status Outcomes:


Note

County is the decedent's county of residence, not the county where the injury occurred.

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Deaths due to Firearm-related Injury

Definition: Deaths with a firearm-related injury as the underlying cause of death. ICD-10 codes: W32-W34 (unintentional), X72-X74 (suicide), X93-X95 (homicide), Y22-Y24 (undetermined intent), Y35.0 (legal intervention)
Numerator: Number of deaths due to firearm-related injuries of all intentions
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Firearm-related Injury (exits this report)

Date Content Last Updated

10/03/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Homicide: Deaths per 100,000 Population, 2016-2020

  • Burlington
    3.5
    95% Confidence Interval (2.8 - 4.3)
    State
    4.1
    U.S.
    6.4
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Violence is a major public health problem in the United States and is the third leading cause of death among persons aged 15-34 years in the U.S. and second in New Jersey.

How Are We Doing?

Homicides had declined in recent years such that there were fewer than 300 homicides of NJ residents in 2019. The age-adjusted homicide rate in New Jersey had remained between 4 and 5 per 100,000 population from 2007 through 2017 before decreasing to 3.7 in 2018 and 3.4 in 2019. However, a nationwide increase in homicides[https://www.cdc.gov/nchs/pressroom/podcasts/2021/20211008/20211008.htm ^1^] resulted in 365 homicides of NJ residents in 2020 and an age-adjusted death rate of 4.4, bringing it back above the Healthy New Jersey 2020 target, which had been met prior to 2020. Homicide victims are predominantly male, accounting for over 80% of homicides in New Jersey. Firearms are used in two-thirds of homicides.

What Is Being Done?

The [https://www.nj.gov/oag/library/SCV-Final-Report--10-13-15.pdf Governor's Study Commission on Violence] released a report of recommendations to the Governor on ways to combat all types of violence from a public health perspective in October, 2015. The New Jersey Department of Health maintains the [http://www.state.nj.us/health/chs/njvdrs/ New Jersey Violent Death Reporting System] (NJVDRS), a CDC-funded surveillance system that tracks suicides, homicides, unintentional firearm deaths, injury deaths of undetermined intent, and deaths by legal intervention and is used to educate public health and public safety professionals in the state and inform their interventions and decision-making, with the ultimate goal of reducing the incidence of violent deaths. NJVDRS is part of the [https://www.cdc.gov/violenceprevention/datasources/nvdrs/index.html National Violent Death Reporting System]. The New Jersey [http://www.nj.gov/dcf/providers/boards/fatality/ Child Fatality and Near-Fatality Review Board] and the New Jersey [http://www.nj.gov/dcf/providers/boards/dvfnfrb/ Domestic Violence Fatality and Near-Fatality Review Board] meet regularly to discuss possible systemic issues relating to incidents involving children and certain legally defined domestic relationships.

Healthy People Objective IVP-29:

Reduce homicides
U.S. Target: 5.5 homicides per 100,000 population (age-adjusted)
State Target: 4.3 homicides per 100,000 population (age-adjusted)

Related Indicators

Relevant Population Characteristics:

Health Status Outcomes:


Note

The homicides that occurred as a result of the events of September 11, 2001, have been excluded. Also, homicides due to legal intervention, which is the death of a person by a police officer in the line of duty, have been excluded.  County is the decedent's county of residence, not the county where the assault occurred. ** The number of deaths in some counties is too small to calculate reliable rates.

Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Homicide

Definition: Deaths where homicide is indicated as the underlying cause of death. Homicide is defined as death resulting from the intentional use of force or power, threatened or actual, against another person, group, or community. ICD-10 Codes: X85-Y09, Y87.1 (homicide)
Numerator: Number of resident deaths due to homicide
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Homicide (exits this report)

Date Content Last Updated

10/03/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov




Suicide: Deaths per 100,000 Population, 2018-2020

  • Burlington
    8.9
    95% Confidence Interval (7.3 - 10.5)
    State
    7.8
    U.S.
    13.9
  • Burlington Compared to State

    gauge ranking
    Description of Gauge

    Description of the Gauge

    This graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
    • Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
    • Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
    • Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
    • Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.

    The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."
    NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.

Why Is This Important?

Suicide was the 12th leading cause of death among Americans and 15th among New Jerseyans in 2020. The average annual suicide count among New Jersey residents is about 740 and there are about twice as many suicides as homicides in the state.

How Are We Doing?

Suicide increased in New Jersey between 2005 and 2017 before declining each year from 2018 through 2020. However, the Healthy New Jersey 2020 target was not achieved. The majority (57%) of suicides are White males and the age-adjusted death rate among this group is at least 1.8 times that of other racial/ethnic/sex groups. County rates per 100,000 population (age-adjusted) in 2018-2020 ranged from 5.6 in Passaic to 11.3 in Atlantic.

What Is Being Done?

In 2013, the [http://www.njhopeline.com/ NJ Hopeline Call Center] was launched to serve as a backup to the [https://suicidepreventionlifeline.org/ National Suicide Prevention Lifeline] network during times of excess call volume or after the Lifeline Crisis Centers' operating hours. The New Jersey [http://www.sprc.org/sites/default/files/New%20Jersey%202015-preventionplan.pdf Strategy for Youth Suicide Prevention 2015] was developed by community partners and the [https://www.nj.gov/dcf/providers/boards/njyspac/ New Jersey Youth Suicide Prevention Advisory Council] to guide the State's efforts to prevent youth suicides and the [http://www.sprc.org/sites/default/files/New%20Jersey%20Adult%20Suicide%20Prevention%20Plan%20Final%202014-17.pdf Adult Suicide Prevention Plan 2014-2017] from the NJ Division of Mental Health and Addiction Services contains strategies and actions in addition to crisis responses for the specific concerns related to adult suicide. The next Adult Suicide Prevention Plan 2018-2023 is nearly finalized, and features the [https://zerosuicide.sprc.org/ Zero Suicide Initiative]. The Governor's Study Commission on Violence [http://nj.gov/oag/newsreleases15/pr20151013a.html released a report] of recommendations to the Governor on ways to combat all types of violence from a public health perspective in October, 2015. The New Jersey Department of Health maintains the [http://www.nj.gov/health/chs/njvdrs/ New Jersey Violent Death Reporting System] (NJVDRS), a CDC-funded surveillance system that tracks suicides, homicides, unintentional firearm deaths, injury deaths of undetermined intent, and deaths by legal intervention and is used to educate public health and public safety professionals in the state and inform their interventions and decision-making, with the ultimate goal of reducing the incidence of violent deaths. NJVDRS is part of the [https://www.cdc.gov/violenceprevention/datasources/nvdrs/index.html National Violent Death Reporting System].

Healthy People Objective MHMD-1:

Reduce the suicide rate
U.S. Target: 10.2 suicides per 100,000 (age-adjusted)
State Target: 5.9 suicides per 100,000 (age-adjusted)

Related Indicators

Relevant Population Characteristics:

Risk Factors:


Data Sources

Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health   Population Estimates, [https://www.nj.gov/labor/lpa/dmograph/est/est_index.html State Data Center], New Jersey Department of Labor and Workforce Development  

Measure Description for Suicide

Definition: Deaths with suicide as the underlying cause. Suicide is defined as death resulting from the intentional use of force against oneself. ICD-10 codes: X60-X84, Y87.0
Numerator: Number of deaths due to suicide
Denominator: Total number of persons in the population

Indicator Profile Report

Age-Adjusted Death Rate due to Suicide (exits this report)

Date Content Last Updated

06/29/2022

For more information:

Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, Web: www.nj.gov/health/chs, e-mail: chs@doh.nj.gov

The information provided above is from the Department of Health's NJSHAD web site (https://nj.gov/health/shad). The information published on this website may be reproduced without permission. Please use the following citation: " Retrieved Thu, 28 March 2024 14:56:09 from Department of Health, New Jersey State Health Assessment Data Web site: https://nj.gov/health/shad ".

Content updated: no date